细胞株Cell Lines 96及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV96
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID WM3758
AC CVCL_AP79
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51328
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 14
ST D18S51: 14,15
ST D19S433: 14,15
ST D21S11: 28,29
ST D2S1338: 17,23
ST D3S1358: 14,17
ST D5S818: 13
ST D7S820: 9,10
ST D8S1179: 11,12
ST FGA: 22
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AP78 ! WM3682
OI CVCL_0B77 ! WM3702
SX Male
CA Cancer cell line
//
ID WM3772F
AC CVCL_0B81
SY WM3772
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51329
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Lung.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 13
ST D18S51: 13,14
ST D19S433: 13,14
ST D21S11: 28,31
ST D2S1338: 20,25
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 10,13
ST D8S1179: 10,15
ST FGA: 20
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0B74 ! WM3618F
SX Female
CA Cancer cell line
//
ID WM3792
AC CVCL_0B82
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51349
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D16S539: 11
ST D18S51: 10,14
ST D19S433: 14,15
ST D21S11: 30,31.2
ST D2S1338: 17,20
ST D3S1358: 18
ST D5S818: 13
ST D7S820: 11,12
ST D8S1179: 9,15
ST FGA: 19,20
ST TH01: 8
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM3854
AC CVCL_6801
SY WM-3854; WM 3854; WC00125
DR Coriell; WC00125
DR Cosmic; 2159435
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51885
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00125; probable.
CC Derived from metastatic site: Right lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,12
ST D16S539: 12
ST D18S51: 12,15
ST D19S433: 13,15
ST D21S11: 29,33.2
ST D2S1338: 17,25
ST D3S1358: 14,17
ST D5S818: 12,13
ST D7S820: 11,13
ST D8S1179: 11,16
ST FGA: 20,24
ST TH01: 7
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3862
AC CVCL_0B83
DR Cosmic; 2159429
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM39
AC CVCL_2240
SY WM-39; WM 39; WC00077
DR CLO; CLO_0009618
DR ATCC; CRL-2811
DR BioSample; SAMN03471795
DR Coriell; WC00077
DR Cosmic; 686399
DR Cosmic; 1155549
DR Cosmic; 1187580
DR Cosmic; 2159437
DR Cosmic; 2163807
DR ESTDAB; ESTDAB-080
DR GEO; GSM186486
DR GEO; GSM186487
DR GEO; GSM186488
DR GEO; GSM555171
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51871
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2811; true.
CC Discontinued: Coriell; WC00077; probable.
ST Source(s): ATCC; ESTDAB; Wistar
ST Amelogenin: X,Y (ATCC; ESTDAB)
ST Amelogenin: X (Wistar)
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 12
ST D18S51: 12,16
ST D19S433: 15,16
ST D21S11: 30
ST D2S1338: 17,19
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 14
ST D8S1179: 13,15
ST FGA: 20,22
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3912
AC CVCL_C278
SY WM-3912; WM 3912
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51357
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Neck.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 10,11
ST D18S51: 13,19
ST D19S433: 12
ST D21S11: 29,31
ST D2S1338: 17,19
ST D3S1358: 14,16
ST D5S818: 11
ST D7S820: 7,8
ST D8S1179: 13,14
ST FGA: 21
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3918
AC CVCL_C279
SY WM-3918; WM 3918
DR GEO; GSM952608
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51355
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 10,13
ST D18S51: 13
ST D19S433: 14,16
ST D21S11: 28,30
ST D2S1338: 19,24
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 12
ST D8S1179: 13,16
ST FGA: 21,24
ST TH01: 6
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM3928
AC CVCL_6802
SY WM-3928; WM 3928; WM3928F; WC00115
DR Coriell; WC00115
DR GEO; GSM952609
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51906
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00115; probable.
CC Derived from metastatic site: Left inguinal lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,9
ST D16S539: 10
ST D18S51: 14,19
ST D19S433: 12,17
ST D21S11: 28,30
ST D2S1338: 17,24
ST D3S1358: 14,15
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 10,13
ST FGA: 21
ST TH01: 7,8
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM4002
AC CVCL_L032
SY WM-4002; WM 4002; WM4002F; WM-4002F; WM 4002F
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51367
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 13
ST D18S51: 15,17
ST D19S433: 14,14.2
ST D21S11: 28,30
ST D2S1338: 17,20
ST D3S1358: 17
ST D5S818: 10,13
ST D7S820: 9
ST D8S1179: 11,13
ST FGA: 20,23
ST TH01: 8,9.3
ST TPOX: 11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM46
AC CVCL_6803
SY WM-46; WM 46; WC00069
DR Coriell; WC00069
DR Cosmic; 1155269
DR Cosmic; 1155552
DR Cosmic; 1187582
DR Cosmic; 1303076
DR GEO; GSM186489
DR GEO; GSM186490
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=51952
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00069; probable.
CC Derived from metastatic site: Skin.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,13
ST D16S539: 11,14
ST D19S433: 13,14
ST D21S11: 29,30
ST D2S1338: 17,18
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 13,14
ST FGA: 22,23,28
ST TH01: 6
ST TPOX: 11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WM47
AC CVCL_C280
SY WM-47; WM 47
DR GEO; GSM186491
DR GEO; GSM186492
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51398
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10,12
ST D16S539: 8,12
ST D21S11: 28,29
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM51
AC CVCL_6995
SY WM-51; WM 51; WC00122
DR Coriell; WC00122
DR Cosmic; 1155276
DR Cosmic; 1155562
DR Cosmic; 1303077
DR GEO; GSM186493
DR GEO; GSM186494
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51551
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00122; probable.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 9,14
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 19
ST D19S433: 15,16
ST D21S11: 30
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 11,13
ST FGA: 22,23,24
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,18,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM740V
AC CVCL_L030
SY WM-740V; WM 740V; WML-740V
RX PubMed=3856042;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C283 ! WM858
OI CVCL_C284 ! WM873-1
OI CVCL_C285 ! WM873-2
OI CVCL_C286 ! WM873-3
SX Female
CA Cancer cell line
//
ID WM75
AC CVCL_7156
SY WM-75; WM 75; WM75C
DR BTO; BTO:0003711
DR Cosmic; 686400
DR Cosmic; 972272
DR Cosmic; 1155551
DR Cosmic; 2163809
DR ESTDAB; ESTDAB-082
DR GEO; GSM185200
DR GEO; GSM185201
DR GEO; GSM186495
DR GEO; GSM186496
RX PubMed=2068080;
RX PubMed=3856042;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51434
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
ST Source(s): ESTDAB; Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,13
ST D21S11: 28,29
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 8,9
ST FGA: 19,20
ST TH01: 6
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C277 ! WM373
SX Male
CA Cancer cell line
//
ID WM793
AC CVCL_8787
AS CVCL_5414
SY WM-793; WM 793; WM793B; WM-793B; WM 793B; WM793b; WC00062
DR BTO; BTO:0004612
DR CLO; CLO_0009619
DR EFO; EFO_0002873
DR ATCC; CRL-2806
DR BioSample; SAMN03471791
DR Coriell; WC00062
DR CCLE; WM793_SKIN
DR Cosmic; 686397
DR Cosmic; 886836
DR Cosmic; 928693
DR Cosmic; 972274
DR Cosmic; 1155266
DR Cosmic; 1155545
DR Cosmic; 1155567
DR Cosmic; 1238114
DR Cosmic; 1303078
DR Cosmic; 2159433
DR Cosmic; 2163810
DR Cosmic-CLP; 1299081
DR ESTDAB; ESTDAB-083
DR GDSC; 1299081
DR GEO; GSM185202
DR GEO; GSM185203
DR GEO; GSM185204
DR GEO; GSM185205
DR GEO; GSM188235
DR GEO; GSM188265
DR GEO; GSM188324
DR GEO; GSM887738
DR GEO; GSM888833
DR GEO; GSM952587
DR GEO; GSM1670581
DR PRIDE; PXD004343
RX PubMed=2068080;
RX PubMed=8342600;
RX PubMed=18632627;
RX PubMed=22460905;
RX PubMed=27087056;
RX PubMed=27397505;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-2806; true.
CC Discontinued: Coriell; WC00062; probable.
ST Source(s): ATCC; Cosmic-CLP; ESTDAB; PubMed=27087056; Wistar
ST Amelogenin: X,Y (ATCC; Cosmic-CLP; ESTDAB; PubMed=27087056)
ST Amelogenin: X (Wistar)
ST CSF1PO: 11
ST D13S317: 8,14
ST D16S539: 12
ST D18S51: 11,14
ST D19S433: 13,15
ST D21S11: 28,29
ST D2S1338: 17,24
ST D3S1358: 14,16
ST D5S818: 10,12
ST D7S820: 10,12 (ATCC; Cosmic-CLP; PubMed=27087056; Wistar)
ST D7S820: 10 (ESTDAB)
ST D8S1179: 12,14
ST FGA: 20,21
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM793-P1N1
AC CVCL_A800
SY 793-P1-N1
DR EFO; EFO_0002874
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8787 ! WM793
SX Male
CA Cancer cell line
//
ID WM793-P1N2
AC CVCL_A801
SY 793-P1-N2
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8787 ! WM793
SX Male
CA Cancer cell line
//
ID WM793-P1N3
AC CVCL_A802
SY 793-P1-N3
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8787 ! WM793
SX Male
CA Cancer cell line
//
ID WM793-P2N1
AC CVCL_A803
SY 793-P2-N1
DR EFO; EFO_0002875
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8787 ! WM793
SX Male
CA Cancer cell line
//
ID WM793-P2N2
AC CVCL_A804
SY 793-P2-N2
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8787 ! WM793
SX Male
CA Cancer cell line
//
ID WM793-P2N3
AC CVCL_A805
SY 793-P2-N3
RX PubMed=8160777;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8787 ! WM793
SX Male
CA Cancer cell line
//
ID WM8
AC CVCL_C281
SY WM-8; WM 8
DR Cosmic; 928683
DR Cosmic; 1155543
DR GEO; GSM185206
DR GEO; GSM185207
DR GEO; GSM952610
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51426
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 19,20
ST D19S433: 12.2,15
ST D21S11: 30
ST D2S1338: 17,23
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 9,13
ST D8S1179: 11,12,14
ST FGA: 22
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID WM852
AC CVCL_6804
SY WM-852; WM 852; WC00065; EST84
DR Coriell; WC00065
DR Cosmic; 886832
DR Cosmic; 972282
DR Cosmic; 1047657
DR Cosmic; 1155275
DR Cosmic; 1303079
DR Cosmic; 2163811
DR Cosmic; 2479249
DR ESTDAB; ESTDAB-084
DR GEO; GSM156017
DR GEO; GSM952601
RX PubMed=8342600;
RX PubMed=17260012;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=51888
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Misspelling: 'VM852' in Cosmic 2479249.
CC Discontinued: Coriell; WC00065; probable.
CC Derived from metastatic site: Skin.
ST Source(s): ESTDAB; Wistar
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 13,14
ST D18S51: 18
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 16,17
ST D3S1358: 15,18
ST D5S818: 13 (ESTDAB)
ST D5S818: 12,13 (Wistar)
ST D7S820: 8,10
ST D8S1179: 12,13
ST FGA: 21,26 (ESTDAB)
ST FGA: 21 (Wistar)
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,17 (ESTDAB)
ST vWA: 14,15 (Wistar)
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM853-2
AC CVCL_C282
SY WM-853-2; WM 853-2
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51465
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 10,13
ST D18S51: 14
ST D19S433: 14,15
ST D21S11: 29,30
ST D2S1338: 17,24
ST D3S1358: 16,17
ST D5S818: 11,13
ST D7S820: 10,12
ST D8S1179: 11
ST FGA: 22
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM858
AC CVCL_C283
SY WM-858; WM 858; Wm858; WML-858
DR Cosmic; 1155558
DR GEO; GSM186497
DR GEO; GSM186498
DR GEO; GSM952588
RX PubMed=3856042;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51478
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 8,12
ST D21S11: 29,32.2
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L030 ! WM740V
OI CVCL_C284 ! WM873-1
OI CVCL_C285 ! WM873-2
OI CVCL_C286 ! WM873-3
SX Female
CA Cancer cell line
//
ID WM873-1
AC CVCL_C284
SY WM-873-1; WM 873-1; WML-873-1
RX PubMed=3856042;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51462
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 8,12
ST D18S51: 14
ST D19S433: 13,15
ST D21S11: 29,32.2
ST D2S1338: 22,23
ST D3S1358: 17
ST D5S818: 10,12
ST D7S820: 9,10
ST D8S1179: 12,13
ST FGA: 20,23
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L030 ! WM740V
OI CVCL_C283 ! WM858
OI CVCL_C285 ! WM873-2
OI CVCL_C286 ! WM873-3
SX Female
CA Cancer cell line
//
ID WM873-2
AC CVCL_C285
SY WM-873-2; WM 873-2; WML-873-2
RX PubMed=3856042;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51505
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Right axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 8
ST D18S51: 14
ST D19S433: 13,15
ST D21S11: 29,32.2
ST D2S1338: 22,23
ST D3S1358: 17
ST D5S818: 10,12
ST D7S820: 9,10
ST D8S1179: 12,13
ST FGA: 20,23
ST TH01: 6,8
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L030 ! WM740V
OI CVCL_C283 ! WM858
OI CVCL_C284 ! WM873-1
OI CVCL_C286 ! WM873-3
SX Female
CA Cancer cell line
//
ID WM873-3
AC CVCL_C286
SY WM-873-3; WM 873-3; WML-873-3
RX PubMed=3856042;
CC Part of: Wistar Institute melanoma cell line collection.
CC Derived from metastatic site: Right axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L030 ! WM740V
OI CVCL_C283 ! WM858
OI CVCL_C284 ! WM873-1
OI CVCL_C285 ! WM873-2
SX Female
CA Cancer cell line
//
ID WM88
AC CVCL_6805
SY WM-88; WM 88; WC00123
DR CCLE; WM88_SKIN
DR Coriell; WC00123
DR Cosmic; 1155563
DR Cosmic; 1303080
DR Cosmic; 1669265
DR GEO; GSM188065
DR GEO; GSM188117
DR GEO; GSM188190
DR GEO; GSM188205
DR GEO; GSM188212
DR GEO; GSM188236
DR GEO; GSM188266
DR GEO; GSM188281
DR GEO; GSM188290
DR GEO; GSM188325
DR GEO; GSM887739
DR GEO; GSM888834
DR GEO; GSM952589
DR SKY/M-FISH/CGH; 4948
RX PubMed=18632627;
RX PubMed=22460905;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51919
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00123; probable.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 10,13
ST D16S539: 11,13
ST D18S51: 15,19
ST D19S433: 12,13
ST D21S11: 29,30
ST D2S1338: 19
ST D3S1358: 15
ST D5S818: 12,13
ST D7S820: 8,10
ST D8S1179: 13,15
ST FGA: 20,21
ST TH01: 9.3
ST TPOX: 12
ST vWA: 18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM9
AC CVCL_6806
SY WM-9; WM 9; WC00056
DR BTO; BTO:0003438
DR Coriell; WC00056
DR Cosmic; 686408
DR GEO; GSM186499
DR GEO; GSM186500
DR GEO; GSM952590
RX PubMed=2068080;
RX PubMed=3020539;
RX PubMed=8342600;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi
WW http://www.rockland-inc.com/Product.aspx?id=51939
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00056; probable.
CC Derived from metastatic site: Left axillary lymph node.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 11,14
ST D18S51: 13
ST D19S433: 12,15
ST D21S11: 29
ST D2S1338: 24,25
ST D3S1358: 14,17
ST D5S818: 9,11
ST D7S820: 9,11
ST D8S1179: 12,13
ST FGA: 20,25
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM902B
AC CVCL_6807
SY WM-902B; WM 902B; WM 902 B; WC00083
DR BTO; BTO:0005780
DR Coriell; WC00083
DR Cosmic; 686398
DR Cosmic; 972273
DR Cosmic; 1155282
DR Cosmic; 1155553
DR Cosmic; 1187581
DR Cosmic; 2163812
DR ESTDAB; ESTDAB-085
DR GDSC; 1240227
DR GEO; GSM186501
DR GEO; GSM186502
DR GEO; GSM952591
RX PubMed=2068080;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51955
CC Part of: Wistar Institute melanoma cell line collection.
CC Discontinued: Coriell; WC00083; probable.
CC Discontinued: ESTDAB; ESTDAB-085; probable.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,13
ST D19S433: 12,13
ST D21S11: 28,30
ST D2S1338: 17,24
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 12,14
ST FGA: 19
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM98-1
AC CVCL_L073
SY WM-98-1; WM 98-1
DR BTO; BTO:0003712
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
CC Part of: Wistar Institute melanoma cell line collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WM983A
AC CVCL_6808
SY WM-983A; WM 983A; WM983-A; WC00048
DR Coriell; WC00048
DR Cosmic; 686405
DR Cosmic; 928685
DR Cosmic; 1155272
DR Cosmic; 1155565
DR Cosmic; 1155569
DR Cosmic; 1303081
DR GEO; GSM185208
DR GEO; GSM185209
DR GEO; GSM186503
DR GEO; GSM186504
RX PubMed=2068080;
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp
WW http://www.rockland-inc.com/Product.aspx?id=51987
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00048; probable.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 11,12
ST D21S11: 29,32.2
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6809 ! WM983B
OI CVCL_A338 ! WM983C
SX Male
CA Cancer cell line
//
ID WM983B
AC CVCL_6809
SY WM-983B; WM 983B; WM983-B; WM-983/B; WC00066
DR BTO; BTO:0005042
DR CCLE; WM983B_SKIN
DR Coriell; WC00066
DR Cosmic; 686406
DR Cosmic; 1155557
DR Cosmic; 1303082
DR GEO; GSM887740
DR GEO; GSM888835
DR GEO; GSM952592
RX PubMed=2068080;
RX PubMed=18632627;
RX PubMed=22460905;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51973
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: Coriell; WC00066; probable.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 10,14
ST D21S11: 29,31.2
ST D2S1338: 25,27
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 8,13
ST FGA: 20,23
ST TH01: 6
ST TPOX: 11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6808 ! WM983A
OI CVCL_A338 ! WM983C
SX Male
CA Cancer cell line
//
ID WM983B-BR
AC CVCL_AP81
SY WM983B BR; WM983BBR; WM983B-R
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=52006
CC Part of: Wistar Institute melanoma cell line collection.
CC Selected for resistance to: ChEBI; CHEBI:131882; SB-590885.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6809 ! WM983B
SX Male
CA Cancer cell line
//
ID WM983C
AC CVCL_A338
SY WM-983C; WM 983C
DR Cosmic; 1155556
DR Cosmic; 1187585
DR Cosmic; 1303083
DR GEO; GSM188069
DR GEO; GSM188121
DR GEO; GSM188194
DR GEO; GSM188209
DR GEO; GSM188214
DR GEO; GSM188237
DR GEO; GSM188267
DR GEO; GSM188285
DR GEO; GSM188294
DR GEO; GSM188326
DR SKY/M-FISH/CGH; 4949
RX PubMed=18632627;
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51519
CC Part of: Wistar Institute melanoma cell line collection.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Wistar
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 11
ST D18S51: 14
ST D19S433: 10,14
ST D21S11: 29,31.2
ST D2S1338: 25,27
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 8,13
ST FGA: 20,23
ST TH01: 6
ST TPOX: 11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6808 ! WM983A
OI CVCL_6809 ! WM983B
SX Male
CA Cancer cell line
//
ID WM989
AC CVCL_0B84
WW http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
WW http://www.rockland-inc.com/Product.aspx?id=51531
CC Part of: Wistar Institute melanoma cell line collection.
ST Source(s): Wistar
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 13
ST D18S51: 10,13
ST D19S433: 13
ST D21S11: 28
ST D2S1338: 18,19
ST D3S1358: 18
ST D5S818: 12,15
ST D7S820: 9,10
ST D8S1179: 13,14
ST FGA: 20
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14,15
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WMM1175
AC CVCL_W753
SY WMM 1175
DR Cosmic; 1102380
RX PubMed=10338330;
RX PubMed=11595726;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WMM1215
AC CVCL_W754
DR Cosmic; 929201
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WMP-1
AC CVCL_C853
SY WMP1
RX PubMed=7606923;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: WMP/PasDnJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID WMP-2
AC CVCL_2241
SY WMP2
DR CLO; CLO_0009620
DR DSMZ; ACC-453
RX PubMed=7606923;
RX PubMed=11124532;
RX PubMed=16391817;
CC Doubling time: ~30-40 hours (DSMZ).
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: WMP/PasDnJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID WMPa
AC CVCL_T689
SY WMPA; Wisconsin-Minnesota Pronephros, strain A
RX PubMed=1087310;
RX PubMed=1429360;
RX PubMed=4545299;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8404; ! Lithobates pipiens
CA Spontaneously immortalized cell line
//
ID WN-R
AC CVCL_0I64
DR CCLV; CCLV-RIE 0755
RX PubMed=19941903;
OX NCBI_TaxID=9902; ! Bison bonasus
CA Finite cell line
//
ID Wo Fel
AC CVCL_3431
DR CLO; CLO_0009621
DR ATCC; CRL-1273
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Wo Jo
AC CVCL_3432
DR CLO; CLO_0009622
DR ATCC; CRL-1247
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Wo Mec
AC CVCL_U668
SY WoMec; XP4BE
DR ATCC; CRL-1162
RX PubMed=225015;
CC Discontinued: ATCC; CRL-1162; true.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WO-E
AC CVCL_0C30
RX PubMed=7736387;
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WOL-1
AC CVCL_F848
RX PubMed=10393935;
CC Characteristics: IL7 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID WON,C
AC CVCL_E878
SY WON, C
DR dbMHC; 49068
DR ECACC; 94082295
DR IHW; IHW9195
DR IMGT/HLA; 11736
WW http://bioinformatics.hsanmartino.it/ecbr/cl195.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WON,I
AC CVCL_E879
SY WON, I; TER238; TER412
DR dbMHC; 49069
DR ECACC; 94082294
DR IHW; IHW9194
DR IMGT/HLA; 11735
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl194.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WON,M
AC CVCL_E880
SY WON, M
DR dbMHC; 49070
DR ECACC; 94082293
DR IHW; IHW9193
DR IMGT/HLA; 11569
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl193.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WON,PY
AC CVCL_E881
SY WON, PY
DR dbMHC; 49071
DR ECACC; 94082256
DR IHW; IHW9156
DR IMGT/HLA; 11699
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl156.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WOO,EM
AC CVCL_E882
SY WOO, EM
DR dbMHC; 49072
DR ECACC; 94082221
DR IHW; IHW9122
DR IMGT/HLA; 11666
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl122.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WOP
AC CVCL_3433
DR CLO; CLO_0009623
DR CLDB; cl4970
DR ICLC; ATL99011
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID WP
AC CVCL_F820
SY TER225
DR IMGT/HLA; 11819
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WPE-int
AC CVCL_K282
DR BTO; BTO:0006000
DR ATCC; CRL-2888
DR BioSample; SAMN03471697
RX PubMed=16351690;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Misspelling: 'WPE1-7-1' in BioSample SAMN03471697.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3791 ! RWPE-1
SX Male
CA Transformed cell line
//
ID WPE-stem
AC CVCL_K283
DR ATCC; CRL-2887
DR BioSample; SAMN03471813
RX PubMed=16351690;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3791 ! RWPE-1
SX Male
CA Transformed cell line
//
ID WPE1-NA22
AC CVCL_3810
DR CLO; CLO_0009624
DR ATCC; CRL-2849
DR BioSample; SAMN03471802
DR GEO; GSM827392
RX PubMed=11304724;
WW http://capcelllines.ca/details.asp?id=116
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3791 ! RWPE-1
SX Male
CA Transformed cell line
//
ID WPE1-NB11
AC CVCL_3811
DR CLO; CLO_0009625
DR ATCC; CRL-2851
DR GEO; GSM827394
RX PubMed=11304724;
WW http://capcelllines.ca/details.asp?id=127
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3791 ! RWPE-1
SX Male
CA Transformed cell line
//
ID WPE1-NB14
AC CVCL_3812
SY WPE-1/NB14
DR CLO; CLO_0009626
DR ATCC; CRL-2850
DR GEO; GSM827570
RX PubMed=11304724;
WW http://capcelllines.ca/details.asp?id=126
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3791 ! RWPE-1
SX Male
CA Transformed cell line
//
ID WPE1-NB26
AC CVCL_3813
DR CLO; CLO_0009627
DR ATCC; CRL-2852
DR GEO; GSM648825
DR GEO; GSM827395
RX PubMed=11304724;
RX PubMed=16471037;
WW http://capcelllines.ca/details.asp?id=125
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3791 ! RWPE-1
SX Male
CA Transformed cell line
//
ID WPE1-NB26-64
AC CVCL_K284
DR ATCC; CRL-2889
RX PubMed=16471037;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3813 ! WPE1-NB26
SX Male
CA Transformed cell line
//
ID WPE1-NB26-65
AC CVCL_K285
DR ATCC; CRL-2890
RX PubMed=16471037;
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,14
ST D16S539: 9,11
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3813 ! WPE1-NB26
SX Male
CA Transformed cell line
//
ID WPF22
AC CVCL_W044
RX PubMed=24556363;
CC Doubling time: 30.2 hours (PubMed=24556363).
CC Breed/subspecies: Wuzhishan miniature pig.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Finite cell line
//
ID WPMY-1
AC CVCL_3814
SY WPMY1
DR BTO; BTO:0003708
DR CLO; CLO_0009628
DR ATCC; CRL-2854
DR BioSample; SAMN03471803
RX PubMed=10383888;
WW http://capcelllines.ca/details.asp?id=154
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 13
ST D13S317: 8,14
ST D16S539: 9
ST D5S818: 12,15
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3791 ! RWPE-1
SX Male
CA Transformed cell line
//
ID WR Di-1
AC CVCL_Z814
SY WR-72-Di-1
DR DGRC; 207
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7250; ! Drosophila immigrans
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WR Dv-1
AC CVCL_Z815
SY WR-75-Dv-1
DR DGRC; 40
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7244; ! Drosophila virilis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WR002
AC CVCL_W060
SY WR2
RX PubMed=2502918;
RX PubMed=3343350;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR004
AC CVCL_W061
SY WR4
RX PubMed=2502918;
RX PubMed=3343350;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR005
AC CVCL_W062
SY WR5
RX PubMed=3343350;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR010
AC CVCL_W063
SY WR10
RX PubMed=3343350;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR011
AC CVCL_W064
SY WR11
RX PubMed=2502918;
RX PubMed=3343350;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR012
AC CVCL_W065
SY WR12
RX PubMed=2502918;
RX PubMed=3343350;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR015
AC CVCL_W066
SY WR15
RX PubMed=2502918;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR016
AC CVCL_W067
SY WR16
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR017
AC CVCL_W068
SY WR17
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR020
AC CVCL_W069
SY WR20
RX PubMed=3343350;
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR035
AC CVCL_W070
SY WR35
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR036
AC CVCL_W071
SY WR36
RX PubMed=3488062;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR063
AC CVCL_W072
SY WR63
RX PubMed=3343350;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR064
AC CVCL_W073
SY WR64
RX PubMed=3343350;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR067
AC CVCL_W074
SY WR67
RX PubMed=2502918;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR077
AC CVCL_W075
SY WR77
RX PubMed=2502918;
RX PubMed=3343350;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR081
AC CVCL_W076
SY WR81
RX PubMed=2502918;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR083
AC CVCL_W077
SY WR83
RX PubMed=2502918;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WR19L
AC CVCL_4338
SY WR 19L; WR 19L.1
DR CLO; CLO_0009629
DR ATCC; TIB-52
DR ECACC; 95050414
RX PubMed=212198;
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5415 ! WR19M.1
SX Female
CA Cancer cell line
//
ID WR19M.1
AC CVCL_5415
SY WR 19M.1; WR 19M
DR CLO; CLO_0009630
DR ATCC; TIB-70
RX PubMed=212198;
RX PubMed=3792703;
CC Breed/subspecies: BALB/c.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_4338 ! WR19L
SX Female
CA Cancer cell line
//
ID WR21
AC CVCL_3623
DR CLO; CLO_0009631
DR ATCC; CRL-2189
RX PubMed=7803707;
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID WR216
AC CVCL_5606
DR CLO; CLO_0050975
DR BioSample; SAMN03472279
DR RCB; RCB0520
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 10,13
ST D7S820: 8,12
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 14
DI NCIt; C121564; Adenine phosphoribosyltransferase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WRC
AC CVCL_4339
DR CLO; CLO_0009632
DR CLDB; cl4729
DR ECACC; 88031148
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3537 ! LLC-WRC 256
SX Female
CA Cancer cell line
//
ID WRL 68
AC CVCL_0581
AS CVCL_D685
SY WRL-68; WRL68
DR BTO; BTO:0002584
DR BTO; BTO:0005288
DR CLO; CLO_0009633
DR MCCL; MCC:0000487
DR CLDB; cl4730
DR ATCC; CL-48
DR BioSample; SAMN03151767
DR ChEMBL-Cells; CHEMBL3307993
DR ChEMBL-Targets; CHEMBL612587
DR ECACC; 89121403
DR IZSLER; BS CL 173
RX Patent=US3935066;
RX PubMed=7522099;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a hepatic fetal epithelial cell line.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Misspelling: Occasionally 'CL-48' (based on the ATCC catalog number).
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 12,13.3 (ATCC)
ST D13S317: 12,14 (ECACC)
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8,12
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID WRLS1
AC CVCL_4W86
RX PubMed=23111106;
CC Problematic cell line: Contaminated. Parent cell line (WRL-68) has been shown to be a HeLa derivative.
CC Selected for resistance to: ChEBI; CHEBI:50924; Sorafenib (Nexavar).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0581 ! WRL 68
SX Female
CA Cancer cell line
//
ID WRO
AC CVCL_0582
AS CVCL_1663
SY WRO82-1; WRO 82-1; WRO-82; WRO82; UCLA RO 82-W-1; UCLA RO-82W-1; UCLA RO82W1; RO 82 W-1; RO82-W-1; RO82W-1; RO82
DR BTO; BTO:0004772
DR CLO; CLO_0008860
DR MCCL; MCC:0000488
DR CLDB; cl4167
DR CLDB; cl4902
DR ChEMBL-Cells; CHEMBL3308779
DR ChEMBL-Targets; CHEMBL1075565
DR Cosmic; 684194
DR Cosmic; 685606
DR Cosmic; 849971
DR Cosmic; 886554
DR Cosmic; 918181
DR Cosmic; 928830
DR Cosmic; 930083
DR Cosmic; 931244
DR Cosmic; 990535
DR Cosmic; 1005459
DR Cosmic; 1094762
DR Cosmic; 1152113
DR Cosmic; 1155332
DR Cosmic; 1161614
DR Cosmic; 1162842
DR Cosmic; 1280051
DR Cosmic; 1699415
DR Cosmic; 2319849
DR Cosmic-CLP; 930083
DR ECACC; 92030502
DR GDSC; 930083
DR GEO; GSM827437
DR GEO; GSM1670384
DR Lonza; 1209
DR ICLC; HTL98002
DR TOKU-E; 4066
RX PubMed=2570483;
RX PubMed=17804723;
RX PubMed=18713817;
RX PubMed=23162534;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ICLC
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 12 (Cosmic-CLP)
ST D16S539: 11,12 (ICLC)
ST D21S11: 29
ST D5S818: 12
ST D7S820: 8,12
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,19 (Cosmic-CLP)
ST vWA: 16,21 (ICLC)
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ws-HMG
AC CVCL_U700
DR ATCC; CRL-1253
CC Discontinued: ATCC; CRL-1253; true.
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WS1
AC CVCL_2766
DR CLO; CLO_0009634
DR CLDB; cl4732
DR ATCC; CRL-1502
DR BioSample; SAMN03471371
DR BCRC; 60300
DR ECACC; 88021104
DR CLS; 300344/NA
RX PubMed=721103;
CC Discontinued: CLS; 300344; true.
ST Source(s): ATCC; ECACC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 13
ST D7S820: 9,10
ST TH01: 8,10
ST TPOX: 8,9
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WS1-CLS
AC CVCL_6211
DR CLS; 300378/p621_WS1-CLS
ST Source(s): CLS
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 12,17
ST D21S11: 29,31.2
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 20,23
ST Penta D: 9,13
ST Penta E: 12,20
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C5585; Skin sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WS1TKB
AC CVCL_J710
DR CLO; CLO_0050654
DR BioSample; SAMN03472305
DR RCB; RCB0409
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 9,10
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J711 ! WS1TKB2
SX Male
CA Finite cell line
//
ID WS1TKB2
AC CVCL_J711
DR CLO; CLO_0050655
DR RCB; RCB0433
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 9,10
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J710 ! WS1TKB
SX Male
CA Finite cell line
//
ID WS2RGB
AC CVCL_T329
DR CLO; CLO_0050696
DR BioSample; SAMN03472337
DR RCB; GMC0006
DR RCB; RCB0154
CC Discontinued: RCB; RCB0154; true.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID WS2TKB
AC CVCL_J712
DR CLO; CLO_0050653
DR BioSample; SAMN03472304
DR RCB; RCB0407
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WS3RGB
AC CVCL_T330
DR CLO; CLO_0050699
DR BioSample; SAMN03472338
DR RCB; GMC0007
DR RCB; RCB0155
CC Discontinued: RCB; RCB0155; true.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 7
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WS6RGB
AC CVCL_T331
DR CLO; CLO_0050694
DR BioSample; SAMN03472353
DR RCB; GMC0009
DR RCB; RCB0387
CC Discontinued: RCB; RCB0387; true.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10
ST D16S539: 9,10
ST D5S818: 7,10
ST D7S820: 8
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID WSB
AC CVCL_J514
SY Mel-WSB
DR Cosmic; 889041
DR Cosmic; 928704
DR Cosmic; 1211151
DR GEO; GSM170983
RX PubMed=8980186;
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17516929;
RX PubMed=23039341;
WW http://biogps.org/dataset/1409/63-melanoma-cell-lines/
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSBM
AC CVCL_R928
SY White Sturgeon Body Muscle
RX PubMed=15801167;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSCU01 iPS#02
AC CVCL_IN40
SY WSCU01-derived iPSC clone 02
RX PubMed=25390333;
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN41 ! WSCU01 iPS#13
OI CVCL_IN42 ! WSCU01 iPS#14
SX Male
CA Induced pluripotent stem cell
//
ID WSCU01 iPS#13
AC CVCL_IN41
SY WSCU01-derived iPSC clone 13
RX PubMed=25390333;
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN40 ! WSCU01 iPS#02
OI CVCL_IN42 ! WSCU01 iPS#14
SX Male
CA Induced pluripotent stem cell
//
ID WSCU01 iPS#14
AC CVCL_IN42
SY WSCU01-derived iPSC clone 14
RX PubMed=25390333;
DI NCIt; C3447; Werner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IN40 ! WSCU01 iPS#02
OI CVCL_IN41 ! WSCU01 iPS#13
SX Male
CA Induced pluripotent stem cell
//
ID WSF
AC CVCL_R929
SY White Sturgeon Fin
RX PubMed=15801167;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSG-R
AC CVCL_0I77
DR CCLV; CCLV-RIE 0378
CC Breed/subspecies: Wild boar.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID WSGO
AC CVCL_R930
SY White Sturgeon Gonad
RX PubMed=9676244;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
OI CVCL_R932 ! WSHO
OI CVCL_R934 ! WSLV
OI CVCL_R935 ! WSNV
OI CVCL_R936 ! WSSB
SX Male
CA Spontaneously immortalized cell line
//
ID WSH-1
AC CVCL_R931
SY White Sturgeon Heart-1
RX DOI=10.1577/1548-8659(1991)120<0528:TCLFWS>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
OI CVCL_R937 ! WSS-2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSHO
AC CVCL_R932
SY White Sturgeon Hematopoeitic Organ
RX PubMed=9676244;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
OI CVCL_R930 ! WSGO
OI CVCL_R934 ! WSLV
OI CVCL_R935 ! WSNV
OI CVCL_R936 ! WSSB
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSHST
AC CVCL_R933
SY White Sturgeon Head Soft Tissue
RX PubMed=15801167;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSL-R
AC CVCL_0I66
DR CCLV; CCLV-RIE 0379
RX PubMed=19941903;
CC Breed/subspecies: Wild boar.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID WSLV
AC CVCL_R934
SY White Sturgeon LiVer
RX PubMed=9676244;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
OI CVCL_R930 ! WSGO
OI CVCL_R932 ! WSHO
OI CVCL_R935 ! WSNV
OI CVCL_R936 ! WSSB
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSN
AC CVCL_9881
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7579408;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WSNV
AC CVCL_R935
RX PubMed=9676244;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
OI CVCL_R930 ! WSGO
OI CVCL_R932 ! WSHO
OI CVCL_R934 ! WSLV
OI CVCL_R936 ! WSSB
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSS-1
AC CVCL_2767
SY WS-1
DR BTO; BTO:0004920
DR CLO; CLO_0009635
DR ATCC; CRL-2029
DR BioSample; SAMN03471421
RX PubMed=1336119;
CC Transfected with: RGD; 61855; Gabra1.
CC Transfected with: RGD; 61966; Gabrg2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID WSS-2
AC CVCL_R937
SY White Sturgeon Spleen-2
RX DOI=10.1577/1548-8659(1991)120<0528:TCLFWS>2.3.CO;2;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
OI CVCL_R931 ! WSH-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSSB
AC CVCL_R936
SY White Sturgeon Swim Bladder
RX PubMed=9676244;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
OI CVCL_R930 ! WSGO
OI CVCL_R932 ! WSHO
OI CVCL_R934 ! WSLV
OI CVCL_R935 ! WSNV
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSSK-1
AC CVCL_S954
SY WSSK; White Sturgeon SKin-1
RX DOI=10.3354/dao011049;
CC Group: Fish cell line.
OX NCBI_TaxID=7904; ! Acipenser transmontanus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WSU-1
AC CVCL_HG33
SY WSU1
DR GEO; GSM1985
RX PubMed=10676951;
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-ALCL
AC CVCL_A036
DR BioSample; SAMN03151623
DR Cosmic; 1086369
RX CelloPub=CLPUB00128;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0207 ! CCRF-CEM
SX Female
CA Cancer cell line
//
ID WSU-AML
AC CVCL_5607
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
DI NCIt; C3171; Acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-BL
AC CVCL_M552
RX DOI=10.1111/j.1749-6632.1989.tb16491.x;
RX PubMed=2527086;
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
CC Characteristics: EBV-negative.
CC Doubling time: 19 hours (PubMed=2527086).
DI NCIt; C7954; Adult Burkitt leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WSU-CLL
AC CVCL_A049
DR BioSample; SAMN03151907
RX PubMed=8558918;
RX PubMed=12200708;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12200708, PubMed=12592342, PubMed=20143388). Was originally thought to originate from a male patient chronic lymphocytic leukemia.
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1650 ! Reh
SX Female
CA Cancer cell line
//
ID WSU-DLCL
AC CVCL_M580
DR Cosmic; 1086347
DR DSMZ; ACC-779
RX PubMed=1540884;
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
CC Doubling time: 20 hours (PubMed=1540884); ~48-72 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 8,9.3
ST TPOX: 9
ST vWA: 16,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WSU-DLCL2
AC CVCL_1902
SY WSU-DLCL(2); WSUDLCL2
DR EFO; EFO_0006775
DR ATCC; CRL-11585
DR BioSample; SAMN03473225
DR CCLE; WSUDLCL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1329090
DR Cosmic; 1629937
DR Cosmic; 1714159
DR Cosmic-CLP; 1331050
DR DSMZ; ACC-575
DR GDSC; 1331050
DR GEO; GSM887741
DR GEO; GSM888836
DR GEO; GSM1670582
RX PubMed=9607591;
RX PubMed=19358282;
RX PubMed=22460905;
RX PubMed=23699601;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 18 hours (PubMed=9607591); ~50-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Misspelling: 'WSU-DCL2' in GEO GSM1374991.
CC Discontinued: ATCC; CRL-11585; probable.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11,14
ST D16S539: 10,13
ST D18S51: 15,16
ST D21S11: 29,32.2
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 10,13
ST Penta E: 14,19
ST TH01: 8,9
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WSU-FSCCL
AC CVCL_1903
SY WSUFSCCL
DR EFO; EFO_0006776
DR BioSample; SAMN03472504
DR DSMZ; ACC-612
RX PubMed=8221615;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~26 hours (PubMed=8221615); ~20-30 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 11,13
ST D18S51: 13,14
ST D21S11: 30
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 10,13
ST D8S1179: 12,14
ST FGA: 22,24
ST Penta D: 9,13
ST Penta E: 7,12
ST TH01: 9.3
ST TPOX: 11
ST vWA: 18,20
DI NCIt; C27810; Malignant non-Hodgkin's lymphoma, cleaved cell
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WSU-HN11
AC CVCL_AX28
RX PubMed=7705939;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-HN12
AC CVCL_5518
SY HN12; HN-12
DR BTO; BTO:0005040
DR Cosmic; 922079
DR Cosmic; 2043897
DR Cosmic; 2296297
DR Cosmic; 2513908
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9049184;
RX PubMed=9389571;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=25275298
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 9
ST D18S51: 14
ST D21S11: 32,33.2
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13
ST FGA: 20,26
ST Penta D: 9,10
ST Penta E: 7
ST TH01: 7,9
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5515 ! WSU-HN4
SX Female
CA Cancer cell line
//
ID WSU-HN13
AC CVCL_5519
SY HN13
DR Cosmic; 922088
DR Cosmic; 2296298
DR Cosmic; 2513909
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9049184;
RX PubMed=9389571;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=25275298
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 12
ST D18S51: 14,15
ST D21S11: 31.2
ST D3S1358: 14,16
ST D5S818: 12
ST D7S820: 9,10
ST D8S1179: 13,15
ST FGA: 21,26
ST Penta D: 9,11
ST Penta E: 12,14
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WSU-HN14
AC CVCL_AX29
RX PubMed=7705939;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-HN17
AC CVCL_5520
SY HN17
DR Cosmic; 922089
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9049184;
RX PubMed=9389571;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AX30 ! WSU-HN18
CA Cancer cell line
//
ID WSU-HN18
AC CVCL_AX30
RX PubMed=7705939;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5520 ! WSU-HN17
CA Cancer cell line
//
ID WSU-HN19
AC CVCL_5521
SY HN19
DR Cosmic; 922090
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9389571;
CC Derived from metastatic site: Lymph node.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-HN22
AC CVCL_5522
SY HN22
DR Cosmic; 922081
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9389571;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5517 ! WSU-HN8
SX Male
CA Cancer cell line
//
ID WSU-HN24
AC CVCL_AX31
RX PubMed=7705939;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-HN25
AC CVCL_AX32
RX PubMed=7705939;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-HN26
AC CVCL_5523
SY HN26
DR Cosmic; 922082
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9049184;
RX PubMed=9389571;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5524 ! WSU-HN27
CA Cancer cell line
//
ID WSU-HN27
AC CVCL_5524
SY HN27
DR Cosmic; 922083
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9389571;
CC Derived from metastatic site: Larynx.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5523 ! WSU-HN26
CA Cancer cell line
//
ID WSU-HN28
AC CVCL_AX33
RX PubMed=7705939;
DI NCIt; C4943; Pyriform fossa squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-HN3
AC CVCL_W196
SY HN3
DR Cosmic; 922086
RX PubMed=7705939;
RX PubMed=8001221;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WSU-HN30
AC CVCL_5525
SY HN30; HN-30
DR BTO; BTO:0005039
DR Cosmic; 922084
DR Cosmic; 2131844
DR Cosmic; 2296299
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9049184;
RX PubMed=9389571;
RX PubMed=21868764;
RX PubMed=25275298;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=21868764; PubMed=25275298
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12 (PubMed=21868764)
ST D13S317: 11 (PubMed=25275298)
ST D16S539: 11,12
ST D18S51: 13,16
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 10
ST D8S1179: 15,17
ST FGA: 20,24
ST Penta D: 2.2
ST Penta E: 8,12
ST TH01: 7,9
ST TPOX: 6,11
ST vWA: 15,18
DI NCIt; C102872; Pharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5526 ! WSU-HN31
SX Male
CA Cancer cell line
//
ID WSU-HN31
AC CVCL_5526
SY HN31
DR Cosmic; 922085
DR Cosmic; 2043893
DR Cosmic; 2131845
DR Cosmic; 2439754
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9389571;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 6,11
ST vWA: 15,18
DI NCIt; C102872; Pharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5525 ! WSU-HN30
SX Male
CA Cancer cell line
//
ID WSU-HN4
AC CVCL_5515
SY HN4
DR Cosmic; 922078
DR Cosmic; 2043894
DR Cosmic; 2131846
DR Cosmic; 2513906
RX PubMed=7705939;
RX PubMed=8001221;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5518 ! WSU-HN12
SX Female
CA Cancer cell line
//
ID WSU-HN6
AC CVCL_5516
SY HN6
DR Cosmic; 922087
DR Cosmic; 2043895
DR Cosmic; 2296295
DR Cosmic; 2513907
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9049184;
RX PubMed=9389571;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=25275298
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 10,12
ST D18S51: 13
ST D21S11: 32.2,33.2
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 21,25
ST Penta D: 9
ST Penta E: 8,14
ST TH01: 6,9
ST TPOX: 8,10
ST vWA: 18,19
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WSU-HN8
AC CVCL_5517
SY HN8
DR Cosmic; 922080
DR Cosmic; 2296296
RX PubMed=7705939;
RX PubMed=8001221;
RX PubMed=9389571;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=25275298
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 13
ST D16S539: 9,12
ST D18S51: 13,19
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 11,12
ST FGA: 22
ST Penta D: 15
ST Penta E: 5,13
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5522 ! WSU-HN22
SX Male
CA Cancer cell line
//
ID WSU-NHL
AC CVCL_1793
SY WSU-NHL-1; WSUNHL
DR CLO; CLO_0009636
DR EFO; EFO_0006777
DR CLDB; cl4734
DR ATCC; CRL-11584
DR BioSample; SAMN03470898
DR BioSample; SAMN03473486
DR ChEMBL-Cells; CHEMBL3308281
DR ChEMBL-Targets; CHEMBL2366193
DR Cosmic; 798674
DR Cosmic; 909785
DR Cosmic; 994177
DR Cosmic; 1086348
DR Cosmic; 1945197
DR Cosmic; 2276344
DR Cosmic-CLP; 909785
DR DSMZ; ACC-58
DR GDSC; 909785
DR GEO; GSM380153
DR GEO; GSM552470
DR GEO; GSM1374992
DR GEO; GSM1670583
RX PubMed=3143865;
RX PubMed=7849311;
RX PubMed=19278952;
RX PubMed=23292937;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~45 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-11584; probable.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11 (Cosmic-CLP; DSMZ)
ST CSF1PO: 11,13 (PubMed=25877200)
ST D13S317: 8,11 (Cosmic-CLP; DSMZ)
ST D13S317: 8,10,11 (PubMed=25877200)
ST D16S539: 11,12 (Cosmic-CLP; DSMZ)
ST D16S539: 10,11,12 (PubMed=25877200)
ST D18S51: 15
ST D19S433: 13,14,15,15.2
ST D21S11: 26,30,31,31.2,32.2
ST D2S1338: 17,23
ST D3S1358: 14,15
ST D5S818: 11,12 (Cosmic-CLP; DSMZ)
ST D5S818: 10,11,12 (PubMed=25877200)
ST D7S820: 10,12
ST D8S1179: 9,12,13,14
ST FGA: 19,20
ST Penta D: 9,10,14
ST Penta E: 5,11,12,13
ST TH01: 6,9 (DSMZ)
ST TH01: 9 (Cosmic-CLP; PubMed=25877200)
ST TPOX: 9,10 (Cosmic-CLP; DSMZ)
ST TPOX: 8,9,10,11 (PubMed=25877200)
ST vWA: 16 (Cosmic-CLP; DSMZ)
ST vWA: 16,17,19 (PubMed=25877200)
DI NCIt; C3209; Follicular lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WSU-Pre-B-ALL
AC CVCL_5608
SY WSU-preAll
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WSU-WM
AC CVCL_5609
SY WM-WSU
DR ATCC; CRL-11586
DR Cosmic; 1762458
RX PubMed=8499639;
RX PubMed=18650470;
RX PubMed=22950966;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
WW http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html
CC Discontinued: ATCC; CRL-11586; probable.
DI NCIt; C80307; Waldenstrom macroglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID WT 10-7
AC CVCL_V443
DR ATCC; CRL-2834
RX PubMed=12734101;
CC Transformant: Ad-SV40.
CC Discontinued: ATCC; CRL-2834; true.
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V442 ! TS 10-7
SX Female
CA Transformed cell line
//
ID WT 9-12
AC CVCL_K230
DR ATCC; CRL-2833
RX PubMed=12734101;
CC Transformant: Ad-SV40.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 19
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V444 ! TS 9-7
OI CVCL_K231 ! WT 9-7
OI CVCL_V445 ! WT 9-9
SX Female
CA Transformed cell line
//
ID WT 9-7
AC CVCL_K231
SY WT97
DR ATCC; CRL-2830
DR BioSample; SAMN03471799
RX PubMed=12734101;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Transformant: Ad-SV40.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 19
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V444 ! TS 9-7
OI CVCL_V445 ! WT 9-9
OI CVCL_K230 ! WT 9-12
SX Female
CA Transformed cell line
//
ID WT 9-9
AC CVCL_V445
DR ATCC; CRL-2832
RX PubMed=12734101;
CC Transformant: Ad-SV40.
CC Discontinued: ATCC; CRL-2832; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 8,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 19
DI NCIt; C84578; Autosomal dominant polycystic kidney disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V444 ! TS 9-7
OI CVCL_K231 ! WT 9-7
OI CVCL_K230 ! WT 9-12
SX Female
CA Transformed cell line
//
ID Wt MEFs
AC CVCL_L690
DR ATCC; CRL-2991
RX PubMed=12527753;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID WT SV40 MEF
AC CVCL_U630
DR ATCC; CRL-2907
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID WT-126
AC CVCL_HA44
DR GEO; GSM1153513
RX PubMed=21074045;
RX PubMed=24153179;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WT-31
AC CVCL_CW51
SY WT31
RX PubMed=2410507;
RX PubMed=2809225;
WW http://www.bdbiosciences.com/ds/is/tds/23-3974.pdf
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID WT-33
AC CVCL_HA45
DR GEO; GSM1153509
DR GEO; GSM1153510
RX PubMed=21074045;
RX PubMed=24153179;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID WT-9
AC CVCL_HA46
DR GEO; GSM1153512
RX PubMed=24153179;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1P27 ! GM22159
SX Male
CA Induced pluripotent stem cell
//
ID WT-ADRC-40
AC CVCL_HA43
SY ADRC-40; ADRC40
DR GEO; GSM1153501
DR GEO; GSM1153507
RX PubMed=21074045;
RX PubMed=24153179;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WT-CLS1
AC CVCL_5904
SY CLS1
DR CLS; 300379-SF/p9957_WT-CLS1
DR Cosmic; 1314022
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,11
ST D16S539: 9,11
ST D18S51: 13,15
ST D21S11: 30,31.2
ST D3S1358: 14,19
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 22,25
ST Penta D: 9
ST Penta E: 9,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WT-E
AC CVCL_0C31
RX PubMed=7736387;
RX PubMed=10100721;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WT-iPS 3F-1
AC CVCL_W316
RX PubMed=22405424;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID WT-iPS 4F-1
AC CVCL_W317
RX PubMed=22405424;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID WT-iPSC1
AC CVCL_GQ07
RX PubMed=27558599;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WT-iPSC2
AC CVCL_GQ08
RX PubMed=27558597;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WT-iPSC4
AC CVCL_GQ09
RX PubMed=27558598;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID WT-Pe.1
AC CVCL_M844
RX PubMed=18558285;
CC Doubling time: ~65 hours (PubMed=18558285).
DI NCIt; C40407; Renal Wilms tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WT-R
AC CVCL_0I65
DR CCLV; CCLV-RIE 0728
OX NCBI_TaxID=9902; ! Bison bonasus
CA Spontaneously immortalized cell line
//
ID WT:CS3
AC CVCL_Z880
SY WT-CS3
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=3919453;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WT:CS5
AC CVCL_Z881
SY WT-CS5
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=3919453;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WT:LM6
AC CVCL_Z882
SY WT-LM6
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=3919453;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WT100
AC CVCL_E919
SY WT-100; GM08602
DR BTO; BTO:0004551
DR CLO; CLO_0010610
DR Coriell; GM08602
DR IMGT/HLA; 13141
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WT100BIS
AC CVCL_E883
DR dbMHC; 49073
DR ECACC; 88052006
DR IHW; IHW9006
DR IMGT/HLA; 11652
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl6.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WT17
AC CVCL_F522
SY GM08599
DR CLO; CLO_0010591
DR Coriell; GM08599
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WT20
AC CVCL_F524
SY GM08067
DR CLO; CLO_0010026
DR Coriell; GM08067
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID WT24
AC CVCL_E884
DR dbMHC; 49074
DR IHW; IHW9015
DR IMGT/HLA; 11651
WW http://bioinformatics.hsanmartino.it/ecbr/cl15.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WT46
AC CVCL_E885
SY GM08068
DR CLO; CLO_0010027
DR Coriell; GM08068
DR dbMHC; 49075
DR IHW; IHW9305
DR IMGT/HLA; 11571
WW http://bioinformatics.hsanmartino.it/ecbr/cl305.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WT47
AC CVCL_E886
DR dbMHC; 49076
DR ECACC; 88052063
DR IHW; IHW9063
DR IMGT/HLA; 11572
WW http://bioinformatics.hsanmartino.it/ecbr/cl63.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WT49
AC CVCL_2242
SY WT-49; TER98; TER180; GM03098
DR CLO; CLO_0013483
DR Coriell; GM03098
DR dbMHC; 49077
DR ECACC; 86052108
DR IHW; IHW9285
DR IMGT/HLA; 11573
WW http://bioinformatics.hsanmartino.it/ecbr/cl285.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WT51
AC CVCL_E887
SY WT-51; GM03103
DR BTO; BTO:0004497
DR CLO; CLO_0013564
DR Coriell; GM03103
DR dbMHC; 49078
DR ECACC; 86052110
DR IHW; IHW9029
DR IMGT/HLA; 11574
WW http://bioinformatics.hsanmartino.it/ecbr/cl29.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WT52
AC CVCL_E888
SY GM08603
DR CLO; CLO_0010609
DR Coriell; GM08603
DR dbMHC; 49079
DR IHW; IHW9306
DR IMGT/HLA; 11575
WW http://bioinformatics.hsanmartino.it/ecbr/cl306.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WT8
AC CVCL_E889
DR dbMHC; 49080
DR IHW; IHW9017
DR IMGT/HLA; 11650
WW http://bioinformatics.hsanmartino.it/ecbr/cl17.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WT87
AC CVCL_F523
SY GM08601
DR CLO; CLO_0010593
DR Coriell; GM08601
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WTC-EGFP-PXN-cl50
AC CVCL_IR30
SY AICS0005; AICS-0005
DR Coriell; AICS0005
WW http://www.allencell.org/cellline/AICS-0005
CC Characteristics: Using CRISPR/Cas9 PXN has been endogenously tagged at the C-terminus with EGFP.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y803 ! GM25256
SX Male
CA Induced pluripotent stem cell
//
ID WTC-mEGFP-DSP-cl65
AC CVCL_IR31
SY AICS0017; AICS-0017
DR Coriell; AICS0017
WW http://www.allencell.org/cellline/AICS-0017
CC Characteristics: Using CRISPR/Cas9 DSP has been endogenously tagged at the C-terminus with mEGFP.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y803 ! GM25256
SX Male
CA Induced pluripotent stem cell
//
ID WTC-mEGFP-LMNB1-cl210
AC CVCL_IR32
SY AICS0013; AICS-0013
DR Coriell; AICS0013
WW http://www.allencell.org/cellline/AICS-0013
CC Characteristics: Using CRISPR/Cas9 LMNB1 has been endogenously tagged at the N-terminus with mEGFP.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y803 ! GM25256
SX Male
CA Induced pluripotent stem cell
//
ID WTC-mEGFP-TOMM20-cl27
AC CVCL_IR33
SY AICS0011; AICS-0011
DR Coriell; AICS0011
WW http://www.allencell.org/cellline/AICS-0011
CC Characteristics: Using CRISPR/Cas9 TOMM20 has been endogenously tagged at the C-terminus with mEGFP.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y803 ! GM25256
SX Male
CA Induced pluripotent stem cell
//
ID WTC-mEGFP-TUBA1B-cl105
AC CVCL_IR34
SY AICS0012; AICS-0012
DR Coriell; AICS0012
WW http://www.allencell.org/cellline/AICS-0012
CC Characteristics: Using CRISPR/Cas9 TUBA1B has been endogenously tagged at the N-terminus with mEGFP.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y803 ! GM25256
SX Male
CA Induced pluripotent stem cell
//
ID WTK-1
AC CVCL_6742
SY WTK1
DR BTO; BTO:0003706
RX PubMed=7744731;
RX PubMed=11566342;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C97074; Hereditary spherocytosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6544 ! WIL2
SX Male
CA Transformed cell line
//
ID WU E-14
AC CVCL_F812
SY WUE-14; 29CE12-1
DR CLO; CLO_0009637
DR ATCC; CRL-2255
CC Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID WU E-4
AC CVCL_F813
SY WUE-4; 1506 A1.4
DR CLO; CLO_0009638
DR ATCC; CRL-2247
RX PubMed=2466929;
RX PubMed=3973009;
CC Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID WU E-7
AC CVCL_2G80
SY WU-E-7
RX PubMed=2466929;
CC Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID WU-CcE-1
AC CVCL_Z976
SY CcE-1
RX PubMed=20471390;
CC Group: Insect cell line.
OX NCBI_TaxID=749652; ! Chrysodeixis chalcites
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID WUZH1
AC CVCL_E890
SY WUZHI
DR dbMHC; 49081
DR IHW; IHW9459
DR IMGT/HLA; 26054
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID WVB-Pcr-02
AC CVCL_Z953
RX DOI=10.14188/j.1671-8836.1997.02.019;
CC Group: Insect cell line.
OX NCBI_TaxID=7127; ! Samia cynthia
SX Female
CA Spontaneously immortalized cell line
//
ID WW
AC CVCL_U798
DR Cosmic; 889042
DR Cosmic; 928722
DR GEO; GSM228379
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WW0008
AC CVCL_8Z01
DR ECACC; 89060702
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WW0240
AC CVCL_8Z02
DR ECACC; 95080208
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WW1
AC CVCL_N782
RX PubMed=7638196;
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID WW165
AC CVCL_G321
DR Cosmic; 1197385
DR Cosmic; 1548845
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=26214590;
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID WW6
AC CVCL_N783
SY ES-WW6
DR EFO; EFO_0005915
DR ATCC; CRL-2239
DR ENCODE; ENCBS120ENC
DR ENCODE; ENCBS121ENC
DR ENCODE; ENCBS134ZWP
DR ENCODE; ENCBS480DYF
DR GEO; GSM1014159
DR GEO; GSM1014160
RX PubMed=7638196;
CC Part of: ENCODE project mouse cell lines.
CC Discontinued: ATCC; CRL-2239; true.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID WWAI
AC CVCL_F821
DR IMGT/HLA; 11577
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WX310
AC CVCL_3434
DR CLO; CLO_0009639
DR CLDB; cl4736
DR ECACC; 85022818
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID Wx67
AC CVCL_A742
SY WX67
DR Cosmic; 687461
RX PubMed=12068308;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID WY005
AC CVCL_F407
DR CLO; CLO_0051099
DR RCB; HSC0072
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY020
AC CVCL_F408
DR CLO; CLO_0051097
DR RCB; HSC0069
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY034
AC CVCL_F409
DR CLO; CLO_0051118
DR RCB; HSC0095
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY035
AC CVCL_F410
DR CLO; CLO_0051103
DR RCB; HSC0076
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY036
AC CVCL_F411
DR CLO; CLO_0051104
DR RCB; HSC0077
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY037
AC CVCL_F412
DR CLO; CLO_0051105
DR RCB; HSC0078
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY038
AC CVCL_F413
DR CLO; CLO_0051106
DR RCB; HSC0079
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY039
AC CVCL_F414
DR CLO; CLO_0051114
DR RCB; HSC0090
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY040
AC CVCL_F415
DR CLO; CLO_0051107
DR RCB; HSC0080
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY043
AC CVCL_F416
DR CLO; CLO_0051070
DR RCB; HSC0035
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY046
AC CVCL_F417
DR CLO; CLO_0051108
DR RCB; HSC0081
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY047
AC CVCL_F418
DR CLO; CLO_0051110
DR RCB; HSC0084
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY048
AC CVCL_F419
DR CLO; CLO_0051109
DR RCB; HSC0082
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY049
AC CVCL_F420
DR CLO; CLO_0051101
DR RCB; HSC0074
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY050
AC CVCL_F421
DR CLO; CLO_0051074
DR RCB; HSC0042
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY051
AC CVCL_F422
DR CLO; CLO_0051167
DR RCB; HSC0130
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY053
AC CVCL_F423
DR CLO; CLO_0051159
DR RCB; HSC0122
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY054
AC CVCL_F424
DR CLO; CLO_0051168
DR RCB; HSC0132
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY055
AC CVCL_F425
DR CLO; CLO_0051160
DR RCB; HSC0123
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY057
AC CVCL_F426
DR CLO; CLO_0051075
DR RCB; HSC0043
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY058
AC CVCL_F427
DR CLO; CLO_0051079
DR RCB; HSC0048
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY059
AC CVCL_F428
DR CLO; CLO_0051089
DR RCB; HSC0059
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY064
AC CVCL_F429
DR CLO; CLO_0051085
DR RCB; HSC0054
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY065
AC CVCL_F430
DR CLO; CLO_0051086
DR RCB; HSC0055
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY071
AC CVCL_F431
DR CLO; CLO_0051180
DR RCB; HSC0091
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY072
AC CVCL_F432
DR CLO; CLO_0051132
DR RCB; HSC0083
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY073
AC CVCL_F433
DR CLO; CLO_0051113
DR RCB; HSC0089
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY074
AC CVCL_F434
DR CLO; CLO_0051111
DR RCB; HSC0086
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY075
AC CVCL_F435
DR CLO; CLO_0051115
DR RCB; HSC0092
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY076
AC CVCL_F436
DR CLO; CLO_0051112
DR RCB; HSC0088
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY077
AC CVCL_F437
DR CLO; CLO_0051179
DR RCB; HSC0087
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY078
AC CVCL_F438
SY WY-078
DR CLO; CLO_0051066
DR RCB; HSC0031
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY080
AC CVCL_F439
DR CLO; CLO_0051073
DR RCB; HSC0040
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY083
AC CVCL_F440
DR CLO; CLO_0051337
DR RCB; HSC0063
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY084
AC CVCL_6E41
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY086
AC CVCL_F441
DR CLO; CLO_0051095
DR RCB; HSC0067
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID WY091
AC CVCL_F442
DR CLO; CLO_0051094
DR RCB; HSC0066
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY092
AC CVCL_F443
DR CLO; CLO_0051096
DR RCB; HSC0068
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID WY102
AC CVCL_F444
DR CLO; CLO_0051080
DR RCB; HSC0049
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Colombia.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID X-01
AC CVCL_C656
DR ISCR; 1777
RX PubMed=21338948;
CC From: Shanghai Institutes for Biological Sciences; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID X-02
AC CVCL_C657
DR ISCR; 1778
RX PubMed=21338948;
CC From: Shanghai Institutes for Biological Sciences; Shanghai; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID X1/5
AC CVCL_2768
SY HtTA-1 clone X1/5
DR CLO; CLO_0009640
DR CLDB; cl4737
DR ECACC; 95051229
RX PubMed=1319065;
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2523 ! HtTA-1
SX Female
CA Cancer cell line
//
ID X16C8.5
AC CVCL_0208
SY X16C
DR CLO; CLO_0009641
DR ATCC; TIB-209
RX PubMed=310843;
CC Breed/subspecies: BALB/cAnN.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID X19
AC CVCL_CW58
RX PubMed=2415533;
CC Monoclonal antibody target: UniProtKB; Q00610; Human CLTC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID X22
AC CVCL_F814
DR CLO; CLO_0009642
DR ATCC; CRL-2228
RX PubMed=2415533;
CC Monoclonal antibody target: UniProtKB; Q00610; Human CLTC (also reacts with other species).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID X25-4
AC CVCL_BW59
RX PubMed=218224;
RX PubMed=223286;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_BW60 ! X25-6
OI CVCL_BW61 ! X25-9
CA Transformed cell line
//
ID X25-6
AC CVCL_BW60
RX PubMed=218224;
RX PubMed=223286;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_BW59 ! X25-4
OI CVCL_BW61 ! X25-9
CA Transformed cell line
//
ID X25-9
AC CVCL_BW61
RX PubMed=218224;
RX PubMed=223286;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_BW59 ! X25-4
OI CVCL_BW60 ! X25-6
CA Transformed cell line
//
ID X50-7
AC CVCL_8277
RX Patent=US5178999;
RX PubMed=218224;
RX PubMed=223286;
RX PubMed=3033285;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID X50-7.8
AC CVCL_J031
DR ATCC; CRL-9694
RX Patent=US5178999;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-9694; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8277 ! X50-7
CA Transformed cell line
//
ID X5563
AC CVCL_H719
SY X-5563; x5563
DR ChEMBL-Cells; CHEMBL3307487
DR ChEMBL-Targets; CHEMBL614250
DR TKG; TKG 0174
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID X63-omIL-2
AC CVCL_Y272
SY X63/OMIL2; XR63-IL2
DR BCRJ; 0250
RX PubMed=2831066;
CC Transfected with: MGI; MGI:96548; Il2.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
SX Female
CA Cancer cell line
//
ID X63-omIL-3
AC CVCL_M352
SY X63/OMIL3; XR63-IL3
DR BCRJ; 0251
DR ChEMBL-Cells; CHEMBL3307917
DR ChEMBL-Targets; CHEMBL614312
RX PubMed=2831066;
CC Transfected with: MGI; MGI:96552; Il3.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
SX Female
CA Cancer cell line
//
ID X63-omIL-4
AC CVCL_Y273
SY X63/OMIL4; XR63-IL4
DR BCRJ; 0252
RX PubMed=2831066;
CC Transfected with: MGI; MGI:96556; Il4.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
SX Female
CA Cancer cell line
//
ID X63-omIL-5
AC CVCL_Y274
SY X63/OMIL5; XR63-IL5
DR BCRJ; 0253
RX PubMed=2831066;
CC Transfected with: MGI; MGI:96557; Il5.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
SX Female
CA Cancer cell line
//
ID X9
AC CVCL_II79
DR ATCC; CRL-3282
RX PubMed=22796012;
CC Breed/subspecies: 129S6/SvEvTac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID XB-2
AC CVCL_3624
SY XB2; XB
DR CLO; CLO_0009644
DR ATCC; CL-177
DR BCRC; 60546
DR IZSLER; BS CL 128
RX Patent=US4016036;
RX PubMed=730781;
RX PubMed=1052770;
RX PubMed=1690090;
CC Breed/subspecies: CXBGB/By.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID XC
AC CVCL_1891
DR BTO; BTO:0005227
DR CLO; CLO_0009645
DR CLO; CLO_0050824
DR CLDB; cl4738
DR CLDB; cl4739
DR CLDB; cl4740
DR CLDB; cl4741
DR CLDB; cl4742
DR ATCC; CCL-165
DR ATCC; CRL-6603
DR BCRC; 60098
DR DSMZ; ACC-118
DR ChEMBL-Cells; CHEMBL3307251
DR ChEMBL-Targets; CHEMBL612812
DR ECACC; 88120601
DR ICLC; ATL96013
DR IFO; IFO50017
DR IZSLER; BS TCL 66
DR RCB; RCB1831
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6603; true.
CC Breed/subspecies: White-Weston.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID XC-v
AC CVCL_D623
DR BTO; BTO:0005229
RX PubMed=4359877;
CC Breed/subspecies: White-Weston.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1891 ! XC
CA Cancer cell line
//
ID XC1.5/51
AC CVCL_3625
DR CLO; CLO_0009646
DR ATCC; TIB-16
CC Breed/subspecies: C3H.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3493 ! C1.18.4
CA Cancer cell line
//
ID XCIII-1F8-D7
AC CVCL_U049
SY P-1
DR ECACC; 08041723
RX PubMed=2450920;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XCIII-3D8-D8
AC CVCL_U050
SY P-2
DR ECACC; 08041724
RX PubMed=2450920;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XCIV-1H2-A8
AC CVCL_U051
SY T-11
DR ECACC; 08041728
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XCp
AC CVCL_7229
DR CLO; CLO_0009648
DR CLDB; cl4744
CC Breed/subspecies: White-Weston.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_1891 ! XC
CA Cancer cell line
//
ID XEM1
AC CVCL_GR61
RX PubMed=1441600;
RX PubMed=1692605;
CC Transfected with: RGD; 2458; Cyp1a1.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID XEM2
AC CVCL_GR62
SY V79-XEM2
RX PubMed=1441600;
RX PubMed=1692605;
RX PubMed=1800893;
CC Transfected with: RGD; 2458; Cyp1a1.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID XEMd-MZ
AC CVCL_GR63
SY XEMd.MZ
RX PubMed=1441600;
RX PubMed=1793487;
RX PubMed=1800893;
CC Transfected with: RGD; 2459; Cyp1a2.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V36 ! V79MZ
SX Male
CA Spontaneously immortalized cell line
//
ID XEMd-NH
AC CVCL_GR64
SY XEMd.NH
RX PubMed=1441600;
RX PubMed=1793487;
CC Transfected with: RGD; 2459; Cyp1a2.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_4V38 ! V79NH
SX Male
CA Spontaneously immortalized cell line
//
ID XF
AC CVCL_6E64
SY Xenopus Fibroblast
RX PubMed=2335521;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XF 498
AC CVCL_8928
SY XF-498; XF498
DR BTO; BTO:0003414
DR ChEMBL-Cells; CHEMBL3308037
DR ChEMBL-Targets; CHEMBL613533
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID XFiPS-F44-3F-1
AC CVCL_C106
SY XF-iPSF44-3F-1; iPSXFII+III-1; ESi031-A
DR BioSamples; SAMEA7781668
DR hPSCreg; ESi031-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/XFiPS-F44-3F-1.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V191 ! FiPS-3F-1
OI CVCL_9S07 ! FiPS-4F-7
OI CVCL_9S08 ! FiPS-4F-8
OI CVCL_C107 ! XFiPS-F44-3F-2
SX Male
CA Induced pluripotent stem cell
//
ID XFiPS-F44-3F-2
AC CVCL_C107
SY XF-iPSF44-3F-2; iPSXFII+III-2; ESi032-A
DR hPSCreg; ESi032-A
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/XFiPS-F44-3F-2.pdf
CC From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V191 ! FiPS-3F-1
OI CVCL_9S07 ! FiPS-4F-7
OI CVCL_9S08 ! FiPS-4F-8
OI CVCL_C106 ! XFiPS-F44-3F-1
SX Male
CA Induced pluripotent stem cell
//
ID XG-1
AC CVCL_4797
SY XG1; XG 1
DR Cosmic; 742957
DR Cosmic; 2081411
DR Cosmic; 2367276
RX PubMed=1753108;
RX PubMed=8204890;
RX PubMed=10087940;
RX PubMed=10557056;
RX PubMed=10936422;
RX PubMed=16956823;
RX PubMed=21173094;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=XG-1
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XG-10
AC CVCL_HX11
SY XG10
RX PubMed=10557056;
RX PubMed=19718049;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-11
AC CVCL_HX12
SY XG11
RX PubMed=19718049;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-12
AC CVCL_HX13
SY XG12
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-13
AC CVCL_HX14
SY XG13
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XG-14
AC CVCL_HX15
SY XG14
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XG-16
AC CVCL_HX16
SY XG16
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XG-19
AC CVCL_HX17
SY XG19
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-2
AC CVCL_4798
SY XG2; XG 2
DR Cosmic; 742959
DR Cosmic; 2081412
DR Cosmic; 2367291
RX PubMed=1753108;
RX PubMed=8204890;
RX PubMed=10557056;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-20
AC CVCL_HX18
SY XG20
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XG-21
AC CVCL_HX19
SY XG21
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XG-24
AC CVCL_HX20
SY XG24
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-3
AC CVCL_4799
SY XG3; XG 3; XG-3P; XG3P
DR Cosmic; 742960
RX PubMed=1753108;
RX PubMed=8204890;
RX PubMed=10936422;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HX21 ! XG-3E
SX Female
CA Cancer cell line
//
ID XG-3E
AC CVCL_HX21
SY XG3E
RX PubMed=8204890;
CC Characteristics: IL6 dependent.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4799 ! XG-3
SX Female
CA Cancer cell line
//
ID XG-4
AC CVCL_4800
SY XG4; XG 4
DR Cosmic; 742961
RX PubMed=1753108;
RX PubMed=8204890;
RX PubMed=10557056;
RX PubMed=10936422;
RX PubMed=21173094;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XG-5
AC CVCL_4801
SY XG5; XG 5
DR Cosmic; 742962
RX PubMed=1753108;
RX PubMed=8204890;
RX PubMed=10557056;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-6
AC CVCL_A771
SY XG6; XG 6
DR Cosmic; 2081413
DR Cosmic; 2367259
DR Lonza; 94
RX PubMed=8204890;
RX PubMed=10557056;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-7
AC CVCL_A772
SY XG7; XG 7
DR Cosmic; 2081414
DR Cosmic; 2367269
RX PubMed=8204890;
RX PubMed=10557056;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-8
AC CVCL_A773
SY XG8; XG 8
RX PubMed=8204890;
RX PubMed=10936422;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XG-9
AC CVCL_A774
SY XG9; XG 9
RX PubMed=8204890;
RX PubMed=10936422;
CC Characteristics: IL6 dependent.
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XGC-2
AC CVCL_HA22
RX PubMed=27633271;
CC Doubling time: ~60 hours (PubMed=27633271).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XGC9811
AC CVCL_0U26
SY XGC-9811; GC9811
RX DOI=10.3321/j.issn:1000-2790.2003.10.004;
RX DOI=10.3969/j.issn.1001-5949.2008.05.004;
RX PubMed=16458253;
RX PubMed=17404872;
CC Omics: Proteome analysis by 2D-DE.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID XGC9811-L
AC CVCL_0U27
SY XGC-9811L
RX DOI=10.3969/j.issn.1001-5949.2008.05.004;
RX PubMed=16458253;
CC Omics: Proteome analysis by 2D-DE.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0U26 ! XGC9811
CA Cancer cell line
//
ID XGL
AC CVCL_DR23
DR CCRID; 3153C0001000000040
DR KCB; KCB 83002
CC Group: Fish cell line.
CC Breed/subspecies: Var. singuonensis.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XH1
AC CVCL_T292
RX PubMed=1911212;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XIII-3E6-B11
AC CVCL_U043
SY B-16; B16
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania braziliensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XIII-3H6-A12
AC CVCL_U042
SY B-12; B12
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania brazilensis and Leishmania panamensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XIV-2A5-A10
AC CVCL_U044
SY B-18; B18
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania brazilensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XL-177
AC CVCL_T684
RX PubMed=562840;
RX PubMed=2416614;
RX PubMed=8327476;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XL-2
AC CVCL_2H45
RX PubMed=26134302;
CC Derived from metastatic site: Ascites.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID XL-2sci
AC CVCL_2H46
RX PubMed=26134302;
CC Derived from metastatic site: Ascites.
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2H45 ! XL-2
SX Male
CA Cancer cell line
//
ID Xl1
AC CVCL_6E60
SY Xenopus laevis 1
RX PubMed=23054192;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XL110
AC CVCL_T702
RX PubMed=2335521;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XL2
AC CVCL_6743
RX PubMed=7239540;
CC Group: Amphibian cell line.
CC Doubling time: 39 hours (PubMed=7239540).
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XLA-07
AC CVCL_J033
RX PubMed=22883674;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XLC002
AC CVCL_IS77
SY QualiCell Human Embryonic Stem Cell-XLC002
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC002-CSC-C00009-item-2659.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC004
AC CVCL_IS78
SY QualiCell Human Embryonic Stem Cell-XLC004
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC004-CSC-C00002-item-2652.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC007
AC CVCL_IS79
SY QualiCell Human Embryonic Stem Cell-XLC007
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC007-CSC-C00005-item-2655.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC009
AC CVCL_IS80
SY QualiCell Human Embryonic Stem Cell-XLC009
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC009-CSC-C00021-item-2671.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC011
AC CVCL_IS81
SY QualiCell Human Embryonic Stem Cell-XLC011
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC011-CSC-C00018-item-2668.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC012
AC CVCL_IS82
SY QualiCell Human Embryonic Stem Cell-XLC012
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC012-CSC-C00010-item-2660.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC013
AC CVCL_IS83
SY QualiCell Human Embryonic Stem Cell-XLC013
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC013-CSC-C00001-item-2651.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC015
AC CVCL_IS84
SY QualiCell Human Embryonic Stem Cell-XLC015
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC015-CSC-C00014-item-2664.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC016
AC CVCL_IS85
SY QualiCell Human Embryonic Stem Cell-XLC016
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC016-CSC-C00004-item-2654.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC017
AC CVCL_IS86
SY QualiCell Human Embryonic Stem Cell-XLC017
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC017-CSC-C00020-item-2670.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC018
AC CVCL_IS87
SY QualiCell Human Embryonic Stem Cell-XLC018
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC018-CSC-C00003-item-2653.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC020
AC CVCL_IS88
SY QualiCell Human Embryonic Stem Cell-XLC020
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC020-CSC-C00008-item-2658.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC021
AC CVCL_IS89
SY QualiCell Human Embryonic Stem Cell-XLC021
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC021-CSC-C00016-item-2666.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC023
AC CVCL_IS90
SY QualiCell Human Embryonic Stem Cell-XLC023
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC023-CSC-C00011-item-2661.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC025
AC CVCL_IS91
SY QualiCell Human Embryonic Stem Cell-XLC025
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC025-CSC-C00013-item-2663.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC027
AC CVCL_IS92
SY QualiCell Human Embryonic Stem Cell-XLC027
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC027-CSC-C00015-item-2665.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC029
AC CVCL_IS93
SY QualiCell Human Embryonic Stem Cell-XLC029
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC029-CSC-C00007-item-2657.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC030
AC CVCL_IS94
SY QualiCell Human Embryonic Stem Cell-XLC030
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC030-CSC-C00019-item-2669.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC033
AC CVCL_IS95
SY QualiCell Human Embryonic Stem Cell-XLC033
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC033-CSC-C00017-item-2667.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC034
AC CVCL_IS96
SY QualiCell Human Embryonic Stem Cell-XLC034
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC034-CSC-C00012-item-2662.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC038
AC CVCL_IS97
SY QualiCell Human Embryonic Stem Cell-XLC038
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC038-CSC-C00006-item-2656.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC041
AC CVCL_IS98
SY QualiCell Human Embryonic Stem Cell-XLC041
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC041-CSC-C00022-item-2672.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC042
AC CVCL_IS99
SY QualiCell Human Embryonic Stem Cell-XLC042
DR ISCR; 2370
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC042-CSC-C00034-item-2684.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC044
AC CVCL_IT00
SY QualiCell Human Embryonic Stem Cell-XLC044
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC044-CSC-C00026-item-2676.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC046
AC CVCL_IT01
SY QualiCell Human Embryonic Stem Cell-XLC046
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC046-CSC-C00024-item-2674.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC048
AC CVCL_IT02
SY QualiCell Human Embryonic Stem Cell-XLC048
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC048-CSC-C00028-item-2678.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC049
AC CVCL_IT03
SY QualiCell Human Embryonic Stem Cell-XLC049
DR ISCR; 2385
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC049-CSC-C00030-item-2680.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC050
AC CVCL_IT04
SY QualiCell Human Embryonic Stem Cell-XLC050
DR ISCR; 2381
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC050-CSC-C00033-item-2683.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC051
AC CVCL_IT05
SY QualiCell Human Embryonic Stem Cell-XLC051
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC051-CSC-C00027-item-2677.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC052
AC CVCL_IT06
SY QualiCell Human Embryonic Stem Cell-XLC052
DR ISCR; 2383
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC052-CSC-C00032-item-2682.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC053
AC CVCL_IT07
SY QualiCell Human Embryonic Stem Cell-XLC053
DR ISCR; 2369
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC053-CSC-C00035-item-2685.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC054
AC CVCL_IT08
SY QualiCell Human Embryonic Stem Cell-XLC054
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC054-CSC-C00023-item-2673.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC055
AC CVCL_IT09
SY QualiCell Human Embryonic Stem Cell-XLC055
DR ISCR; 2386
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC055-CSC-C00029-item-2679.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC056
AC CVCL_IT10
SY QualiCell Human Embryonic Stem Cell-XLC056
DR ISCR; 2367
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC056-CSC-C00037-item-2687.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC057
AC CVCL_IT11
SY QualiCell Human Embryonic Stem Cell-XLC057
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC057-CSC-C00025-item-2675.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC060
AC CVCL_IT12
SY QualiCell Human Embryonic Stem Cell-XLC060
DR ISCR; 2384
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC060-CSC-C00031-item-2681.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC061
AC CVCL_IT13
SY QualiCell Human Embryonic Stem Cell-XLC061
DR ISCR; 2368
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC061-CSC-C00036-item-2686.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC064
AC CVCL_IT14
SY QualiCell Human Embryonic Stem Cell-XLC064
DR ISCR; 2362
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC064-CSC-C00042-item-2692.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC065
AC CVCL_IT15
SY QualiCell Human Embryonic Stem Cell-XLC065
DR ISCR; 2365
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC065-CSC-C00039-item-2689.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC068
AC CVCL_IT16
SY QualiCell Human Embryonic Stem Cell-XLC068
DR ISCR; 2348
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC068-CSC-C00046-item-2696.htm
CC From: Creative Bioarray.
CC Characteristics: Has Lox sites for Cre-mediated gene insertion and constitutive transgene expression.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLC069
AC CVCL_IT17
SY QualiCell Human Embryonic Stem Cell-XLC069
DR ISCR; 2361
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC069-CSC-C00043-item-2693.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC070
AC CVCL_IT18
SY QualiCell Human Embryonic Stem Cell-XLC070
DR ISCR; 2364
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC070-CSC-C00040-item-2690.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC072
AC CVCL_IT19
SY QualiCell Human Embryonic Stem Cell-XLC072
DR ISCR; 2350
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC072-CSC-C00044-item-2694.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID XLC073
AC CVCL_IT20
SY QualiCell Human Embryonic Stem Cell-XLC073
DR ISCR; 2347
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC073-CSC-C00047-item-2697.htm
CC From: Creative Bioarray.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLC074
AC CVCL_IT21
SY QualiCell Human Embryonic Stem Cell-XLC074
DR ISCR; 2366
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC074-CSC-C00038-item-2688.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC076
AC CVCL_IT22
SY QualiCell Human Embryonic Stem Cell-XLC076
DR ISCR; 2341
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC076-CSC-C00051-item-2701.htm
CC From: Creative Bioarray.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLC077
AC CVCL_IT23
SY QualiCell Human Embryonic Stem Cell-XLC077
DR ISCR; 2363
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC077-CSC-C00041-item-2691.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID XLC080
AC CVCL_IT24
SY QualiCell Human Embryonic Stem Cell-XLC080
DR ISCR; 2349
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC080-CSC-C00045-item-2695.htm
CC From: Creative Bioarray.
CC Characteristics: Has a EGFP-POU5F1 knock-in.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLC081
AC CVCL_IT25
SY QualiCell Human Embryonic Stem Cell-XLC081
DR ISCR; 2322
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC081-CSC-C00052-item-2702.htm
CC From: Creative Bioarray.
CC Characteristics: A GFP cassette is inserted to the OLIG2 locus via homologous recombination.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9726 ! BG01
SX Male
CA Embryonic stem cell
//
ID XLC083
AC CVCL_IT26
SY QualiCell Human Embryonic Stem Cell-XLC083
DR ISCR; 2345
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC083-CSC-C00049-item-2699.htm
CC From: Creative Bioarray.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLC088
AC CVCL_IT27
SY QualiCell Human Embryonic Stem Cell-XLC088
DR ISCR; 2346
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC088-CSC-C00048-item-2698.htm
CC From: Creative Bioarray.
CC Characteristics: POU5F1 promoter driving GFP expression and Zeo resistance.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLC090
AC CVCL_IT28
SY QualiCell Human Embryonic Stem Cell-XLC090
DR ISCR; 2344
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC090-CSC-C00050-item-2700.htm
CC From: Creative Bioarray.
CC Characteristics: Cardiac specific troponin T promoter driving GFP expression and Zeo resistance.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLC303
AC CVCL_IT52
SY XLC-303; CBi002-A
DR BioSamples; SAMEA103988342
DR hPSCreg; CBi002-A
WW http://www.creative-bioarray.com/QualiCell-Induced-Pluripotent-Stem-Cell-XLC303-CSC-C00122-item-2745.htm
CC From: Creative Bioarray.
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID XLC348
AC CVCL_IT53
SY XLC-348; CBi001-A
DR BioSamples; SAMEA4458267
DR hPSCreg; CBi001-A
WW http://www.creative-bioarray.com/QualiCell-Induced-Pluripotent-Stem-Cell-XLC348-CSC-C00123-item-2746.htm
CC From: Creative Bioarray.
DI NCIt; C3362; Schizophrenia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID XLC449
AC CVCL_IT29
SY QualiCell Human Embryonic Stem Cell-XLC449
DR ISCR; 2321
WW http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC449-CSC-C00317-item-2873.htm
CC From: Creative Bioarray.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID XLI-ND
AC CVCL_E891
SY TER341
DR dbMHC; 49082
DR ECACC; 94022554
DR IHW; IHW9220
DR IMGT/HLA; 11580
WW http://bioinformatics.hsanmartino.it/ecbr/cl220.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XLIV-5A2-B9
AC CVCL_U045
SY B-19; B19
RX PubMed=8734946;
CC Monoclonal antibody target: Leishmania guyanensis.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XLK-WG
AC CVCL_5655
SY XLKWG; Xenopus Laevis Kidney - Wu & Gall
DR CLO; CLO_0009649
DR ATCC; CRL-2527
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Female
CA Finite cell line
//
ID XLK2
AC CVCL_H009
SY XlK2; XLK-2; XlK-2; XL-K2; Xl K2
RX PubMed=2342463;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Finite cell line
//
ID XLT-15
AC CVCL_6744
SY XLT15
DR BTO; BTO:0001956
RX PubMed=9030578;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XM
AC CVCL_R938
SY Xiphophorus Melanoma
RX PubMed=18377217;
CC Group: Fish cell line.
OX NCBI_TaxID=8086; ! Xiphophorus xiphidium
SX Sex undetermined
CA Cancer cell line
//
ID XMG1.2
AC CVCL_2H37
SY XMG 1.2; XMG-1.2
DR BCRJ; 0249
RX PubMed=2960769;
CC Monoclonal antibody target: UniProtKB; P01580; Mouse Ifng.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybridoma
//
ID XMMCO-791
AC CVCL_F815
DR CLO; CLO_0009650
DR ATCC; HB-9173
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XMMEN-OE5
AC CVCL_F816
SY AAB-647; AAB647
DR CLO; CLO_0009651
DR ATCC; HB-9081
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID XMMME-001
AC CVCL_F817
DR CLO; CLO_0009652
DR ATCC; HB-8759
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID XMMME-002
AC CVCL_F818
DR CLO; CLO_0009653
DR ATCC; HB-8760
CC Discontinued: ATCC; HB-8760; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID XP-1
AC CVCL_Z271
RX PubMed=10614871;
CC Group: Insect cell line.
OX NCBI_TaxID=1191636; ! Xylotrechus pyrrhoderus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XP-4
AC CVCL_U695
SY XP4RO
DR ATCC; CRL-1260
RX PubMed=7471106;
CC Discontinued: ATCC; CRL-1260; true.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP0006
AC CVCL_8Z03
DR ECACC; 03060734
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XP0007
AC CVCL_8Z04
DR ECACC; 03060735
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID XP0008
AC CVCL_8Z05
DR ECACC; 00306116
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C110940; Panhypopituitarism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8Z10 ! XP0013
SX Male
CA Transformed cell line
//
ID XP0009
AC CVCL_8Z06
DR ECACC; 03061162
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C110940; Panhypopituitarism
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID XP0010
AC CVCL_8Z07
DR ECACC; 03081426
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID XP0011
AC CVCL_8Z08
DR ECACC; 03081427
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C110940; Panhypopituitarism
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XP0012
AC CVCL_8Z09
DR ECACC; 03082243
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID XP0013
AC CVCL_8Z10
DR ECACC; 03082244
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C110940; Panhypopituitarism
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8Z05 ! XP0008
SX Male
CA Transformed cell line
//
ID XP0014
AC CVCL_8Z11
DR ECACC; 03082351
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C110940; Panhypopituitarism
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XP10OS
AC CVCL_9S67
DR JCRB; KURB1320
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID XP11BR
AC CVCL_W049
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2556 ! LB205
SX Male
CA Finite cell line
//
ID XP125LO
AC CVCL_W053
DI NCIt; C3969; Xeroderma pigmentosum, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2572 ! LB83
SX Female
CA Finite cell line
//
ID XP12SE
AC CVCL_U870
DR JCRB; KURB1042
RX PubMed=202381;
RX PubMed=6865988;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8767 ! XPL 12
SX Male
CA Finite cell line
//
ID XP15OS
AC CVCL_9S68
DR JCRB; KURB1326
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP15SE
AC CVCL_U869
DR JCRB; KURB1363
RX PubMed=202381;
RX PubMed=6865988;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8768 ! XPL 15
SX Male
CA Finite cell line
//
ID XP165MA
AC CVCL_4T40
RX PubMed=23370536;
DI NCIt; C3969; Xeroderma pigmentosum, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP17BE
AC CVCL_3815
SY GM10428
DR CLO; CLO_0009661
DR CLO; CLO_0028646
DR ATCC; CRL-1360
DR BioSample; SAMN03471356
DR Coriell; GM10428
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,10
ST D5S818: 12,13
ST D7S820: 9,11
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 15,19
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L778 ! GM02253
SX Male
CA Finite cell line
//
ID XP17SE
AC CVCL_W724
RX PubMed=202381;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8769 ! XPL 17
SX Female
CA Finite cell line
//
ID XP18SE
AC CVCL_U866
DR JCRB; KURB1182
RX PubMed=6865988;
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U865 ! XPL 18
SX Male
CA Finite cell line
//
ID XP19SE
AC CVCL_U867
DR JCRB; KURB1183
RX PubMed=6865988;
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8770 ! XPL 19
SX Male
CA Finite cell line
//
ID XP24KO
AC CVCL_F514
DR JCRB; JCRB3012
DR JCRB; KURB1081
RX PubMed=10771487;
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP27OS
AC CVCL_9S69
DR JCRB; KURB1335
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP2OS(SV)
AC CVCL_3242
SY XP2OS-SV; XP20S-SV40; XP20s(SV40)
DR JCRB; JCRB0301
DR JCRB; KURB1008
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 12
ST D5S818: 11
ST D7S820: 8,12
ST TH01: 9
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F510 ! GM04312
SX Female
CA Transformed cell line
//
ID XP2SA
AC CVCL_3243
DR JCRB; JCRB0305
DR JCRB; KURB1123
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,9
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP2YO
AC CVCL_F598
SY GM04313; GM04313D
DR CLO; CLO_0019547
DR Coriell; GM04313
DR JCRB; KURB1092
DR JCRB; KURB1093
DI NCIt; C3968; Xeroderma pigmentosum, complementation group F
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP2YO(SV)
AC CVCL_3244
SY XP2YO-SV; GM08437; GM08437B
DR CLO; CLO_0010546
DR BioSample; SAMN03471615
DR Coriell; GM08437
DR JCRB; JCRB0302
DR JCRB; KURB1094
DR JCRB; KURB1095
RX PubMed=1660831;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 11
ST D5S818: 10,13
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8
ST vWA: 13,17
DI NCIt; C3968; Xeroderma pigmentosum, complementation group F
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F598 ! XP2YO
SX Female
CA Transformed cell line
//
ID XP30RO
AC CVCL_7395
AS CVCL_G334
SY XP-V XP30RO; XP-V (XP30RO); GM03617; GM3617
DR BTO; BTO:0004753
DR CLO; CLO_0017188
DR Coriell; GM03617
RX PubMed=7471106;
RX PubMed=7565859;
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XP35OS
AC CVCL_3247
DR JCRB; JCRB0304
DR JCRB; KURB1164
RX PubMed=1372102;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 9,10
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP35OS(SVT)
AC CVCL_4Y31
DR JCRB; KURB1165
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3247 ! XP35OS
CA Transformed cell line
//
ID XP39OS
AC CVCL_3248
DR JCRB; JCRB0326
DR JCRB; KURB1013
RX PubMed=1372102;
RX PubMed=3814505;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 10,12
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP39OS(SVT)
AC CVCL_4Y32
DR JCRB; KURB1014
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3248 ! XP39OS
SX Female
CA Transformed cell line
//
ID XP39OSTERT
AC CVCL_3249
SY XP39OS hTERT
DR BioSample; SAMN03472494
DR JCRB; JCRB1057
DR JCRB; KURB1015
DR JCRB; NIHS0307
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0307; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,11
ST D16S539: 10,12
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3248 ! XP39OS
SX Female
CA Telomerase immortalized cell line
//
ID XP39R
AC CVCL_9S66
RX PubMed=26090552;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3248 ! XP39OS
SX Female
CA Induced pluripotent stem cell
//
ID XP3OS
AC CVCL_3245
AS CVCL_F511
SY XP30S; GM04314
DR CLO; CLO_0019557
DR Coriell; GM04314
DR JCRB; JCRB0303
DR JCRB; KURB1002
DR JCRB; KURB1003
DR JCRB; KURB1004
RX PubMed=1372102;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 9,12
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP3OS(SVT)
AC CVCL_3246
DR BioSample; SAMN03472492
DR JCRB; JCRB1055
DR JCRB; KURB1005
DR JCRB; NIHS0304
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: JCRB; NIHS0304; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 9,12
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3245 ! XP3OS
SX Female
CA Transformed cell line
//
ID XP3R
AC CVCL_9S65
RX PubMed=26090552;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3245 ! XP3OS
SX Female
CA Induced pluripotent stem cell
//
ID XP40GO
AC CVCL_4T42
RX PubMed=23370536;
DI NCIt; C3969; Xeroderma pigmentosum, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP40OS
AC CVCL_3250
DR BioSample; SAMN03793112
DR JCRB; JCRB0327
DR JCRB; KURB1168
DR JCRB; KURB1169
RX PubMed=26697316;
CC Omics: Deep exome analysis.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 10,12
ST D5S818: 10,13,14
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID XP40OS iPS
AC CVCL_CV31
RX PubMed=26697316;
CC Omics: Deep exome analysis.
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3250 ! XP40OS
SX Male
CA Induced pluripotent stem cell
//
ID XP40OSTERT
AC CVCL_3251
DR BioSample; SAMN03472495
DR JCRB; JCRB1058
DR JCRB; NIHS0308
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: JCRB; NIHS0308; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,9
ST D16S539: 10,12
ST D5S818: 10,14
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3250 ! XP40OS
SX Male
CA Telomerase immortalized cell line
//
ID XP44RO
AC CVCL_M221
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8013 ! XP44RO(Mel)
SX Male
CA Finite cell line
//
ID XP44RO(Mel)
AC CVCL_8013
SY XP44RO(MEL); GM13030
DR CLO; CLO_0014031
DR Coriell; GM13030
RX PubMed=2645048;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M221 ! XP44RO
SX Male
CA Cancer cell line
//
ID XP4PA(SV)
AC CVCL_6E33
SY XP4PA-SV
DR JCRB; KURB1064
RX PubMed=1660831;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XP4PA-SE1
AC CVCL_F627
SY GM16247
DR CLO; CLO_0019445
DR Coriell; GM16247
RX PubMed=10681431;
CC Transfected with: HGNC; 12816; XPC.
CC Transfected with: UniProtKB; P03211; EBV EBNA1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F625 ! XP4PA-SV-EB
SX Male
CA Transformed cell line
//
ID XP4PA-SE2
AC CVCL_F628
SY GM16248
DR CLO; CLO_0019446
DR Coriell; GM16248
RX PubMed=10681431;
CC Transfected with: HGNC; 12816; XPC.
CC Transfected with: UniProtKB; P03211; EBV EBNA1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F625 ! XP4PA-SV-EB
SX Male
CA Transformed cell line
//
ID XP4PA-SV-EB
AC CVCL_F625
SY GM15983
DR CLO; CLO_0018741
DR Coriell; GM15983
RX PubMed=1660831;
RX PubMed=10681431;
CC Transfected with: UniProtKB; P03211; EBV EBNA1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6E33 ! XP4PA(SV)
SX Male
CA Transformed cell line
//
ID XP5BE
AC CVCL_U762
SY XP5 BE; Be Wen
DR ATCC; CRL-1160
DR JCRB; KURB1071
CC Discontinued: ATCC; CRL-1160; probable.
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP5SE
AC CVCL_U871
DR JCRB; KURB1358
RX PubMed=202381;
RX PubMed=6865988;
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8773 ! XPL 5
SX Male
CA Finite cell line
//
ID XP6TO
AC CVCL_9S70
DR JCRB; KURB1370
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP70TO
AC CVCL_F513
DR JCRB; JCRB3013
DR JCRB; JCRB3014
DR JCRB; KURB1082
DR JCRB; KURB1083
RX PubMed=1376435;
RX PubMed=10771487;
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XP72MA
AC CVCL_4T41
RX PubMed=23370536;
DI NCIt; C3969; Xeroderma pigmentosum, complementation group G
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP7TO
AC CVCL_9S71
DR JCRB; KURB1043
RX PubMed=1372102;
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP80TO
AC CVCL_DE29
DR JCRB; KURB1084
RX PubMed=1376435;
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP81TO
AC CVCL_DE30
DR JCRB; KURB1085
RX PubMed=1376435;
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XP8BR
AC CVCL_W051
DI NCIt; C3967; Xeroderma pigmentosum, complementation group D
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2560 ! LB316
SX Male
CA Finite cell line
//
ID XP95TO
AC CVCL_4Y29
RX PubMed=1376435;
RX PubMed=9539981;
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XPA-1
AC CVCL_9502
SY XPA1; PX-184; PX184; PXA184
DR Cosmic; 1198218
RX PubMed=14520411;
RX PubMed=16912165;
CC From: Maitra A.; Johns Hopkins University; Baltimore; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID XPA-2
AC CVCL_9503
SY XPA2; PX-196; PX196; PXA196
RX PubMed=14520411;
RX PubMed=16912165;
CC From: Maitra A.; Johns Hopkins University; Baltimore; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID XPA-3
AC CVCL_9504
SY XPA3; XPa3; PX-154; PX154
DR Cosmic; 1198219
RX PubMed=14520411;
RX PubMed=16912165;
CC From: Maitra A.; Johns Hopkins University; Baltimore; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID XPA-4
AC CVCL_9505
SY XPA4; XPa4
DR Cosmic; 1198220
CC From: Maitra A.; Johns Hopkins University; Baltimore; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID XPBHBE
AC CVCL_U763
SY XP1MI
DR ATCC; CRL-1333
DR JCRB; KURB1117
CC Discontinued: ATCC; CRL-1333; true.
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID XPEMB-1
AC CVCL_3252
SY XPEMB1
DR JCRB; JCRB0325
RX PubMed=1372102;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 11,14
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID XPET6/1
AC CVCL_4Y30
RX PubMed=9539981;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4Y29 ! XP95TO
CA Transformed cell line
//
ID XPKMSF
AC CVCL_U764
DR ATCC; CRL-1203
CC Discontinued: ATCC; CRL-1203; probable.
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID XPL 12
AC CVCL_8767
SY XPL12
RX PubMed=202381;
RX PubMed=6865988;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U870 ! XP12SE
SX Male
CA Transformed cell line
//
ID XPL 15
AC CVCL_8768
SY XPL15
DR TKG; TKG 0310
RX PubMed=202381;
RX PubMed=1906129;
RX PubMed=6865988;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U869 ! XP15SE
SX Male
CA Transformed cell line
//
ID XPL 17
AC CVCL_8769
SY XPL17
DR CLO; CLO_0051020
DR BioSample; SAMN03471955
DR RCB; RCB2286
DR TKG; TKG 0311
RX PubMed=202381;
RX PubMed=1906129;
RX PubMed=6865988;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 9
ST D5S818: 10,12
ST D7S820: 8,11
ST TH01: 6,7
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W724 ! XP17SE
SX Female
CA Transformed cell line
//
ID XPL 18
AC CVCL_U865
SY XPL18
RX PubMed=6865988;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U866 ! XP18SE
SX Male
CA Transformed cell line
//
ID XPL 19
AC CVCL_8770
SY XPL19
DR CLO; CLO_0050493
DR BioSample; SAMN03471924
DR RCB; RCB2539
DR TKG; TKG 0312
RX PubMed=1906129;
RX PubMed=6865988;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 10,13
ST D7S820: 8,14
ST TH01: 5,6
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U867 ! XP19SE
SX Male
CA Transformed cell line
//
ID XPL 20
AC CVCL_8771
SY XPL20
DR CLO; CLO_0050477
DR BioSample; SAMN03471956
DR RCB; RCB2287
DR TKG; TKG 0313
RX PubMed=1906129;
RX PubMed=6865988;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 12,14
ST D16S539: 10,13
ST D5S818: 9,12
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8
ST vWA: 14
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XPL 24
AC CVCL_8772
SY XPL24
DR CLO; CLO_0051021
DR BioSample; SAMN03471925
DR RCB; RCB2540
DR TKG; TKG 0314
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,13
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C3452; Xeroderma pigmentosum
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID XPL 5
AC CVCL_8773
SY XPL5
DR CLO; CLO_0050476
DR BioSample; SAMN03472081
DR RCB; RCB1875
DR TKG; TKG 0309
RX PubMed=202381;
RX PubMed=6865988;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 10,11
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C114771; Xeroderma pigmentosum, complementation group E
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U871 ! XP5SE
SX Male
CA Transformed cell line
//
ID XPL15OS
AC CVCL_3253
DR JCRB; JCRB0307
DR JCRB; KURB1281
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,10
ST D16S539: 11,13
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 8,9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3965; Xeroderma pigmentosum, complementation group A
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID XPL3KA
AC CVCL_3254
DR JCRB; JCRB0306
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,13
ST D16S539: 10,11
ST D5S818: 9,11
ST D7S820: 8,11
ST TH01: 9
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C114770; Xeroderma pigmentosum, complementation group C
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XPML17
AC CVCL_F907
RX PubMed=202381;
RX PubMed=1906129;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID XPPL17
AC CVCL_F908
RX PubMed=202381;
RX PubMed=1906129;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID XPTS-1
AC CVCL_9U60
RX PubMed=21575431;
RX PubMed=22932480;
CC Misspelling: 'XTPS-1' in PubMed=22932480 (everywhere in the paper including in the title).
DI NCIt; C7394; Juvenile capillary hemangioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XQH
AC CVCL_J129
DR ATCC; CRL-11864
RX Patent=US5976860;
CC Discontinued: ATCC; CRL-11864; probable.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID XR-1
AC CVCL_K253
SY CHO XR-1; CHO.XR-1; GM16147
DR CLO; CLO_0019811
DR CLO; CLO_0050426
DR Coriell; GM16147
DR RCB; RCB2331
RX PubMed=2164147;
RX PubMed=6836453;
RX PubMed=10047779;
CC Characteristics: Both alleles of Xrcc4 are deleted in this cell line.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_K254 ! CHO 4364
SX Female
CA Spontaneously immortalized cell line
//
ID XR-C1
AC CVCL_S146
SY XRC-1; XRC1; GM16135
DR CLO; CLO_0018814
DR Coriell; GM16135
RX PubMed=9628911;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D898 ! CHO-9
SX Female
CA Spontaneously immortalized cell line
//
ID XR-V10B
AC CVCL_F517
RX PubMed=9742232;
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_6296 ! V79B
SX Male
CA Spontaneously immortalized cell line
//
ID XR-V11B
AC CVCL_F518
RX PubMed=9742232;
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_6296 ! V79B
SX Male
CA Spontaneously immortalized cell line
//
ID XR-V12B
AC CVCL_F519
RX PubMed=9742232;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_6296 ! V79B
SX Male
CA Spontaneously immortalized cell line
//
ID XR-V13B
AC CVCL_F520
RX PubMed=9742232;
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_6296 ! V79B
SX Male
CA Spontaneously immortalized cell line
//
ID XR-V15B
AC CVCL_3271
SY GM16144
DR CLO; CLO_0009694
DR CLO; CLO_0018891
DR CLO; CLO_0051580
DR ATCC; CRL-2349
DR Coriell; GM16144
DR RCB; RCB2339
RX PubMed=2460764;
RX PubMed=8657125;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_6296 ! V79B
SX Male
CA Spontaneously immortalized cell line
//
ID XR-V16B
AC CVCL_F521
SY GM16145
DR CLO; CLO_0018890
DR Coriell; GM16145
RX PubMed=9742232;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_6296 ! V79B
SX Male
CA Spontaneously immortalized cell line
//
ID XR-V9B
AC CVCL_HM60
RX PubMed=1438689;
RX PubMed=8657125;
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_6296 ! V79B
SX Male
CA Spontaneously immortalized cell line
//
ID XR-V9B-4
AC CVCL_8651
DR CLO; CLO_0051581
DR RCB; RCB2338
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HM60 ! XR-V9B
SX Male
CA Spontaneously immortalized cell line
//
ID XR1
AC CVCL_T691
SY Xenopus retina 1
RX DOI=10.1006/ncmn.1993.1060;
RX PubMed=2659410;
RX PubMed=3257022;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XR8
AC CVCL_T692
SY Xenopus retina 8
RX PubMed=2659410;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XR9
AC CVCL_T693
SY Xenopus retina 9
RX PubMed=2659410;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID XRpe1
AC CVCL_T694
RX DOI=10.1006/ncmn.1993.1060;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
CA Spontaneously immortalized cell line
//
ID XRpe2
AC CVCL_T695
RX DOI=10.1006/ncmn.1993.1060;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
CA Spontaneously immortalized cell line
//
ID XRpe4
AC CVCL_T696
RX DOI=10.1006/ncmn.1993.1060;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
CA Spontaneously immortalized cell line
//
ID XRpe5
AC CVCL_T697
RX DOI=10.1006/ncmn.1993.1060;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
CA Spontaneously immortalized cell line
//
ID XS20
AC CVCL_AV87
RX PubMed=7490479;
RX PubMed=7876542;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID XS52
AC CVCL_K270
RX PubMed=7490479;
RX PubMed=7876542;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID XS63
AC CVCL_3626
DR CLO; CLO_0009695
DR ATCC; TIB-17
RX PubMed=5439579;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID XT67E1
AC CVCL_AS08
SY XT
DR GEO; GSM397402
DR GEO; GSM397403
DR GEO; GSM397404
DR GEO; GSM397405
DR GEO; GSM397406
DR GEO; GSM397407
RX PubMed=8538762;
RX PubMed=19581487;
RX PubMed=23850244;
CC Omics: DNA methylation analysis.
CC Omics: H3K27me3 ChIP-seq epigenome analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Breed/subspecies: PGK x 129/Ola/Hsd.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_AS07 ! PGK12.1
SX Female
CA Embryonic stem cell
//
ID XTC-1
AC CVCL_9916
SY XTC1; XTC; XTC-UC1; XTC.UC1
DR Cosmic; 1084281
DR Cosmic; 1162844
DR Cosmic; 2036689
DR Cosmic; 2328761
RX PubMed=9669284;
RX PubMed=11349830;
RX PubMed=16646677;
RX PubMed=17725429;
RX PubMed=19087340;
CC Derived from metastatic site: Breast.
DI NCIt; C4946; Thyroid gland oncocytic follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XTC-YF
AC CVCL_5610
SY XTC-2
DR CLO; CLO_0050158
DR RCB; RCB0771
RX PubMed=4708349;
CC Group: Amphibian cell line.
CC Caution: According to RCB0771 XTC-YF and XTC-2 are identical.
OX NCBI_TaxID=8355; ! Xenopus laevis
CA Spontaneously immortalized cell line
//
ID XTH-2
AC CVCL_1892
DR CLO; CLO_0009696
DR CLDB; cl4785
DR DSMZ; ACC-190
RX CelloPub=CLPUB00129;
RX PubMed=3091251;
CC Group: Amphibian cell line.
CC Doubling time: ~10-12 days (DSMZ).
OX NCBI_TaxID=8355; ! Xenopus laevis
CA Spontaneously immortalized cell line
//
ID XTK0
AC CVCL_7228
DR CLO; CLO_0009697
DR CLDB; cl4786
RX PubMed=6278782;
CC Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HSV-2).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_3256 ! XTK2
CA Transformed cell line
//
ID XTK1
AC CVCL_3255
DR CLO; CLO_0009698
DR CLDB; cl4787
RX PubMed=6278782;
CC Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HSV-2).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Transformed cell line
//
ID XTK2
AC CVCL_3256
DR CLO; CLO_0009699
DR CLDB; cl4788
RX PubMed=6278782;
CC Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HSV-2).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Transformed cell line
//
ID XTUU 139/30
AC CVCL_9V36
RX PubMed=1335463;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybrid cell line
//
ID XTUU D10
AC CVCL_9V37
RX PubMed=1335463;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybrid cell line
//
ID XTY
AC CVCL_5611
DR CLO; CLO_0050157
DR RCB; RCB0770
RX PubMed=1737584;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8355; ! Xenopus laevis
CA Cancer cell line
//
ID XVI E6E6G10
AC CVCL_F819
DR CLO; CLO_0009700
DR ATCC; HB-9496
RX Patent=US4816417;
CC Monoclonal antibody target: UniProtKB; A3RGC1; Pig VDR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID XWLC-05
AC CVCL_IQ71
SY XuanWei Lung Cancer-05
RX PubMed=17222362;
CC Doubling time: 32.8 hours (PubMed=17222362).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID XX406
AC CVCL_F543
SY TER165; TER250; TER269
DR IMGT/HLA; 11581
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Y-17
AC CVCL_E991
DR CLO; CLO_0009704
DR ATCC; HB-179
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Y-1K
AC CVCL_8774
RX PubMed=7918028;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Y-3
AC CVCL_E990
DR CLO; CLO_0009705
DR ATCC; HB-176
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Y-3P
AC CVCL_E989
DR CLO; CLO_0009708
DR ATCC; HB-183
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Y-79
AC CVCL_1893
SY Y79; GM01232
DR BTO; BTO:0002920
DR CLO; CLO_0009709
DR CLO; CLO_0030277
DR CLO; CLO_0051564
DR EFO; EFO_0002392
DR CLDB; cl4796
DR CLDB; cl4797
DR CLDB; cl4798
DR CLDB; cl4984
DR ATCC; HTB-18
DR BCRC; 60422
DR BCRJ; 0380
DR BioSample; SAMN01821607
DR BioSample; SAMN03472733
DR BioSample; SAMN03473388
DR CCRID; 3111C0001CCC000269
DR ChEMBL-Cells; CHEMBL3308054
DR ChEMBL-Targets; CHEMBL613820
DR CLS; 300382/p661_Y-79
DR Cosmic; 688120
DR Cosmic; 808507
DR Cosmic; 1071899
DR Cosmic; 1176623
DR DSMZ; ACC-246
DR ECACC; 86093003
DR Coriell; GM01232
DR ICLC; HTL99029
DR IGRhCellID; Y79
DR NCBI_Iran; C201
DR RCB; RCB0427
DR RCB; RCB1645
RX DOI=10.5795/jjscc.24.451;
RX PubMed=1679230;
RX PubMed=4135597;
RX PubMed=18799932;
RX PubMed=21697133;
CC Doubling time: ~40 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: Transcriptome analysis.
CC Anecdotal: Named Y-79 because it was the result of the 79th attempt of a group at Yale to establish a retinoblastoma cell line.
CC Discontinued: RCB; RCB0427; true.
ST Source(s): ATCC; CLS; DSMZ; ECACC; ICLC; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 13,14
ST D18S51: 13,16
ST D21S11: 30,32
ST D3S1358: 15,16
ST D5S818: 11,12 (ATCC; CLS; DSMZ; ECACC; RCB)
ST D5S818: 11 (ICLC)
ST D7S820: 8,9
ST D8S1179: 13,16
ST FGA: 22
ST Penta D: 12
ST Penta E: 13,18
ST TH01: 6,9.3 (ATCC; CLS; ECACC; ICLC; RCB)
ST TH01: 6,10 (DSMZ)
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C7541; Retinoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Y-MESO-12
AC CVCL_5178
DR GEO; GSM552526
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-14
AC CVCL_5179
SY Y-Meso-14
DR GEO; GSM552527
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-21
AC CVCL_5180
DR GEO; GSM552528
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-22
AC CVCL_5181
DR GEO; GSM552529
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-25
AC CVCL_5182
DR GEO; GSM552530
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-26B
AC CVCL_5183
DR GEO; GSM552531
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-27
AC CVCL_5184
DR GEO; GSM552533
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-28
AC CVCL_5185
DR GEO; GSM552534
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-29
AC CVCL_5186
DR GEO; GSM552535
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-30
AC CVCL_5187
DR GEO; GSM552536
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-32
AC CVCL_M203
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-37
AC CVCL_M204
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-43
AC CVCL_M205
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-45
AC CVCL_M206
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-MESO-8A
AC CVCL_5188
RX PubMed=16630136;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5189 ! Y-MESO-8D
SX Male
CA Cancer cell line
//
ID Y-MESO-8D
AC CVCL_5189
DR GEO; GSM552524
RX PubMed=16630136;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5188 ! Y-MESO-8A
SX Male
CA Cancer cell line
//
ID Y-MESO-9
AC CVCL_5190
DR GEO; GSM552525
RX PubMed=19380521;
RX PubMed=22286761;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Y-ML-1B
AC CVCL_4779
RX PubMed=12377411;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Y-ML-1B
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Y.I.
AC CVCL_E892
SY YI
DR dbMHC; 49086
DR ECACC; 94061620
DR IHW; IHW9352
DR IMGT/HLA; 11583
WW http://bioinformatics.hsanmartino.it/ecbr/cl352.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Y0
AC CVCL_2783
SY YO; YB2/3.0Ag30
DR CLO; CLO_0009715
DR CLDB; cl4804
DR ECACC; 85110501
DR NCBI_Iran; C133
RX PubMed=22358559;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8984 ! YB2/0
CA Hybrid cell line
//
ID Y1
AC CVCL_0585
SY Y-1; Y 1; Clone Y-1; Clone Y1; GM05384
DR BTO; BTO:0000046
DR CLO; CLO_0009701
DR CLO; CLO_0024853
DR CLO; CLO_0051608
DR MCCL; MCC:0000491
DR CLDB; cl4789
DR CLDB; cl4791
DR CLDB; cl4792
DR CLDB; cl4793
DR ATCC; CCL-79
DR BCRC; 60363
DR BCRJ; 0254
DR CCRID; 3131C0001000300014
DR ChEMBL-Cells; CHEMBL3307727
DR ChEMBL-Targets; CHEMBL614872
DR CLS; 400477/NA
DR Coriell; GM05384
DR ECACC; 85062807
DR IZSLER; BS TCL 67
DR JCRB; JCRB9056
DR NCBI_Iran; C199
DR RCB; RCB0533
RX PubMed=423792;
RX PubMed=5930699;
RX PubMed=15541570;
CC Discontinued: CLS; 400477; true.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5F74 ! Y6
SX Male
CA Cancer cell line
//
ID Y1-8BrcAMPr-1
AC CVCL_5G24
SY 8BrcAMPr-1
RX PubMed=200506;
RX PubMed=215599;
CC Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-BS1
AC CVCL_W154
SY Y1BS1
DR BTO; BTO:0004236
RX PubMed=423792;
RX PubMed=2713387;
RX PubMed=6270152;
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0585 ! Y1
SX Male
CA Cancer cell line
//
ID Y1-Cyc-101
AC CVCL_5G15
SY Cyc-101; Cyc 101
RX PubMed=221910;
RX PubMed=6270152;
CC Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-Cyc-102
AC CVCL_5G16
SY Cyc-102; Cyc 102
RX PubMed=221910;
RX PubMed=6270152;
CC Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-Cyc-103
AC CVCL_5G17
SY Cyc-103; Cyc 103
RX PubMed=221910;
RX PubMed=6270152;
CC Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-Forsk-10r-1
AC CVCL_5G18
SY Forsk-10r-1
RX PubMed=6538878;
CC Selected for resistance to: ChEBI; CHEBI:42471; Forskolin.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-Forsk-10r-6
AC CVCL_5G19
SY Forsk-10r-6; 10r6
RX PubMed=6538878;
RX PubMed=15541570;
CC Selected for resistance to: ChEBI; CHEBI:42471; Forskolin.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-Forsk-10r-9
AC CVCL_5G20
SY Forsk-10r-9; 10r9
RX PubMed=6538878;
RX PubMed=15541570;
CC Selected for resistance to: ChEBI; CHEBI:42471; Forskolin.
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-HGPRT-
AC CVCL_5G26
RX PubMed=198663;
RX PubMed=6270152;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0585 ! Y1
SX Male
CA Cancer cell line
//
ID Y1-Kin-2
AC CVCL_5G21
SY Kin-2; Kin 2
RX PubMed=221910;
RX PubMed=6270152;
RX PubMed=8388994;
RX PubMed=15541570;
CC Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-Kin-7
AC CVCL_5G22
SY Kin-7; Kin 7
RX PubMed=221910;
RX PubMed=6270152;
RX PubMed=8388994;
RX PubMed=15541570;
CC Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y1-Kin-8
AC CVCL_5G23
SY Kin-8; Kin 8
RX PubMed=221910;
RX PubMed=6270152;
RX PubMed=8388994;
RX PubMed=15541570;
CC Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W154 ! Y1-BS1
SX Male
CA Cancer cell line
//
ID Y13-238
AC CVCL_8982
DR CLO; CLO_0009702
DR ATCC; CRL-1741
DR ECACC; 89111411
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID Y13-259
AC CVCL_8983
DR CLO; CLO_0009703
DR ATCC; CRL-1742
DR ECACC; 89111412
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID Y16
AC CVCL_5416
SY Y-16
RX PubMed=2265612;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Y16
CC Characteristics: IL5 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID Y3-Ag 1.2.3
AC CVCL_4342
SY Y3.AG.1.2.3; Y3-Ag1.2.3; Y3-Ag1,2,3; Y3Ag1.2.3; 210RCY3-Ag1.2.3; Y3; Y3M
DR CLO; CLO_0009706
DR CLO; CLO_0009707
DR CLDB; cl4794
DR CLDB; cl4795
DR ATCC; CRL-1631
DR CCRID; 3131C0001001200008
DR ECACC; 85110502
DR JCRB; JCRB9091
DR TKG; TKG 0283
RX PubMed=310519;
RX PubMed=22358559;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: LOU/C.
DI NCIt; C125416; Rat plasma cell myeloma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID Y6
AC CVCL_5F74
SY Y-6
RX PubMed=4311571;
RX PubMed=6270152;
RX PubMed=7588376;
RX PubMed=15541570;
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0585 ! Y1
SX Male
CA Cancer cell line
//
ID Y8-10C2
AC CVCL_2Z37
SY Sa11; WC00004
DR CLO; CLO_0013430
DR BioSamples; SAME17761
DR Coriell; WC00004
RX PubMed=9712021;
CC Discontinued: Coriell; WC00004; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID Y9-iPSC
AC CVCL_DD56
SY Y09-iPSC
RX PubMed=25843045;
RX PubMed=27191603;
ST Source(s): PubMed=27191603
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11
ST D21S11: 28
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DD55 ! ND34791
SX Female
CA Induced pluripotent stem cell
//
ID YAA
AC CVCL_8466
DR BioSample; SAMN03151986
RX PubMed=9067707;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID YAC-1
AC CVCL_2244
SY Yac-1
DR CLO; CLO_0009710
DR CLO; CLO_0050173
DR CLO; CLO_0050187
DR CLDB; cl4800
DR CLDB; cl4801
DR CLDB; cl4802
DR CLDB; cl4803
DR ATCC; TIB-160
DR BCRC; 60147
DR BCRJ; 0255
DR CCRID; 3111C0001CCC000089
DR CCRID; 3131C0001000800028
DR CCRID; 3142C0001000000001
DR ChEMBL-Cells; CHEMBL3308419
DR ChEMBL-Targets; CHEMBL612814
DR CLS; 400383/p711_Yac-1
DR DSMZ; ACC-96
DR ECACC; 86022801
DR IZSLER; BS TCL 243
DR KCB; KCB 93031YJ
DR KCLB; 40160
DR NCBI_Iran; C552
DR RCB; RCB1165
DR RCB; RCB2799
DR TKG; TKG 0387
WW http://www.cells-talk.com/index.php/page/copelibrary?key=YAC-1
CC Doubling time: ~20 hours (DSMZ).
CC Breed/subspecies: A/Sn.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID YADK-04
AC CVCL_6F17
RX Patent=RU2335537;
OX NCBI_TaxID=9925; ! Capra hircus
HI CVCL_M729 ! CG-91
SX Female
CA Spontaneously immortalized cell line
//
ID YaFuSS
AC CVCL_L809
DR Cosmic; 1319810
RX PubMed=15814652;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Yak-BL
AC CVCL_7212
SY Yak
RX PubMed=9882297;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAM-P
AC CVCL_F445
DR CLO; CLO_0051139
DR RCB; HSC0006
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAM-RTK1
AC CVCL_8014
SY YAM-RTK-1
CC From: Sugita K.; Yamanashi Medical University; Kofu; Japan.
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Yamada
AC CVCL_FA16
RX PubMed=21908323;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Originally thought to be an osteosarcoma cell line of dog origin but found to be from mouse (PubMed=21908323).
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Undefined cell line type
//
ID Yamane
AC CVCL_DN30
DR GEO; GSM1974801
RX PubMed=27197945;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID Yamato-SS
AC CVCL_6C44
DR RCB; RCB3577
RX PubMed=20518020;
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YAMB-1
AC CVCL_A292
RX PubMed=20519628;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID YAMB-3
AC CVCL_A293
RX PubMed=20519628;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID YAMB-4
AC CVCL_A294
RX PubMed=20519628;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID YAMB-9
AC CVCL_A295
RX PubMed=20519628;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID YAMC
AC CVCL_6E40
SY Young Adult Mouse Colon
RX PubMed=7678459;
WW https://www.abmgood.com/Immortalized-(Conditionally)-Mouse-Colonic-Epithelial-Cells-(YAMC)-T0567.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID YAML 501.4
AC CVCL_J777
DR ECACC; 11060812
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YAML 555.6
AC CVCL_J778
DR ECACC; 11060816
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YAMN-73
AC CVCL_8015
SY YAMN73
RX PubMed=10360377;
RX PubMed=10942233;
RX PubMed=12506034;
RX PubMed=20519628;
DI NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAMN-74
AC CVCL_W272
SY YAMN74
RX PubMed=10360377;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAMN-90
AC CVCL_A079
SY YAMN90
RX PubMed=20519628;
DI NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAMN-91
AC CVCL_8016
SY YAMN91
RX PubMed=12506034;
RX PubMed=20519628;
DI NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAMN-92
AC CVCL_A080
SY YAMN92
RX PubMed=20519628;
DI NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAMRT
AC CVCL_EJ26
DR Cosmic; 2144787
RX PubMed=24418192;
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAMT-12
AC CVCL_A081
RX PubMed=20519628;
CC Miscellaneous: Only mentioned as a T-ALL cell line in PubMed=20519628.
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YAN3102
AC CVCL_F446
DR CLO; CLO_0051166
DR RCB; HSC0128
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3103
AC CVCL_F447
DR CLO; CLO_0051164
DR RCB; HSC0124
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3119
AC CVCL_F448
DR CLO; CLO_0051052
DR RCB; HSC0010
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3136
AC CVCL_F449
DR CLO; CLO_0051175
DR RCB; HSC0136
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3140
AC CVCL_F450
DR CLO; CLO_0051053
DR RCB; HSC0011
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3141
AC CVCL_F451
DR CLO; CLO_0051060
DR RCB; HSC0022
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3142
AC CVCL_F452
DR CLO; CLO_0051051
DR RCB; HSC0008
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3143
AC CVCL_F453
DR CLO; CLO_0051054
DR RCB; HSC0012
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3150
AC CVCL_F454
DR CLO; CLO_0051055
DR RCB; HSC0014
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3152
AC CVCL_F455
DR CLO; CLO_0051087
DR RCB; HSC0057
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3154
AC CVCL_F456
DR CLO; CLO_0051063
DR RCB; HSC0025
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3161
AC CVCL_F457
DR CLO; CLO_0051057
DR RCB; HSC0018
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3191
AC CVCL_F458
DR CLO; CLO_0051144
DR RCB; HSC0019
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3206
AC CVCL_F459
DR CLO; CLO_0051093
DR RCB; HSC0065
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3241
AC CVCL_F460
DR CLO; CLO_0051120
DR RCB; HSC0099
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3242
AC CVCL_F461
DR CLO; CLO_0051067
DR RCB; HSC0032
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3244
AC CVCL_F462
DR CLO; CLO_0051116
DR RCB; HSC0093
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3245
AC CVCL_F463
DR CLO; CLO_0051056
DR RCB; HSC0015
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3252
AC CVCL_F464
DR CLO; CLO_0051058
DR RCB; HSC0020
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3255
AC CVCL_F465
DR CLO; CLO_0051165
DR RCB; HSC0129
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3259
AC CVCL_F466
DR CLO; CLO_0051126
DR RCB; HSC0104
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3260
AC CVCL_F467
DR CLO; CLO_0051158
DR RCB; HSC0121
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3261
AC CVCL_F468
DR CLO; CLO_0051061
DR RCB; HSC0023
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3264
AC CVCL_F469
DR CLO; CLO_0051062
DR RCB; HSC0024
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3265
AC CVCL_F470
DR CLO; CLO_0051147
DR RCB; HSC0030
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3268
AC CVCL_F471
DR CLO; CLO_0051059
DR RCB; HSC0021
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3269
AC CVCL_F472
DR CLO; CLO_0051122
DR RCB; HSC0098
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3270
AC CVCL_F473
DR CLO; CLO_0051125
DR RCB; HSC0103
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3273
AC CVCL_F474
DR CLO; CLO_0051128
DR RCB; HSC0110
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3274
AC CVCL_F475
DR CLO; CLO_0051121
DR RCB; HSC0100
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3275
AC CVCL_F476
DR CLO; CLO_0051117
DR RCB; HSC0094
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3280
AC CVCL_F477
DR CLO; CLO_0051065
DR RCB; HSC0029
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID YAN3285
AC CVCL_F478
DR CLO; CLO_0051090
DR RCB; HSC0060
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3286
AC CVCL_F479
DR CLO; CLO_0051064
DR RCB; HSC0026
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAN3301
AC CVCL_F480
DR CLO; CLO_0051050
DR RCB; HSC0005
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: Venezuela.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YAP
AC CVCL_8467
DR BioSample; SAMN03151987
RX PubMed=8738564;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID YAPC
AC CVCL_1794
DR CLO; CLO_0009711
DR EFO; EFO_0006778
DR BioSample; SAMN03472904
DR BioSample; SAMN03473329
DR CCLE; YAPC_PANCREAS
DR ChEMBL-Cells; CHEMBL3307253
DR ChEMBL-Targets; CHEMBL612815
DR Cosmic; 909904
DR Cosmic; 2046537
DR Cosmic; 2434108
DR Cosmic-CLP; 909904
DR DSMZ; ACC-382
DR GDSC; 909904
DR GEO; GSM887742
DR GEO; GSM888837
DR GEO; GSM1670584
DR IGRhCellID; YAPC
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=YAPC
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'YPAC' in EFO EFO_0002393.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 9
ST D18S51: 17
ST D21S11: 31,31.2
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 9,11
ST D8S1179: 13,15
ST FGA: 21,22
ST Penta D: 10,13
ST Penta E: 5,19.4
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16,17 (Cosmic-CLP; DSMZ)
ST vWA: 17 (PubMed=25877200)
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YAR
AC CVCL_2192
DR dbMHC; 49083
DR ECACC; 95042721
DR IHW; IHW9026
DR IMGT/HLA; 11587
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl26.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID YB2/0
AC CVCL_8984
SY YB2/O; YB2/3HL.P2.G11.16Ag.20; YB2/3.0 Ag20; YB2/3.0Ag20
DR CLO; CLO_0009712
DR ATCC; CRL-1662
RX PubMed=6811596;
CC Group: Hybridoma fusion partner cell line.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybrid cell line
//
ID YBM 15.1.6
AC CVCL_G181
SY YBM15.1.6
DR ECACC; 89040602
RX PubMed=3330997;
CC Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YBM 29.2.1
AC CVCL_G182
SY YBM29.2.1
DR ECACC; 11060806
CC Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YBM 5.10.4
AC CVCL_G183
SY YBM5.10.4
DR ECACC; 11060805
RX PubMed=3330997;
CC Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YBM 6.1.10
AC CVCL_G184
SY YBM6.1.10
DR ECACC; 89040601
RX PubMed=3330997;
CC Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YCC-1
AC CVCL_9646
SY YCC1
DR EFO; EFO_0002876
DR Cosmic; 1482082
DR GEO; GSM562409
DR GEO; GSM1237682
DR GEO; GSM1237707
RX PubMed=10402490;
RX PubMed=18804159;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-10
AC CVCL_9647
SY YCC10
DR EFO; EFO_0002877
DR GEO; GSM562399
RX PubMed=18804159;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-11
AC CVCL_9648
SY YCC11
DR EFO; EFO_0002878
DR Cosmic; 1482084
DR GEO; GSM562412
DR GEO; GSM1237683
DR GEO; GSM1237708
RX PubMed=18804159;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-16
AC CVCL_9649
SY YCC16
DR EFO; EFO_0002879
DR GEO; GSM562413
DR GEO; GSM1237684
DR GEO; GSM1237709
RX PubMed=18804159;
RX PubMed=18922971;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YCC-17
AC CVCL_X027
SY YCC17
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-18
AC CVCL_9650
SY YCC18
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-19
AC CVCL_9651
SY YCC19
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-2
AC CVCL_9652
SY YCC2
DR GEO; GSM562414
DR GEO; GSM1237685
DR GEO; GSM1237710
RX PubMed=10402490;
RX PubMed=18804159;
RX PubMed=18922971;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-20
AC CVCL_9653
SY YCC20
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YCC-21
AC CVCL_9654
SY YCC21
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YCC-22
AC CVCL_9655
SY YCC22
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-23
AC CVCL_9656
SY YCC23
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YCC-3
AC CVCL_9657
SY YCC3
DR EFO; EFO_0002880
DR Cosmic; 1482083
DR GEO; GSM562415
DR GEO; GSM1237686
DR GEO; GSM1237711
RX PubMed=10402490;
RX PubMed=18804159;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-3/R
AC CVCL_9658
RX PubMed=20661724;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9657 ! YCC-3
SX Male
CA Cancer cell line
//
ID YCC-3/TP
AC CVCL_9659
RX PubMed=18922971;
CC Transfected with: HGNC; 3148; TYMP.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9657 ! YCC-3
SX Male
CA Cancer cell line
//
ID YCC-4
AC CVCL_9660
SY YCC4
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YCC-5
AC CVCL_9661
SY YCC5
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YCC-6
AC CVCL_9662
SY YCC6
DR EFO; EFO_0002881
DR GEO; GSM562410
DR GEO; GSM1237687
DR GEO; GSM1237712
RX PubMed=18804159;
RX PubMed=18922971;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YCC-7
AC CVCL_9663
SY YCC7
DR EFO; EFO_0002882
DR GEO; GSM562398
DR GEO; GSM1237688
DR GEO; GSM1237713
RX PubMed=10402490;
RX PubMed=18804159;
CC From: Yonsei Cancer Center; Seoul; South Korea.
CC Omics: Transcriptome analysis.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCC-9
AC CVCL_9664
SY YCC9
DR GEO; GSM562411
DR GEO; GSM1237689
DR GEO; GSM1237714
RX PubMed=18922971;
CC From: Yonsei Cancer Center; Seoul; South Korea.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCCEL1
AC CVCL_L440
RX PubMed=23175241;
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCR
AC CVCL_BT07
SY Yellow-Checked Rat cell line
DR CCRID; 3153C0001000000023
DR KCB; KCB 88001
OX NCBI_TaxID=69074; ! Rattus flavipectus
CA Undefined cell line type
//
ID YCR-1
AC CVCL_A397
DR Cosmic; 849377
RX PubMed=3528602;
RX PubMed=11146448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YCU-H891
AC CVCL_8017
DR Cosmic; 1136975
DR Cosmic; 1556186
RX PubMed=18097577;
RX PubMed=26780976;
RX PubMed=26781072;
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26780976, PubMed=26781072). Originally thought to originate from an hypopharyngeal squamous cell carcinoma.
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID YCU-L891
AC CVCL_8018
DR Cosmic; 1136977
DR Cosmic; 1556187
RX PubMed=18097577;
RX PubMed=26780976;
RX PubMed=26781072;
CC Problematic cell line: Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976, PubMed=26781072).
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8023 ! YCU-T891
CA Cancer cell line
//
ID YCU-M862
AC CVCL_8019
DR Cosmic; 1136972
DR Cosmic; 1556182
RX PubMed=18097577;
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
DI NCIt; C8181; Oropharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YCU-M911
AC CVCL_8020
DR Cosmic; 1136974
DR Cosmic; 1556197
RX PubMed=18097577;
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
DI NCIt; C8181; Oropharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YCU-MS861
AC CVCL_8021
DR Cosmic; 1136970
DR Cosmic; 1556183
RX PubMed=18097577;
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YCU-OR891
AC CVCL_8022
DR Cosmic; 1136962
DR Cosmic; 1556189
RX PubMed=18097577;
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YCU-T891
AC CVCL_8023
DR Cosmic; 1136968
DR Cosmic; 1556188
RX PubMed=18097577;
RX PubMed=26780976;
RX PubMed=26781072;
CC Problematic cell line: Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976, PubMed=26781072).
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8018 ! YCU-L891
CA Cancer cell line
//
ID YCU-T892
AC CVCL_8024
DR Cosmic; 1136969
DR Cosmic; 1556190
RX PubMed=18097577;
CC From: Tsukuda M.; Yokohama City University; Yokohama; Japan.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YCUB-2
AC CVCL_A082
SY YCUB2
RX PubMed=11417493;
RX PubMed=19157546;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCUB-4
AC CVCL_A083
RX PubMed=19157546;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A084 ! YCUB-4R
SX Male
CA Cancer cell line
//
ID YCUB-4R
AC CVCL_A084
RX PubMed=19157546;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A083 ! YCUB-4
SX Male
CA Cancer cell line
//
ID YCUB-5
AC CVCL_A085
RX PubMed=19157546;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A086 ! YCUB-5R
SX Male
CA Cancer cell line
//
ID YCUB-5R
AC CVCL_A086
RX PubMed=19157546;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A085 ! YCUB-5
SX Male
CA Cancer cell line
//
ID YCUB-6
AC CVCL_A087
RX PubMed=19157546;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YCUS-5
AC CVCL_N853
RX PubMed=10398195;
RX PubMed=16557275;
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YD-10B
AC CVCL_8929
SY YD10B
DR CCLE; YD10B_UPPER_AERODIGESTIVE_TRACT
DR GEO; GSM887743
DR GEO; GSM888838
DR KCLB; 60503
RX PubMed=16264262;
RX PubMed=17404023;
RX PubMed=22460905;
RX PubMed=23708675;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=16264262
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,9 (KCLB)
ST D13S317: 9 (PubMed=16264262)
ST D16S539: 10,11
ST D18S51: 14
ST D21S11: 30,32
ST D3S1358: 17
ST D5S818: 11,13
ST D7S820: 11
ST D8S1179: 11
ST DXS101: 22
ST FGA: 23
ST Penta D: 8,9
ST Penta E: 5,8
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18,19,20 (PubMed=16264262)
ST vWA: 18,19 (KCLB)
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YD-15
AC CVCL_8930
SY YD15
DR CCLE; YD15_SALIVARY_GLAND
DR GEO; GSM887744
DR GEO; GSM888839
DR KCLB; 60504
RX PubMed=16264262;
RX PubMed=21496182;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=16264262
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 14
ST D21S11: 30,31.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 12,13
ST D8S1179: 15
ST FGA: 23
ST Penta D: 9
ST Penta E: 14,19
ST TH01: 6,9
ST TPOX: 9
ST vWA: 15
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L078 ! YD-15M
SX Male
CA Cancer cell line
//
ID YD-15M
AC CVCL_L078
SY YD15M
DR KCLB; 60505
RX PubMed=16264262;
CC Derived from metastatic site: Lymph node.
ST Source(s): KCLB; PubMed=16264262
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 14
ST D21S11: 30,31.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 12,13
ST D8S1179: 15
ST FGA: 23
ST Penta D: 9
ST Penta E: 14,19
ST TH01: 6,9
ST TPOX: 9
ST vWA: 15
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8930 ! YD-15
SX Male
CA Cancer cell line
//
ID YD-17
AC CVCL_L081
SY YD17
RX PubMed=16264262;
ST Source(s): PubMed=16264262
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9,12
ST D18S51: 14,16
ST D21S11: 28,31
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 24
ST Penta D: 9,13
ST Penta E: 5,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L082 ! YD-17M
SX Male
CA Cancer cell line
//
ID YD-17M
AC CVCL_L082
SY YD17M
RX PubMed=16264262;
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=16264262
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9,12
ST D18S51: 14,16
ST D21S11: 28,31
ST D3S1358: 14,15
ST D5S818: 12
ST D7S820: 10,11
ST D8S1179: 13,15
ST FGA: 24
ST Penta D: 9,13
ST Penta E: 5,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L081 ! YD-17
SX Male
CA Cancer cell line
//
ID YD-38
AC CVCL_L083
SY YD38
DR CCLE; YD38_UPPER_AERODIGESTIVE_TRACT
DR GEO; GSM887745
DR GEO; GSM888840
DR KCLB; 60508
RX PubMed=16264262;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=16264262
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 12,13
ST D18S51: 14
ST D21S11: 30,31
ST D3S1358: 16
ST D5S818: 14
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 22,25
ST Penta D: 8,12
ST Penta E: 12,19
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YD-39
AC CVCL_B482
RX PubMed=22621906;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YD-8
AC CVCL_L079
SY YD8
DR CCLE; YD8_UPPER_AERODIGESTIVE_TRACT
DR GEO; GSM887746
DR GEO; GSM888841
DR KCLB; 60501
RX PubMed=16264262;
RX PubMed=22460905;
RX PubMed=23708675;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): KCLB; PubMed=16264262
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 9,11
ST D18S51: 15,16
ST D21S11: 29,30
ST D3S1358: 15.2 (KLCB)
ST D3S1358: 15,16 (PubMed=16264262)
ST D5S818: 12
ST D7S820: 10,13
ST D8S1179: 13,16
ST FGA: 24
ST Penta D: 13
ST Penta E: 12,15
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YD-9
AC CVCL_L080
SY YD9
DR KCLB; 60502
RX PubMed=16264262;
ST Source(s): KCLB; PubMed=16264262
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 12,13
ST D18S51: 13
ST D21S11: 30
ST D3S1358: 15,16
ST D5S818: 10,12
ST D7S820: 11,12
ST D8S1179: 11,13
ST FGA: 25
ST Penta D: 9
ST Penta E: 15,17
ST TH01: 6
ST TPOX: 8,9
ST vWA: 14,19
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YDOV-157
AC CVCL_W954
RX PubMed=18682896;
CC Omics: Proteome analysis by 2D-DE.
CC Omics: Transcriptome analysis.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YEL-13
AC CVCL_R989
SY Yamame Embryonal Liver-13
RX CelloPub=CLPUB00130;
RX DOI=10.2331/suisan.54.1881;
CC Group: Fish cell line.
OX NCBI_TaxID=8020; ! Oncorhynchus masou
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID YEO,AM
AC CVCL_E893
SY YEO, AM
DR dbMHC; 49084
DR IHW; IHW9137
DR IMGT/HLA; 11680
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl137.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID YES-1
AC CVCL_E321
SY YES1
DR GEO; GSM301574
RX PubMed=1770930;
RX PubMed=1819237;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YES-2
AC CVCL_E322
SY YES2
DR Cosmic; 2395009
DR GEO; GSM301575
RX CelloPub=CLPUB00005;
RX PubMed=1770930;
CC Doubling time: 23.7 hours (CelloPub=CLPUB00005).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YES-2CSC
AC CVCL_S526
RX PubMed=23983818;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E322 ! YES-2
SX Male
CA Cancer cell line
//
ID YES-3
AC CVCL_E323
RX PubMed=1770930;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YES-4
AC CVCL_S528
SY Yes-4
RX PubMed=8590302;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YES-5
AC CVCL_S529
RX PubMed=8590302;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YES-6
AC CVCL_S530
SY Yes-6
RX PubMed=8590302;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YFC 118.12
AC CVCL_J779
DR ECACC; 11072204
CC Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YFC 120.5
AC CVCL_J780
DR ECACC; 11060808
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YFEF
AC CVCL_9U61
SY Yak Fetal Ear Fibroblast
RX PubMed=23161386;
CC Doubling time: 35 hours (PubMed=23161386).
OX NCBI_TaxID=30521; ! Bos mutus grunniens
OI CVCL_9U62 ! YFLF
SX Male
CA Finite cell line
//
ID YFLF
AC CVCL_9U62
SY Yak Fetal Lung Fibroblast
RX PubMed=23161386;
CC Doubling time: 30 hours (PubMed=23161386).
OX NCBI_TaxID=30521; ! Bos mutus grunniens
OI CVCL_9U61 ! YFEF
SX Male
CA Finite cell line
//
ID YFP-SF1
AC CVCL_F702
RX PubMed=21959845;
CC Group: Cetacean cell line.
CC Doubling time: 31.45 hours (at 7th passage), 50.24 hours (at 20th passage) (PubMed=21959845).
CC Breed/subspecies: Asiaeorientalis.
OX NCBI_TaxID=34892; ! Neophocaena phocaenoides
SX Male
CA Finite cell line
//
ID YG10003
AC CVCL_8557
DR JCRB; JCRB0119
DR JCRB; NIHS0160
RX PubMed=8137280;
CC Transfected with: UniProtKB; Q00267; Salmonella typhimurium nhoA.
CC Discontinued: JCRB; NIHS0160; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID YG10007
AC CVCL_8558
DR JCRB; JCRB0120
DR JCRB; NIHS0161
RX PubMed=8137280;
CC Transfected with: HGNC; 7645; NAT1.
CC Discontinued: JCRB; NIHS0161; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID YG10008
AC CVCL_8559
DR JCRB; JCRB0121
DR JCRB; NIHS0162
RX PubMed=8137280;
CC Transfected with: HGNC; 7646; NAT2.
CC Discontinued: JCRB; NIHS0162; true.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0212 ! CHL
SX Female
CA Spontaneously immortalized cell line
//
ID YGY 016
AC CVCL_E894
SY YGY016
DR dbMHC; 49085
DR ECACC; 94082290
DR IHW; IHW9190
DR IMGT/HLA; 11732
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl190.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID YH-13
AC CVCL_1795
SY YH
DR BioSample; SAMN03472800
DR CCLE; YH13_CENTRAL_NERVOUS_SYSTEM
DR CGH-DB; 158-1
DR ChEMBL-Cells; CHEMBL3308223
DR ChEMBL-Targets; CHEMBL2366164
DR Cosmic; 687591
DR Cosmic; 909905
DR Cosmic; 2367556
DR Cosmic-CLP; 909905
DR GDSC; 909905
DR GEO; GSM887747
DR GEO; GSM888842
DR GEO; GSM1670585
DR IFO; IFO50493
RX PubMed=7947440;
RX PubMed=8145054;
RX PubMed=16232199;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9,12
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 8,12
ST TH01: 8
ST TPOX: 8
ST vWA: 18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YJ
AC CVCL_8931
DR BioSample; SAMN03151778
RX PubMed=9737693;
RX PubMed=12592342;
RX PubMed=19344951;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342, PubMed=19344951, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID YK-M2
AC CVCL_9919
DR Cosmic; 975313
DR Cosmic; 1281363
RX PubMed=3465438;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YI 328-18
AC CVCL_E987
SY YI328-18
DR CLO; CLO_0009713
DR ATCC; HB-9306
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID YI 328-51
AC CVCL_E988
SY YI328-51
DR ATCC; HB-9307
CC Discontinued: ATCC; HB-9307; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID YKG-1
AC CVCL_1796
SY YKG1
DR CLO; CLO_0050640
DR BioSample; SAMN01821722
DR BioSample; SAMN03472510
DR CCLE; YKG1_CENTRAL_NERVOUS_SYSTEM
DR CGH-DB; 159-1
DR ChEMBL-Cells; CHEMBL3308093
DR ChEMBL-Targets; CHEMBL1075612
DR Cosmic; 687592
DR Cosmic; 2367557
DR Cosmic; 2516045
DR Cosmic-CLP; 687592
DR GDSC; 687592
DR GEO; GSM827215
DR GEO; GSM887748
DR GEO; GSM888843
DR GEO; GSM1670586
DR JCRB; JCRB0746
DR RCB; RCB2110
DR TKG; TKG 0453
RX PubMed=2589023;
RX PubMed=9290701;
RX PubMed=16232199;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 28 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YL1/2
AC CVCL_J781
DR ECACC; 92092402
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YLC-KK1
AC CVCL_L216
RX PubMed=9290701;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YM
AC CVCL_IU39
RX PubMed=9747876;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 36-48 hours (PubMed=9747876).
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YM-1
AC CVCL_AP55
RX PubMed=26432330;
CC Doubling time: 40.66 hours (PubMed=26432330).
ST Source(s): PubMed=26432330
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 11
ST D16S539: 10,12
ST D18S51: 10,14
ST D19S433: 14.2,15.2
ST D21S11: 28
ST D2S1338: 20,23
ST D3S1358: 15,16
ST D5S818: 8
ST D7S820: 11,12
ST D8S1179: 12,15
ST FGA: 24,27
ST TH01: 8
ST TPOX: 12
ST vWA: 16,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YMB-1
AC CVCL_2814
SY YMB1
DR BTO; BTO:0002404
DR EFO; EFO_0006779
DR BioSample; SAMN03152042
DR CCLE; YMB1_BREAST
DR GEO; GSM827238
DR GEO; GSM887749
DR GEO; GSM888844
DR JCRB; JCRB0823
RX PubMed=6534930;
RX PubMed=9290701;
RX PubMed=23136038;
RX PubMed=22460905;
RX PubMed=25485619;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a ZR-75-1 derivative (PubMed=23136038).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 11
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID YMB-1-C
AC CVCL_B372
CC Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2814 ! YMB-1
SX Female
CA Cancer cell line
//
ID YMB-1-E
AC CVCL_2815
SY YMB1-E
DR BTO; BTO:0002583
DR EFO; EFO_0006780
DR BioSample; SAMN03152043
DR ChEMBL-Cells; CHEMBL3307353
DR ChEMBL-Targets; CHEMBL614251
DR Cosmic; 1571791
DR Cosmic-CLP; 1303911
DR GDSC; 1303911
DR GEO; GSM1670587
DR JCRB; JCRB0825
DR TKG; TKG 0440
RX PubMed=9290701;
RX PubMed=23136038;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative (PubMed=23136038).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP; JCRB; TKG
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 11
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2814 ! YMB-1
SX Female
CA Cancer cell line
//
ID YMB-A
AC CVCL_0586
DR MCCL; MCC:0000492
RX PubMed=11179484;
CC Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2814 ! YMB-1
SX Female
CA Cancer cell line
//
ID YMB-S
AC CVCL_D103
RX PubMed=8144402;
RX PubMed=11179484;
CC Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2814 ! YMB-1
SX Female
CA Cancer cell line
//
ID YME4
AC CVCL_6C73
RX CelloPub=CLPUB00299;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID Ymnu
AC CVCL_6F43
RX PubMed=7733619;
RX PubMed=7847838;
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: NMRI.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID YMU
AC CVCL_E895
DR dbMHC; 49087
DR IHW; IHW9356
DR IMGT/HLA; 11592
WW http://bioinformatics.hsanmartino.it/ecbr/cl356.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID YN
AC CVCL_Y579
RX PubMed=3541491;
RX PubMed=23882450;
DI NCIt; C8971; Embryonal rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YN-1
AC CVCL_8775
DR BTO; BTO:0004624
DR TKG; TKG 0695
RX PubMed=3476772;
RX PubMed=7918028;
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D5S818: 9,10
ST D7S820: 12
ST TH01: 9.3,10
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YN-1-0-A
AC CVCL_F916
DR TKG; TKG 0696
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,14
ST D5S818: 9,10
ST D7S820: 12
ST TH01: 9.3,10
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8775 ! YN-1
CA Cancer cell line
//
ID YN-4
AC CVCL_5G86
RX PubMed=6467198;
RX PubMed=7306960;
RX PubMed=24259225;
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID YN1/1.7.4
AC CVCL_8985
DR CLO; CLO_0009714
DR ATCC; CRL-1878
DR BCRC; 60411
DR ECACC; 90110706
RX PubMed=2981916;
CC Monoclonal antibody target: UniProtKB; P13597; Mouse Icam1/Cd54.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YNH-1
AC CVCL_1927
DR BioSample; SAMN03473442
DR Cosmic; 787488
DR Cosmic; 975314
DR Cosmic; 996309
DR Cosmic; 998745
DR Cosmic; 1037657
DR Cosmic; 1106592
DR Cosmic; 1281364
DR Cosmic; 1295724
DR Cosmic; 2089649
DR DSMZ; ACC-692
DR RCB; RCB1291
RX PubMed=9096702;
RX PubMed=10354136;
RX PubMed=23955599;
CC Doubling time: ~80 hours (DSMZ).
CC Discontinued: RCB; RCB1291; true.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 6,9
ST TPOX: 11,12
ST vWA: 14,16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YNK
AC CVCL_R990
SY Yamame Normal Kidney
RX DOI=10.2331/suisan.44.415;
RX DOI=10.3147/jsfp.28.27;
CC Group: Fish cell line.
OX NCBI_TaxID=8020; ! Oncorhynchus masou
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID YO-K
AC CVCL_6F98
RX PubMed=15325525;
CC Group: Fish cell line.
OX NCBI_TaxID=8255; ! Paralichthys olivaceus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID YOL1/34
AC CVCL_J782
DR ECACC; 85102247
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID Yoruba68IPSC4
AC CVCL_9999
SY TFDF1iPSC10
DR ISCR; 1481
RX PubMed=20038950;
CC From: The Scripps Research Institute; La Jolla; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID YOS-B
AC CVCL_H193
RX PubMed=1486031;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H194 ! YOS-M
SX Male
CA Cancer cell line
//
ID YOS-M
AC CVCL_H194
DR Cosmic; 787509
RX PubMed=1486031;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_H193 ! YOS-B
SX Male
CA Cancer cell line
//
ID Yoshida sarcoma
AC CVCL_4U54
SY YS; YOSHIDA; Yoshida ascites sarcoma cell; Ascites sarcoma of Nagasaki strain
DR BTO; BTO:0001213
DR TKG; TKG 0088
RX CelloPub=CLPUB00267;
RX PubMed=12979052;
RX PubMed=14906546;
CC Miscellaneous: This is not a cell line but a xenograft, it is the parent tumor for many cell lines.
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID Yoshizaki
AC CVCL_W836
DR Cosmic; 945373
RX PubMed=8980248;
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YOU
AC CVCL_N819
DR Cosmic; 1656047
RX PubMed=15274292;
RX PubMed=22426987;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YP-MEL
AC CVCL_L217
RX PubMed=7520166;
RX PubMed=9290701;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YPBE-1
AC CVCL_0J55
RX PubMed=8839795;
CC Transformant: Ad12-SV40.
CC Breed/subspecies: Copenhagen.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID YPEN-1
AC CVCL_0587
SY YPEN1
DR CLO; CLO_0009716
DR MCCL; MCC:0000493
DR ATCC; CRL-2222
RX PubMed=8900918;
CC Transformant: Ad12-SV40.
CC Breed/subspecies: Copenhagen.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID YPEN-2
AC CVCL_0J52
RX PubMed=8900918;
CC Transformant: Ad12-SV40.
CC Breed/subspecies: Copenhagen.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID YPK-1
AC CVCL_CZ89
RX CelloPub=CLPUB00333;
CC Doubling time: 49.3 hours (CelloPub=CLPUB00333).
CC Derived from metastatic site: Ascites.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YR-A
AC CVCL_0C32
DR Cosmic; 2239094
RX PubMed=9559344;
RX PubMed=9815546;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YROS-1
AC CVCL_W630
RX PubMed=7479367;
CC Breed/subspecies: Wistar.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID YROS-2
AC CVCL_W631
RX PubMed=7479367;
CC Breed/subspecies: Wistar.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID YS-5Fu-R-TC
AC CVCL_4U62
SY YS-5Fu-R
DR TKG; TKG 0094
DR TKG; TKG 0655
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS-6MP-R-TC
AC CVCL_4U55
SY YS-6MP-R
DR TKG; TKG 0098
DR TKG; TKG 0656
CC Selected for resistance to: ChEBI; CHEBI:50667; Mercaptopurine (6-MP).
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS-DM-R-TC
AC CVCL_4U56
SY YS-DM-R
DR TKG; TKG 0092
DR TKG; TKG 0657
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS-EX-R-TC
AC CVCL_4U57
SY YS-EX-R
DR TKG; TKG 0093
DR TKG; TKG 0658
CC Selected for resistance to: ChEBI; CHEBI:4027; Cyclophosphamide (CP; Endoxan).
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS-G-TC
AC CVCL_4U58
SY YS-G
DR TKG; TKG 0089
DR TKG; TKG 0688
CC Selected for resistance to: ChEBI; CHEBI:82354; Nitrogen mustard N-oxide.
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS-MC-R-TC
AC CVCL_4U59
SY YS-MC-R
DR TKG; TKG 0096
DR TKG; TKG 0659
CC Selected for resistance to: ChEBI; CHEBI:27504; Mitomycin C (MMC).
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS-PPB
AC CVCL_5436
RX PubMed=9686589;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=YS-PPB
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID YS-TC
AC CVCL_G359
DR ChEMBL-Cells; CHEMBL3308014
DR ChEMBL-Targets; CHEMBL612816
DR TKG; TKG 0654
RX PubMed=7829394;
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS-TM-R-TC
AC CVCL_4U60
SY YS-TM-R
DR TKG; TKG 0100
DR TKG; TKG 0660
CC Selected for resistance to: ChEBI; CHEBI:34638; Chromomycin A3.
CC Derived from metastatic site: Ascites.
DI NCIt; C60505; Rat sarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4U54 ! Yoshida sarcoma
CA Cancer cell line
//
ID YS001
AC CVCL_6474
DR CLO; CLO_0009717
DR ATCC; CRL-11776
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID YS08
AC CVCL_4J68
RX Patent=US7476540;
RX PubMed=15857173;
CC Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-000123.
CC Monoclonal antibody target: Membrane protein antigen of human mesenchymal stem cells.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID YS14
AC CVCL_4J69
RX Patent=US7476540;
RX PubMed=15857173;
CC Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-000124.
CC Monoclonal antibody target: Membrane protein antigen of human mesenchymal stem cells.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID YS18
AC CVCL_4J70
RX Patent=US7476540;
RX PubMed=15857173;
CC Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-000125.
CC Monoclonal antibody target: Membrane protein antigen of human mesenchymal stem cells.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID YS9;22
AC CVCL_A743
SY YS9:22; YS9-22; YS 9:22
DR CGH-DB; 9220-4
DR Cosmic; 1012129
RX PubMed=7808006;
RX PubMed=16408098;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YSCCC
AC CVCL_3629
DR CLO; CLO_0050859
DR BioSample; SAMN03472100
DR RCB; RCB1549
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YSK
AC CVCL_6745
DR JCRB; JCRB0619
CC Discontinued: JCRB; JCRB0619; true.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID YSK-21
AC CVCL_E942
RX PubMed=11550287;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YST-1
AC CVCL_5192
DR CLO; CLO_0050136
DR BioSample; SAMN03472012
DR RCB; RCB2136
DR TKG; TKG 0454
RX PubMed=1980563;
RX PubMed=9290701;
RX PubMed=16510576;
ST Source(s): RCB; TKG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,12
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3269; Schwannoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YSWS-SF
AC CVCL_IJ28
SY Yunnan Semi-fine Wool Sheep-Skin Fibroblast
RX PubMed=24448770;
CC Doubling time: 26 hours (PubMed=24448770).
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.
CC Breed/subspecies: Yunnan semi-fine wool sheep.
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID YT
AC CVCL_1797
DR BTO; BTO:0005228
DR CLO; CLO_0009718
DR BioSample; SAMN03473541
DR ChEMBL-Cells; CHEMBL3308146
DR ChEMBL-Targets; CHEMBL2366114
DR Cosmic; 850219
DR Cosmic; 946358
DR Cosmic; 991546
DR Cosmic; 1012130
DR Cosmic; 1524828
DR Cosmic; 1542072
DR Cosmic; 2390120
DR Cosmic-CLP; 946358
DR DSMZ; ACC-434
DR GDSC; 946358
DR GEO; GSM236811
DR GEO; GSM236847
DR GEO; GSM472010
DR GEO; GSM1670588
DR Lonza; 95
RX PubMed=10803505;
RX PubMed=16408098;
RX PubMed=19194464;
RX PubMed=21052088;
RX PubMed=25586472;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=YT
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 10,12
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17,20 (Cosmic-CLP)
ST vWA: 17,18,20 (DSMZ)
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YT-1
AC CVCL_EJ05
SY YT1
DR Cosmic; 2024371
RX PubMed=7911075;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1797 ! YT
SX Male
CA Cancer cell line
//
ID YT-nu
AC CVCL_H524
SY YT-NU
DR ChEMBL-Cells; CHEMBL3307254
DR ChEMBL-Targets; CHEMBL612817
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID YT1
AC CVCL_T024
SY YT1-hES
RX PubMed=22287285;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID YT2
AC CVCL_T025
SY YT2-hES
RX PubMed=22287285;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID YT3
AC CVCL_T026
SY YT3-hES
RX PubMed=22287285;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID YTA 3.1.2
AC CVCL_J783
DR ECACC; 89040603
CC Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTA 74.4.4
AC CVCL_J784
DR ECACC; 11060804
CC Monoclonal antibody target: UniProtKB; Q62351; Mouse Tfrc/Cd71.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTF
AC CVCL_6F99
SY Yellow Tail Fin
RX DOI=10.3147/jsfp.29.29;
CC Group: Fish cell line.
OX NCBI_TaxID=8161; ! Seriola quinqueradiata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID YTH 30.15
AC CVCL_J785
DR ECACC; 11060807
CC Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 470.5
AC CVCL_T981
DR ECACC; 11072206
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 53.1
AC CVCL_J786
DR ECACC; 11060813
CC Monoclonal antibody target: UniProtKB; P13987; Human CD59.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 71.3
AC CVCL_T982
DR ECACC; 11072205
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 76.3
AC CVCL_J787
DR ECACC; 11060815
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 80.103
AC CVCL_J788
DR ECACC; 11060811
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 81.5
AC CVCL_J789
DR ECACC; 11072203
CC Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 862.2
AC CVCL_J790
DR ECACC; 11060817
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 89.1
AC CVCL_J791
DR ECACC; 11060814
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 906.9HL
AC CVCL_J792
DR ECACC; 11060809
CC Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTH 913.12
AC CVCL_J793
DR ECACC; 11060810
CC Monoclonal antibody target: UniProtKB; P10747; Human CD28.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTK
AC CVCL_R991
SY Yellow Tail Kidney
RX DOI=10.3147/jsfp.15.201;
CC Group: Fish cell line.
OX NCBI_TaxID=8161; ! Seriola quinqueradiata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID YTMLC-90
AC CVCL_6959
SY YTMLC 90
DR CCRID; 3153C0001000000061
RX PubMed=15207095;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YTS
AC CVCL_D324
DR Lonza; 96
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1797 ! YT
SX Male
CA Cancer cell line
//
ID YTS 105.18.10
AC CVCL_J794
DR ECACC; 11060802
CC Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS 121.5.2
AC CVCL_J795
DR ECACC; 87072283
CC Monoclonal antibody target: UniProtKB; P13379; Mouse Cd5.
CC Discontinued: ECACC; 87072283; probable.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS 154.7.7.10
AC CVCL_J796
DR ECACC; 87072285
CC Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS 156.7.7
AC CVCL_J797
DR ECACC; 89040604
CC Monoclonal antibody target: UniProtKB; P10300; Mouse Cd8b.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS 169.4.2.1
AC CVCL_J798
DR ECACC; 87072284
CC Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS 177.9.6.1
AC CVCL_J799
DR ECACC; 11060819
CC Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS 191.1.1.2
AC CVCL_J800
DR ECACC; 87072282
CC Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS 213.1.1
AC CVCL_J801
DR ECACC; 11060803
CC Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID YTS-1
AC CVCL_6746
SY YTS1
DR BTO; BTO:0003554
RX PubMed=2733301;
RX PubMed=3573461;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YTS-Eco
AC CVCL_EG36
SY YTS/Eco; YTS/eco; YTS ECO; YTS eco; YTSeco
CC Transfected with: MGI; MGI:88117; Slc7a1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D324 ! YTS
SX Male
CA Cancer cell line
//
ID YUAME
AC CVCL_EI13
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUAVEY
AC CVCL_K001
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Yub 10F
AC CVCL_3257
SY Yub10F
DR BioSample; SAMN03472454
DR JCRB; JCRB1116
DR JCRB; NIHS0420
DR SKIP; SKIP000333
CC Discontinued: JCRB; NIHS0420; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 10,13
ST D5S818: 10
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 13,14
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID Yub621b
AC CVCL_3258
DR BioSample; SAMN03472451
DR JCRB; JCRB1112
DR JCRB; NIHS0416
DR SKIP; SKIP000329
CC Discontinued: JCRB; NIHS0416; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3259 ! Yub621BMC
OI CVCL_3260 ! Yub621c
CA Adult stem cell
//
ID Yub621BMC
AC CVCL_3259
SY Yub621_BMC
DR JCRB; JCRB1113
DR JCRB; NIHS0417
DR SKIP; SKIP000330
RX PubMed=21155951;
CC Discontinued: JCRB; NIHS0417; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3258 ! Yub621b
OI CVCL_3260 ! Yub621c
CA Adult stem cell
//
ID Yub621c
AC CVCL_3260
DR JCRB; JCRB1111
DR JCRB; NIHS0415
DR SKIP; SKIP000328
CC Discontinued: JCRB; NIHS0415; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 8,11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3258 ! Yub621b
OI CVCL_3259 ! Yub621BMC
CA Adult stem cell
//
ID Yub622
AC CVCL_3261
DR BioSample; SAMN03472452
DR JCRB; JCRB1114
DR JCRB; NIHS0418
DR SKIP; SKIP000331
CC Discontinued: JCRB; NIHS0418; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID Yub623
AC CVCL_3262
DR BioSample; SAMN03472453
DR JCRB; JCRB1115
DR JCRB; NIHS0419
DR SKIP; SKIP000332
CC Discontinued: JCRB; NIHS0419; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 9.1,11
ST TH01: 9
ST TPOX: 8
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID Yub625
AC CVCL_3263
DR BioSample; SAMN03472468
DR JCRB; JCRB1155
DR JCRB; NIHS0461
CC Discontinued: JCRB; NIHS0461; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 9,12
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID Yub631
AC CVCL_3264
DR BioSample; SAMN03472469
DR JCRB; JCRB1156
DR JCRB; NIHS0462
CC Discontinued: JCRB; NIHS0462; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6
ST TPOX: 8,12
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID Yub632
AC CVCL_3265
DR BioSample; SAMN03472470
DR JCRB; JCRB1157
DR JCRB; NIHS0463
CC Discontinued: JCRB; NIHS0463; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 9,11
ST D5S818: 10,11
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 7,8
ST vWA: 18,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID Yub633
AC CVCL_3266
DR BioSample; SAMN03472471
DR JCRB; JCRB1158
DR JCRB; NIHS0464
RX PubMed=21155951;
CC Discontinued: JCRB; NIHS0464; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID Yub634
AC CVCL_3267
DR BioSample; SAMN03472473
DR JCRB; JCRB1161
DR JCRB; NIHS0465
RX PubMed=21155951;
CC Discontinued: JCRB; NIHS0465; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 8,12
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID Yub635
AC CVCL_3268
DR BioSample; SAMN03472474
DR JCRB; JCRB1162
DR JCRB; NIHS0473
RX PubMed=21155951;
CC Discontinued: JCRB; NIHS0473; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 10,11
ST D7S820: 8,9
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID Yub636
AC CVCL_3269
DR BioSample; SAMN03472420
DR JCRB; JCRB1169
DR JCRB; NIHS0475
CC Discontinued: JCRB; NIHS0475; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,13
ST D16S539: 9,10
ST D5S818: 9,11
ST D7S820: 9,12
ST TH01: 9
ST TPOX: 8
ST vWA: 14,16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Adult stem cell
//
ID Yub637b
AC CVCL_3270
SY Yub637B
DR BioSample; SAMN03472475
DR JCRB; JCRB1163
DR JCRB; NIHS0474
RX PubMed=21155951;
CC Discontinued: JCRB; NIHS0474; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 10
ST D5S818: 10,11
ST D7S820: 9,12
ST TH01: 9
ST TPOX: 9
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3240 ! Yub637s
SX Male
CA Adult stem cell
//
ID Yub637s
AC CVCL_3240
DR JCRB; JCRB1173
DR JCRB; NIHS0476
CC Discontinued: JCRB; NIHS0476; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 10
ST D5S818: 10,11
ST D7S820: 9,12
ST TH01: 9
ST TPOX: 9
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3270 ! Yub637b
SX Male
CA Adult stem cell
//
ID Yub642
AC CVCL_2954
DR BioSample; SAMN03472421
DR JCRB; JCRB1172
DR JCRB; NIHS0477
CC Discontinued: JCRB; NIHS0477; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 9,10
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 10,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2824 ! Yub642b
OI CVCL_2823 ! Yub642p
SX Male
CA Adult stem cell
//
ID Yub642b
AC CVCL_2824
DR JCRB; JCRB1174
DR JCRB; NIHS0479
CC Discontinued: JCRB; NIHS0479; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 9,10
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 10,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2954 ! Yub642
OI CVCL_2823 ! Yub642p
SX Male
CA Adult stem cell
//
ID Yub642p
AC CVCL_2823
SY Yub642P
DR JCRB; JCRB1171
DR JCRB; NIHS0478
RX PubMed=21155951;
CC Discontinued: JCRB; NIHS0478; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8,10
ST D16S539: 9,10
ST D5S818: 10,13
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 10,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2954 ! Yub642
OI CVCL_2824 ! Yub642b
SX Male
CA Adult stem cell
//
ID YUBEL
AC CVCL_J515
DR Cosmic; 1548846
RX PubMed=21543894;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUBRUSE
AC CVCL_K002
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUBUNE
AC CVCL_J516
DR Cosmic; 1548847
RX PubMed=21543894;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUCAL
AC CVCL_J532
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUCAS
AC CVCL_J065
DR Cosmic; 1548848
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUCHER
AC CVCL_J517
DR Cosmic; 1548849
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUCHIME
AC CVCL_EI14
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUCHUFA
AC CVCL_K003
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUCINJ
AC CVCL_K004
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUCLAT
AC CVCL_J518
DR Cosmic; 1548850
RX PubMed=21543894;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUCLIR
AC CVCL_J533
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUCOT
AC CVCL_J066
DR Cosmic; 1548851
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUCRENA
AC CVCL_K005
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUCYLO
AC CVCL_EI15
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUDAN3
AC CVCL_J541
SY YUDAN-3; YUDAN 3
DR Cosmic; 1020271
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUDATE
AC CVCL_K006
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUDEDE
AC CVCL_G322
RX PubMed=20149136;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUDEW
AC CVCL_J519
DR Cosmic; 1548880
DR Cosmic; 2439309
RX PubMed=21543894;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUDOSO
AC CVCL_G323
DR Cosmic; 1548852
DR Cosmic; 2439312
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUDUTY
AC CVCL_K007
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUFIC
AC CVCL_G324
DR Cosmic; 1548853
DR Cosmic; 2439314
RX PubMed=20149136;
RX PubMed=21543894;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUFULO
AC CVCL_G325
RX PubMed=20149136;
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUGAFFE
AC CVCL_K008
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUGANK
AC CVCL_K009
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Brain.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUGASP
AC CVCL_J520
DR Cosmic; 1548854
RX PubMed=21543894;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUGATOR
AC CVCL_EI17
DR Cosmic; 2439318
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUGEK
AC CVCL_J540
DR Cosmic; 1548886
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUGEN8
AC CVCL_A744
SY YUGEN-8; YUGEN 8
DR Cosmic; 1197387
DR Cosmic; 1548855
DR Cosmic; 2439320
RX PubMed=9177196;
RX PubMed=20149136;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUGLIDE
AC CVCL_K010
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUGOE
AC CVCL_J067
DR Cosmic; 1548856
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUHEF
AC CVCL_G326
DR Cosmic; 1548857
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUHEIK
AC CVCL_J073
DR Cosmic; 1548858
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUHOIN
AC CVCL_J521
DR Cosmic; 1548859
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C114828; Mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUHUY
AC CVCL_G327
DR Cosmic; 1548860
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUKADI
AC CVCL_K011
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUKARN
AC CVCL_K012
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUKIM
AC CVCL_G328
DR Cosmic; 1548861
DR Cosmic; 2439332
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUKOLI
AC CVCL_G329
DR Cosmic; 1548862
RX PubMed=20149136;
RX PubMed=21543894;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUKSI
AC CVCL_J068
DR Cosmic; 1548863
DR Cosmic; 2439333
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YULAC
AC CVCL_B483
DR Cosmic; 1197390
DR Cosmic; 1548864
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YULAPE
AC CVCL_K013
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YULAXER
AC CVCL_K014
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YULIN
AC CVCL_J522
DR Cosmic; 1548879
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YULOCUS
AC CVCL_EI19
DR Cosmic; 2439338
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YULOMA
AC CVCL_K015
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YULONE
AC CVCL_J523
DR Cosmic; 1548865
DR Cosmic; 2439339
RX PubMed=21543894;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YULOVY
AC CVCL_G330
RX PubMed=20149136;
RX PubMed=21569352;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUMAC
AC CVCL_A745
DR Cosmic; 1197386
DR Cosmic; 1548866
RX PubMed=20149136;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUMAG
AC CVCL_J534
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUMINE
AC CVCL_K016
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUMOBER
AC CVCL_EI20
DR Cosmic; 2439344
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Yumoto
AC CVCL_B484
SY YUMOTO
DR Cosmic; 877464
DR Cosmic; 1152542
RX PubMed=9790785;
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUMUT
AC CVCL_G331
DR Cosmic; 1548867
RX PubMed=20149136;
RX PubMed=21543894;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUNACK
AC CVCL_EI21
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUNIBO
AC CVCL_J535
DR Cosmic; 2439350
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUNIGE
AC CVCL_J524
DR Cosmic; 1548868
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUNUFF
AC CVCL_K017
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUNUVO
AC CVCL_J525
DR Cosmic; 1548885
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUPAC7
AC CVCL_EI22
DR Cosmic; 2439353
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUPAO
AC CVCL_J536
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUPEET
AC CVCL_K018
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUPLA
AC CVCL_J069
DR Cosmic; 1548869
DR Cosmic; 2439355
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUPOM
AC CVCL_EI23
DR Cosmic; 2439356
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YURDE
AC CVCL_K019
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YURED
AC CVCL_K020
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YURIF
AC CVCL_B485
DR Cosmic; 1197391
DR Cosmic; 1548870
DR Cosmic; 2013572
RX PubMed=20149136;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YURKEN
AC CVCL_K021
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUROB
AC CVCL_B486
DR Cosmic; 1548871
DR Cosmic; 2439361
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUROL
AC CVCL_J070
DR Cosmic; 1548872
DR Cosmic; 2439364
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUSAC2
AC CVCL_A746
SY YUSAC-2; YUSAC 2; YUSAC
DR Cosmic; 1197388
RX PubMed=9177196;
RX PubMed=20149136;
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUSAN
AC CVCL_J526
DR Cosmic; 1548873
RX PubMed=21543894;
RX PubMed=22842228;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C114828; Mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUSARI
AC CVCL_K022
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUSIK
AC CVCL_B487
DR Cosmic; 1548874
RX PubMed=20149136;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUSIPU
AC CVCL_EI16
DR Cosmic; 2439372
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUSIT1
AC CVCL_A747
SY YUSIT-1; YUSIT 1; Yusit-1; YUSITI; Yusiti; YUSIT
DR Cosmic; 1197389
DR Cosmic; 1921229
DR Cosmic; 2439373
RX PubMed=9177196;
RX PubMed=20149136;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUSIT1-B11
AC CVCL_R736
DR Cosmic; 1921231
RX Patent=US20130231347;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A747 ! YUSIT1
SX Male
CA Cancer cell line
//
ID YUSIT1-B31
AC CVCL_R737
DR Cosmic; 1921232
RX Patent=US20130231347;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A747 ! YUSIT1
SX Male
CA Cancer cell line
//
ID YUSIT1-B5
AC CVCL_R738
DR Cosmic; 1921230
RX Patent=US20130231347;
RX PubMed=22389471;
CC Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A747 ! YUSIT1
SX Male
CA Cancer cell line
//
ID YUSIV
AC CVCL_G332
DR Cosmic; 1548875
DR Cosmic; 2439374
RX PubMed=20149136;
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUSTE
AC CVCL_J527
DR Cosmic; 1548876
RX PubMed=21543894;
RX PubMed=21569352;
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUSUBA
AC CVCL_K023
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUSWI
AC CVCL_K024
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Small intestine.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUTER
AC CVCL_K025
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUTHO
AC CVCL_J528
DR Cosmic; 1548881
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUTICA
AC CVCL_J071
DR Cosmic; 1548877
DR Cosmic; 2439381
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUTUR
AC CVCL_J539
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUVON3
AC CVCL_G333
SY YUVON
DR Cosmic; 1548882
RX PubMed=20149136;
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUWAGE
AC CVCL_K026
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUWALI
AC CVCL_K027
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUWERA
AC CVCL_J530
DR Cosmic; 1548883
RX PubMed=21543894;
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID YUWHIM
AC CVCL_K028
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUWIM
AC CVCL_J531
DR Cosmic; 1548878
RX PubMed=21543894;
CC Part of: Yale University (YU) melanoma cell collection.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUZAZ
AC CVCL_EI18
DR Cosmic; 2439392
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUZEAL
AC CVCL_K029
RX PubMed=22842228;
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUZEST
AC CVCL_EI24
RX PubMed=26214590;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YUZOR
AC CVCL_J072
DR Cosmic; 1548884
RX PubMed=21521745;
RX PubMed=21543894;
RX PubMed=21569352;
CC Part of: Yale University (YU) melanoma cell collection.
CC Omics: Transcriptome analysis.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID YW 62.3.20
AC CVCL_J091
SY YW62.3.20
DR ECACC; 11072202
RX PubMed=3330997;
CC Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID Z-119
AC CVCL_IU88
SY Z119
DR Cosmic; 2491094
RX PubMed=8600166;
RX PubMed=9067587;
CC Doubling time: 20-30 hours (PubMed=8600166).
DI NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Z-138
AC CVCL_B077
SY Z138
DR EFO; EFO_0005479
DR ATCC; CRL-3001
DR BioSample; SAMN03471023
DR Cosmic; 2078183
DR Cosmic; 2088021
DR Cosmic; 2296992
DR GEO; GSM115807
DR Lonza; 1605
RX PubMed=9669839;
RX PubMed=16183118;
RX PubMed=16203034;
RX PubMed=16960149;
RX PubMed=25315077;
CC Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC Doubling time: 24 hours (PubMed=25315077).
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 11
ST D18S51: 14,18
ST D21S11: 30,32.2
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 8
ST D8S1179: 8,13
ST FGA: 20,22
ST Penta D: 13,15
ST Penta E: 7,18
ST TH01: 6
ST TPOX: 8
ST vWA: 15,18
DI NCIt; C4337; Mantle cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Z-181
AC CVCL_IU89
SY Z181
DR Cosmic; 2491095
RX PubMed=8600166;
RX PubMed=9067587;
CC Doubling time: 30-40 hours (PubMed=8600166).
DI NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Z-33
AC CVCL_4796
SY Z33
RX PubMed=8751477;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Z-33
DI NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Z2
AC CVCL_J056
DR ECACC; 93022522
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Z24
AC CVCL_HB35
RX PubMed=1430210;
RX PubMed=1689731;
RX PubMed=1750930;
RX PubMed=11330042;
RX PubMed=17045664;
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID Z26
AC CVCL_J057
DR ECACC; 93022519
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Z310
AC CVCL_F753
RX PubMed=12470873;
RX PubMed=17825520;
RX PubMed=18162136;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID Z34
AC CVCL_J058
DR ECACC; 93022521
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Z41
AC CVCL_J059
DR ECACC; 93022520
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Z65
AC CVCL_HB89
RX PubMed=1430210;
RX PubMed=1689731;
RX PubMed=1750930;
RX PubMed=9184070;
RX PubMed=11330042;
RX PubMed=17045664;
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID ZA
AC CVCL_D596
DR CGH-DB; 361-2
DR Cosmic; 930337
DR Cosmic; 1046039
DR Cosmic; 1123029
RX PubMed=2228902;
RX PubMed=2654810;
RX PubMed=12632084;
RX PubMed=17052259;
RX PubMed=17599052;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Zajdela-Hepatoma
AC CVCL_1D00
SY ZH-CLS
DR CLS; 500306/p652_Zajdela-Hepatoma
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID ZC-7901
AC CVCL_R992
DR KCB; KCB 93047YJ
RX CelloPub=CLPUB00036;
CC Group: Fish cell line.
CC Misspelling: 'ZC-79001' in KCB 93047YJ.
OX NCBI_TaxID=7959; ! Ctenopharyngodon idella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZC-7901S1
AC CVCL_R993
RX CelloPub=CLPUB00036;
CC Group: Fish cell line.
OX NCBI_TaxID=7959; ! Ctenopharyngodon idella
HI CVCL_R992 ! ZC-7901
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZC15.K
AC CVCL_S366
DR ATCC; CRL-6537
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6537; true.
OX NCBI_TaxID=9704; ! Zalophus californianus
OI CVCL_S331 ! ZC15.Lu
SX Sex undetermined
CA Finite cell line
//
ID ZC15.Lu
AC CVCL_S331
DR ATCC; CRL-6606
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6606; true.
OX NCBI_TaxID=9704; ! Zalophus californianus
OI CVCL_S366 ! ZC15.K
SX Sex undetermined
CA Finite cell line
//
ID ZC2.Sk/Mu
AC CVCL_S367
DR ATCC; CRL-6536
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Characteristics: Possibly infected by seal poxvirus.
CC Discontinued: ATCC; CRL-6536; true.
OX NCBI_TaxID=9704; ! Zalophus californianus
SX Sex undetermined
CA Finite cell line
//
ID ZEB2
AC CVCL_6E09
RX PubMed=15602876;
RX PubMed=17141029;
RX PubMed=18399791;
CC Group: Fish cell line.
CC Characteristics: Requires feeder cells. Maintenance of ZEB2 depends on the presence of cell line RTS34st (CVCL_L016).
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Embryonic stem cell
//
ID ZEB2J
AC CVCL_6E10
RX PubMed=18399791;
RX PubMed=19116758;
CC Group: Fish cell line.
CC Characteristics: Does not require feeder cells.
CC Transfected with: UniProtKB; P42212; GFP.
OX NCBI_TaxID=7955; ! Danio rerio
HI CVCL_6E09 ! ZEB2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZEM
AC CVCL_R818
RX PubMed=1591622;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZEM-2
AC CVCL_5678
SY ZEM2
RX PubMed=7765109;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZEM-2A
AC CVCL_J060
RX PubMed=7765109;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
HI CVCL_5678 ! ZEM-2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZEM2S
AC CVCL_3274
SY ZEM-2S
DR CLO; CLO_0009723
DR ATCC; CRL-2147
DR BCRC; 60253
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
HI CVCL_5678 ! ZEM-2
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZEMH
AC CVCL_R819
RX PubMed=1591622;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZEN
AC CVCL_5417
SY 7-1-144
DR JCRB; JCRB1311
RX DOI=10.1021/jf00097a040;
CC Monoclonal antibody target: ChEBI; CHEBI:10106; Zearalenone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Zeng01i-iPSH9
AC CVCL_AS49
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/zeng01i-ipsh9.cmsx
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12,13
ST D18S51: 13
ST D21S11: 30
ST D3S1358: 13,16
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 8,14
ST FGA: 26,28
ST Penta D: 11,13
ST Penta E: 11,14
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9773 ! WA09
SX Female
CA Induced pluripotent stem cell
//
ID Zeng02i-iPSH14
AC CVCL_AS50
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/zeng02i-ipsh14.cmsx
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,13
ST D18S51: 12,14
ST D21S11: 30,31
ST D3S1358: 15,16
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 21
ST Penta D: 12,13
ST Penta E: 13,20
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9775 ! WA14
SX Male
CA Induced pluripotent stem cell
//
ID ZES1
AC CVCL_6E11
SY Zebrafish ES-like 1
RX PubMed=24967707;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Embryonic stem cell
//
ID ZF13
AC CVCL_6G00
SY ZF-13; ZF 13
RX PubMed=7737359;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZF29
AC CVCL_6G01
SY ZF-29; ZF 29
RX PubMed=7737359;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZF4
AC CVCL_3275
DR CLO; CLO_0009724
DR EFO; EFO_0001261
DR ATCC; CRL-2050
DR BCRC; 60246
DR KCB; KCB 2014059YJ
DR Lonza; 1135
RX PubMed=18377224;
CC Group: Fish cell line.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZFB1
AC CVCL_6E12
SY ZebraFish Bone 1
RX DOI=10.1111/j.1439-0426.2010.01411.x;
RX PubMed=23909483;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZFL
AC CVCL_3276
SY ZF-L; ZebraFish Liver
DR CLO; CLO_0009725
DR ATCC; CRL-2643
DR BCRC; 60454
DR BCRJ; 0256
RX PubMed=7994634;
RX PubMed=24355757;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Zfp57+/- clone 6909
AC CVCL_DR00
RX PubMed=27345984;
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:99204; Zfp57.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Zfp57+/- clone 6911
AC CVCL_DR01
RX PubMed=27345984;
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:99204; Zfp57.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Zfp57-/- clone 406
AC CVCL_DR02
RX PubMed=27345984;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Zfp57-/- clone 631
AC CVCL_DR03
RX PubMed=27345984;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Zfp57-/- clone 634
AC CVCL_DR04
RX PubMed=27345984;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID ZFTMA
AC CVCL_4Z52
RX PubMed=21359817;
RX PubMed=22922019;
CC Group: Bird cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=59729; ! Taeniopygia guttata
SX Female
CA Cancer cell line
//
ID ZG
AC CVCL_R820
SY Zebrafish Gill
RX PubMed=1591622;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Zh1
AC CVCL_V187
SY ZZU-hESC-1
DR ISCR; 2258
RX PubMed=22711576;
CC From: Reproductive Medical Center, the First Affiliated Hospital; ZhengZhou University; ZhengZhou; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Zh21
AC CVCL_V188
SY ZZU-hESC-21
DR ISCR; 2259
RX PubMed=22711576;
CC From: Reproductive Medical Center, the First Affiliated Hospital; ZhengZhou University; ZhengZhou; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID ZHBTc4
AC CVCL_C715
SY ZHBTc4-mESC; ZHBTc4 ES
DR EFO; EFO_0005914
DR ENCODE; ENCBS071NKO
DR ENCODE; ENCBS173ENC
DR ENCODE; ENCBS174ENC
DR ENCODE; ENCBS175ENC
DR ENCODE; ENCBS809MFF
DR ENCODE; ENCBS898AKA
DR GEO; GSM137761
DR GEO; GSM137763
DR GEO; GSM137765
DR GEO; GSM137767
DR GEO; GSM137769
DR GEO; GSM138138
DR GEO; GSM137786
DR GEO; GSM137787
DR GEO; GSM137788
DR GEO; GSM137789
DR GEO; GSM137790
DR GEO; GSM138139
DR GEO; GSM137791
DR GEO; GSM137792
DR GEO; GSM137793
DR GEO; GSM137794
DR GEO; GSM137795
DR GEO; GSM138140
DR GEO; GSM137770
DR GEO; GSM137775
DR GEO; GSM137780
DR GEO; GSM137762
DR GEO; GSM137771
DR GEO; GSM137776
DR GEO; GSM137764
DR GEO; GSM137772
DR GEO; GSM137777
DR GEO; GSM137766
DR GEO; GSM137773
DR GEO; GSM137778
DR GEO; GSM137768
DR GEO; GSM137774
DR GEO; GSM137779
DR GEO; GSM1014150
DR GEO; GSM1014152
DR GEO; GSM1014169
DR GEO; GSM1385517
DR RCB; AES0136
RX PubMed=10742100;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/ZhBTc4_Stam_protocol.pdf
CC Part of: ENCODE project mouse cell lines.
CC Discontinued: RCB; AES0136; probable.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C714 ! ZHTc6
SX Male
CA Embryonic stem cell
//
ID ZHTc6
AC CVCL_C714
DR GEO; GSM137796
DR GEO; GSM137797
DR GEO; GSM137798
DR GEO; GSM137799
DR GEO; GSM137800
DR GEO; GSM138141
DR GEO; GSM137806
DR GEO; GSM137807
DR GEO; GSM137808
DR GEO; GSM137809
DR GEO; GSM137810
DR GEO; GSM138142
DR GEO; GSM137816
DR GEO; GSM137817
DR GEO; GSM137818
DR GEO; GSM137819
DR GEO; GSM137820
DR GEO; GSM138143
DR GEO; GSM137785
DR GEO; GSM137805
DR GEO; GSM137815
DR GEO; GSM137781
DR GEO; GSM137801
DR GEO; GSM137811
DR GEO; GSM137782
DR GEO; GSM137802
DR GEO; GSM137812
DR GEO; GSM137783
DR GEO; GSM137803
DR GEO; GSM137813
DR GEO; GSM137784
DR GEO; GSM137804
DR GEO; GSM137814
DR RCB; AES0137
RX PubMed=10742100;
CC Discontinued: RCB; AES0137; probable.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3987 ! CGR8
SX Male
CA Embryonic stem cell
//
ID ZIZ-LD-1
AC CVCL_Z243
DR ECACC; 93022523
RX DOI=10.1016/0022-1910(92)90116-U;
CC Group: Insect cell line.
CC Discontinued: ECACC; 93022523; probable.
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZIZ-LD-1-15
AC CVCL_Z244
RX DOI=10.1016/0022-1910(92)90116-U;
CC Group: Insect cell line.
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
HI CVCL_Z243 ! ZIZ-LD-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZIZ-LD-1-3
AC CVCL_Z245
RX DOI=10.1016/0022-1910(92)90116-U;
CC Group: Insect cell line.
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
HI CVCL_Z243 ! ZIZ-LD-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZIZ-LD-1-4
AC CVCL_Z246
RX DOI=10.1016/0022-1910(92)90116-U;
CC Group: Insect cell line.
OX NCBI_TaxID=7539; ! Leptinotarsa decemlineata
HI CVCL_Z243 ! ZIZ-LD-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZK-58
AC CVCL_9920
SY ZK58
DR Cosmic; 1529906
DR GEO; GSM879224
RX PubMed=12645653;
RX PubMed=15150091;
RX PubMed=19787792;
RX PubMed=21519327;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ZK-H
AC CVCL_W465
RX CelloPub=CLPUB00011;
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W466 ! ZK-N
SX Male
CA Cancer cell line
//
ID ZK-N
AC CVCL_W466
RX CelloPub=CLPUB00011;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W465 ! ZK-H
SX Male
CA Transformed cell line
//
ID ZKOP
AC CVCL_6756
DR CLO; CLO_0050526
DR RCB; RCB2151
RX PubMed=16198317;
CC Knockout cell: Method=KO mouse; MGI; MGI:1346865; Mapk14.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6753 ! KOP
SX Female
CA Spontaneously immortalized cell line
//
ID ZKS
AC CVCL_5905
SY Zebrafish Kidney Stromal
RX PubMed=19433857;
CC Group: Fish cell line.
CC Breed/subspecies: AB.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Stromal cell line
//
ID ZL34
AC CVCL_5906
SY ZL-34
DR BTO; BTO:0003992
DR ECACC; 11120713
RX PubMed=1373705;
RX PubMed=21729925;
CC From: University Hospital; Zurich; Switzerland.
CC Doubling time: 29 hours (PubMed=1373705).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 11
ST D7S820: 9
ST TH01: 6
ST TPOX: 8
ST vWA: 18,20
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ZL5
AC CVCL_5907
DR ECACC; 11120715
RX PubMed=1373705;
CC From: University Hospital; Zurich; Switzerland.
CC Doubling time: 31 hours (PubMed=1373705).
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ZL55
AC CVCL_5908
DR ECACC; 12050301
DR PRIDE; PXD000589
RX PubMed=1373705;
RX PubMed=21729925;
RX PubMed=24207061;
RX PubMed=25894527;
CC From: University Hospital; Zurich; Switzerland.
CC Doubling time: 38 hours (PubMed=1373705).
CC Omics: Cell surface proteome.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 8
ST D16S539: 12
ST D5S818: 10,13
ST D7S820: 7,11
ST TH01: 6
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ZL92
AC CVCL_T735
RX PubMed=1373705;
CC From: University Hospital; Zurich; Switzerland.
CC Doubling time: 87 hours (PubMed=1373705).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ZM
AC CVCL_E896
DR dbMHC; 49088
DR IHW; IHW9246
DR IMGT/HLA; 11609
WW http://bioinformatics.hsanmartino.it/ecbr/cl246.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ZM-FC
AC CVCL_E897
DR dbMHC; 49089
DR ECACC; 94071440
DR IHW; IHW9349
DR IMGT/HLA; 11610
WW http://bioinformatics.hsanmartino.it/ecbr/cl349.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ZMAC-1
AC CVCL_X750
SY UIMAC FBAL-A; FBAL-A
DR ATCC; PTA-8764
RX Patent=US8202717;
WW http://www.pork.org/filelibrary/researchdocuments/05-200-zuckerman-uofill.pdf
OX NCBI_TaxID=9823; ! Sus scrofa
CA Finite cell line
//
ID ZN-R
AC CVCL_0I67
SY ZN-R1
DR CCLV; CCLV-RIE 0122
RX PubMed=19941903;
OX NCBI_TaxID=9925; ! Capra hircus
CA Finite cell line
//
ID ZO
AC CVCL_M694
RX PubMed=2557656;
DI NCIt; C9357; Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Zos
AC CVCL_R779
RX PubMed=18298897;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_R780 ! Zos-M
SX Male
CA Cancer cell line
//
ID Zos-M
AC CVCL_R780
RX PubMed=18298897;
CC Derived from metastatic site: Bone skip lesion.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_R779 ! Zos
SX Male
CA Cancer cell line
//
ID ZP101
AC CVCL_HA98
RX PubMed=9016792;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP102
AC CVCL_HA99
RX PubMed=9016792;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP103
AC CVCL_HB00
RX PubMed=9016792;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP104
AC CVCL_HB01
RX PubMed=9184070;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP105
AC CVCL_HB02
RX PubMed=9184070;
RX PubMed=9418886;
RX PubMed=11330042;
RX PubMed=17045664;
RX PubMed=23009329;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Characteristics: Has a mutation in PEX5.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP106
AC CVCL_HB03
RX PubMed=9184070;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP107
AC CVCL_HB04
RX PubMed=9184070;
RX PubMed=11330042;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP108
AC CVCL_HB05
RX PubMed=9184070;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP109
AC CVCL_HB06
RX PubMed=9184070;
RX PubMed=11330042;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP110
AC CVCL_HB07
RX PubMed=9270878;
RX PubMed=11330042;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP111
AC CVCL_HB08
RX PubMed=9270878;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP112
AC CVCL_HB09
RX PubMed=9270878;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP113
AC CVCL_HB10
RX PubMed=9270878;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP114
AC CVCL_HB11
RX PubMed=9270878;
RX PubMed=11330042;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP115
AC CVCL_HB12
RX PubMed=9270878;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP116
AC CVCL_HB13
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP117
AC CVCL_HB14
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP118
AC CVCL_HB15
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP119
AC CVCL_HB16
RX PubMed=9727033;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP120
AC CVCL_HB17
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP121
AC CVCL_U980
SY ZP-121
DR BTO; BTO:0003993
RX PubMed=10222139;
RX PubMed=16529741;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP122
AC CVCL_HA95
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP123
AC CVCL_HA96
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP124
AC CVCL_U981
RX PubMed=10222139;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP125
AC CVCL_HB33
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP126
AC CVCL_U982
RX PubMed=10222139;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP127
AC CVCL_U983
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP128
AC CVCL_HB18
RX PubMed=10441330;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP137
AC CVCL_HA97
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP139
AC CVCL_HB19
RX PubMed=9418886;
RX PubMed=11330042;
RX PubMed=17045664;
RX PubMed=23009329;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Characteristics: Has a mutation in PEX5.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP150
AC CVCL_HB20
RX PubMed=10441330;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Characteristics: Has mutations in both alleles of PEX13.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP151
AC CVCL_HB21
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP158
AC CVCL_HB22
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP159
AC CVCL_HB23
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP160
AC CVCL_HB24
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP161
AC CVCL_HB25
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP162
AC CVCL_HB26
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP163
AC CVCL_HB27
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP164
AC CVCL_HB28
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP165
AC CVCL_HB29
RX PubMed=9727033;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP166
AC CVCL_HB30
RX PubMed=10222139;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP167
AC CVCL_HB31
RX PubMed=10222139;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB34 ! CHOTKa
SX Female
CA Transformed cell line
//
ID ZP92
AC CVCL_HB32
RX PubMed=1430210;
RX PubMed=9184070;
RX PubMed=11330042;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Transformed cell line
//
ID ZPEG101
AC CVCL_HB38
RX PubMed=23009329;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Characteristics: Has mutations in both alleles of PEX5.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB36 ! CHOTKaEG1
SX Female
CA Transformed cell line
//
ID ZPEG224
AC CVCL_HB40
RX PubMed=12054588;
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG227
AC CVCL_HB41
RX PubMed=12054588;
CC Characteristics: Has mutations in both alleles of PEX7.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG228
AC CVCL_HB42
RX PubMed=12054588;
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG229
AC CVCL_HB43
RX PubMed=12054588;
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG230
AC CVCL_HB44
RX PubMed=12054588;
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG231
AC CVCL_HB45
RX PubMed=12054588;
CC Characteristics: Does not express PEX7 mRNA.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG232
AC CVCL_HB46
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG233
AC CVCL_HB47
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG234
AC CVCL_HB48
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG235
AC CVCL_HB49
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG236
AC CVCL_HB50
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG237
AC CVCL_HB51
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG238
AC CVCL_HB52
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Characteristics: Has a mutation in both alleles of PEX3.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG239
AC CVCL_HB53
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Characteristics: Has a mutation in both alleles of PEX2.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG240
AC CVCL_HB54
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG241
AC CVCL_HB55
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG242
AC CVCL_HB56
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG243
AC CVCL_HB57
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG244
AC CVCL_HB58
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG245
AC CVCL_HB59
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG246
AC CVCL_HB60
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG247
AC CVCL_HB61
RX PubMed=18543353;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPEG252
AC CVCL_HB39
RX PubMed=16723118;
CC Characteristics: Has a mutation in both alleles of PEX1.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB37 ! CHOTKaEG2
SX Female
CA Transformed cell line
//
ID ZPG101
AC CVCL_HB64
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB62 ! CHOTKaG1
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG102
AC CVCL_HB65
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB62 ! CHOTKaG1
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG103
AC CVCL_HB66
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB62 ! CHOTKaG1
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG113
AC CVCL_HB67
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB62 ! CHOTKaG1
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG115
AC CVCL_HB68
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB62 ! CHOTKaG1
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG117
AC CVCL_HB69
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB62 ! CHOTKaG1
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG118
AC CVCL_HB70
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB62 ! CHOTKaG1
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG203
AC CVCL_HB71
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB63 ! CHOTKaG2
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG205
AC CVCL_HB72
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB63 ! CHOTKaG2
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG206
AC CVCL_HB73
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB63 ! CHOTKaG2
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG207
AC CVCL_HB74
RX PubMed=10222140;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB63 ! CHOTKaG2
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG208
AC CVCL_HB75
RX PubMed=10222140;
RX PubMed=17045664;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB63 ! CHOTKaG2
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG209
AC CVCL_HB76
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB63 ! CHOTKaG2
SX Female
CA Spontaneously immortalized cell line
//
ID ZPG210
AC CVCL_HB77
RX PubMed=10222140;
CC Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC Transfected with: RGD; 61814; Pex2.
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_HB63 ! CHOTKaG2
SX Female
CA Spontaneously immortalized cell line
//
ID ZQNK-29
AC CVCL_4U93
RX Patent=CN102876632A;
RX PubMed=26299072;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201278.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ZR-75-1
AC CVCL_0588
SY ZR751; ZR75-1; ZR75_1
DR BTO; BTO:0003136
DR CLO; CLO_0009727
DR EFO; EFO_0001262
DR MCCL; MCC:0000494
DR CLDB; cl4817
DR CLDB; cl4818
DR CLDB; cl4819
DR CLDB; cl4820
DR CLDB; cl4821
DR CLDB; cl4946
DR ATCC; CRL-1500
DR BCRC; 60055
DR BioSample; SAMN01821608
DR BioSample; SAMN03471337
DR CCLE; ZR751_BREAST
DR CCRID; 3111C0001CCC000090
DR CCRID; 3131C0001000700126
DR ChEMBL-Cells; CHEMBL3307615
DR ChEMBL-Targets; CHEMBL614393
DR CLS; 300163/p689_ZR-75-1
DR Cosmic; 687503
DR Cosmic; 755295
DR Cosmic; 871152
DR Cosmic; 877452
DR Cosmic; 894094
DR Cosmic; 904398
DR Cosmic; 934532
DR Cosmic; 944296
DR Cosmic; 979717
DR Cosmic; 991333
DR Cosmic; 997927
DR Cosmic; 1010919
DR Cosmic; 1044205
DR Cosmic; 1046930
DR Cosmic; 1047720
DR Cosmic; 1136344
DR Cosmic; 1152530
DR Cosmic; 1175836
DR Cosmic; 1287904
DR Cosmic; 1289421
DR Cosmic; 1309006
DR Cosmic; 1326279
DR Cosmic; 1571792
DR Cosmic; 1523772
DR Cosmic; 1524343
DR Cosmic; 1603229
DR Cosmic; 1609464
DR Cosmic; 2165028
DR Cosmic; 2301536
DR Cosmic; 2318372
DR Cosmic; 2361354
DR ECACC; 87012601
DR GEO; GSM73744
DR GEO; GSM115120
DR GEO; GSM155214
DR GEO; GSM217613
DR GEO; GSM344360
DR GEO; GSM344410
DR GEO; GSM350508
DR GEO; GSM378142
DR GEO; GSM388216
DR GEO; GSM481332
DR GEO; GSM783956
DR GEO; GSM845400
DR GEO; GSM847449
DR GEO; GSM847509
DR GEO; GSM844725
DR GEO; GSM887750
DR GEO; GSM888845
DR GEO; GSM1008921
DR GEO; GSM1215256
DR GEO; GSM1374993
DR GEO; GSM1374994
DR GEO; GSM1374995
DR GEO; GSM1401648
DR GEO; GSM1556182
DR GEO; GSM1556183
DR GEO; GSM1556184
DR GEO; GSM1556185
DR GEO; GSM1556186
DR GEO; GSM1664567
DR ICLC; HTL99006
DR IZSLER; BS TCL 75
DR KCB; KCB 2010136YJ
DR KCLB; 21500
DR LINCS; 50574
DR PRIDE; PXD001327
DR RCB; RCB1906
RX PubMed=688225;
RX PubMed=1911442;
RX PubMed=6582512;
RX PubMed=10862037;
RX PubMed=11044355;
RX PubMed=12353263;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=15767549;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=19727395;
RX PubMed=20070913;
RX PubMed=21378333;
RX PubMed=22460905;
RX PubMed=24162158;
RX PubMed=25238572;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/zr-75-1.htm
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=ZR-75-1
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: RCB; RCB1906; true.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; CLS; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9
ST D16S539: 11
ST D18S51: 13,14
ST D21S11: 31
ST D3S1358: 15,16
ST D5S818: 13
ST D7S820: 10,11 (ATCC; CLS; ECACC; PubMed=25877200)
ST D7S820: 10 (KCLB)
ST D8S1179: 11,13
ST FGA: 20,22
ST Penta D: 14
ST Penta E: 7,14
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ZR-75-27
AC CVCL_5612
RX PubMed=688225;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1661 ! ZR-75-30
SX Female
CA Cancer cell line
//
ID ZR-75-30
AC CVCL_1661
SY ZR7530; ZR75-30
DR BTO; BTO:0004915
DR CLO; CLO_0009728
DR EFO; EFO_0001263
DR CLDB; cl4822
DR CLDB; cl4823
DR CLDB; cl4824
DR ATCC; CRL-1504
DR BCRC; 60056
DR BioSample; SAMN03471856
DR CCLE; ZR7530_BREAST
DR CCRID; 3111C0001CCC000240
DR CCRID; 3131C0001000700060
DR CCRID; 3131C0001001200003
DR CCRID; 3142C0001000000053
DR ChEMBL-Cells; CHEMBL3308094
DR ChEMBL-Targets; CHEMBL1075613
DR Cosmic; 687504
DR Cosmic; 871160
DR Cosmic; 877444
DR Cosmic; 894095
DR Cosmic; 904399
DR Cosmic; 909907
DR Cosmic; 921977
DR Cosmic; 949194
DR Cosmic; 979716
DR Cosmic; 1046953
DR Cosmic; 1047719
DR Cosmic; 1136346
DR Cosmic; 1152523
DR Cosmic; 1287913
DR Cosmic; 1289422
DR Cosmic; 1571790
DR Cosmic; 1603230
DR Cosmic; 2165016
DR Cosmic-CLP; 909907
DR ECACC; 88113004
DR GDSC; 909907
DR GEO; GSM69200
DR GEO; GSM73747
DR GEO; GSM115121
DR GEO; GSM217611
DR GEO; GSM344379
DR GEO; GSM344429
DR GEO; GSM350533
DR GEO; GSM783957
DR GEO; GSM847450
DR GEO; GSM847510
DR GEO; GSM844727
DR GEO; GSM844726
DR GEO; GSM887751
DR GEO; GSM888846
DR GEO; GSM1401666
DR GEO; GSM1661991
DR GEO; GSM1670589
DR LINCS; 50575
RX PubMed=688225;
RX PubMed=11044355;
RX PubMed=11414198;
RX PubMed=17157791;
RX PubMed=19582160;
RX PubMed=20070913;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/ZR-75-30.html
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 60 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,11
ST D16S539: 9
ST D18S51: 17
ST D21S11: 31
ST D3S1358: 15,18
ST D5S818: 12,13
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 2.2,10
ST Penta E: 5,7
ST TH01: 8,9
ST TPOX: 10,11
ST vWA: 18,19
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5612 ! ZR-75-27
SX Female
CA Cancer cell line
//
ID ZR-75-9a1
AC CVCL_5613
RX PubMed=2713239;
CC Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID ZR-75-B
AC CVCL_5614
SY ZR75-B; ZR-75B; ZR-75b; ZR75B
DR EFO; EFO_0001264
DR Cosmic; 1136345
DR Cosmic; 1176641
DR GEO; GSM1215271
DR LINCS; 51096
RX PubMed=6178756;
RX PubMed=17157791;
RX PubMed=18516279;
RX PubMed=24162158;
CC Misspelling: Occasionally 'ZRB75'.
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID ZR-78
AC CVCL_8025
SY ZR78
DR BTO; BTO:0004916
RX PubMed=3460088;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID ZR-78.1
AC CVCL_8026
DR BTO; BTO:0004917
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_8025 ! ZR-78
SX Female
CA Spontaneously immortalized cell line
//
ID ZR-82
AC CVCL_8027
DR BTO; BTO:0004918
RX PubMed=3460088;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID ZR-87
AC CVCL_8028
RX PubMed=3460088;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID ZR75-1 25DOCR
AC CVCL_4Y42
RX PubMed=25312014;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID ZR75-1 25PACR
AC CVCL_4Y44
RX PubMed=25312014;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID ZR75-1 50DOCR
AC CVCL_4Y43
RX PubMed=25312014;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID ZR75-1 50PACR
AC CVCL_4Y45
RX PubMed=25312014;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID ZR75T
AC CVCL_IW49
RX PubMed=8430082;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0588 ! ZR-75-1
SX Female
CA Cancer cell line
//
ID ZS-1
AC CVCL_9R46
RX Patent=US9340815;
CC Group: Bird cell line.
CC Breed/subspecies: East Lansing Line 0.TVB*S1.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Spontaneously immortalized cell line
//
ID ZSM
AC CVCL_F481
DR CLO; CLO_0051136
DR RCB; HSC0001
RX PubMed=21383383;
CC Part of: Sonoda-Tajima cell collection.
CC Population: China.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ZSSJ
AC CVCL_6E22
RX PubMed=19116758;
CC Group: Fish cell line.
OX NCBI_TaxID=7955; ! Danio rerio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ZZ-R 127
AC CVCL_5418
SY ZZ-R
DR CCLV; CCLV-RIE 0127
RX PubMed=19656987;
RX PubMed=19941903;
OX NCBI_TaxID=9925; ! Capra hircus
CA Spontaneously immortalized cell line
//
ID __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
AC CVCL_3449
RX PubMed=9809040;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
- 公告/新闻
免费订购电话: 400-800-2947